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1 
Introduction 

1.1 Clinical and genetic aspects 
Clinical aspects 
Febrile seizures are described as a temporary seizure disorder of childhood; the attacks occur 
by definition in association with fever and are usually accompanied by sudden tonic-clonic 
muscle contractions and reduced consciousness, usually lasting not longer than 5 to 10 
minutes. According to the commonly accepted definition of the National Institutes of Health 
consensus meeting of febrile seizures in 1980, 'a febrile seizure (an abnormal, sudden, 
excessive electrical discharge of neurons [grey malter] which propagates down the neuronal 
processes [white matter] to affect an end organ in a clinically measurable fashion) is an event 
in infancy or childhood, usually occurring between three months and five years of age, 
associated with fever but without evidence of intracranial infection or defined cause. Seizures 
with fever in children who have suffered a previous nonfebrile seizure are excluded. Febrile 
seizures are to be distinguished from epilepsy, which is characterised by recurrent non febrile 
seizures'. 1 In the context of this thesis, fever has been defined as a rectally measured body 
temperature of 38.5 °C or higher. Complex febrile seizures have one or more of the foHowing 
characteristics: the seizure lasts for more than 15 minutes (prolonged) or 30 minutes or more 
(febrile status epilepticus); there are one or more recurrences within 24 hours (multiple type 
febrile seizures); the seizure has partial features, i.e. a focal onset of the seizure or a postictal 
Todd paresis of facial muscles or Iimbs.2-4 Seizures are referred to as simple, if they last less 
than 15 minutes, do not recur within 24 hours (single-type) and are generalised. 
Several studies have described the clinical presentation of febrile seizures.4. 11 Males are more 
frequently affected than females; ratios vary between 1.1 and 1.6. Half of the children have 
their initial seizure at 16-18 months of age. On average 65 to 80% of all children with febrile 
seizures suffer from a simple initial febrile seizure. If initial and recurrent seizures are 
considered, 60 to 67% of the children experience simple febrile seizures only. About half of 
the seizures are of two minutes' duration or less. Only 4 to 14% of the children have an initial 
febrile seizure lasting longer than 15 minutes. Of the children with febrile seizures 2 to 6% 
experience a partial initial seizure, although one large study reported a much higher number of 
18%.5 9 to 19% suffer from a multiple-type initial seizure; one hospital based study reported a 
higher frequency of 25%. II There is a strong correlation between focality and prolonged 
seizure duration for both first and recurrent seizures. In children with recurrent febrile 
seizures, complex characteristics tend to reiterate, especially if the duration is long.4 
Upper respiratory tract infections. gastro-enteritis and viral exanthem are most often the cause 
of fever in children with febrile seizures. In about 25% of the patients with an initial febrile 
seizure, no clinical diagnosis of the cause of the fever is found. 5,12 Conflicting evidence exists 
about the role of viral infections in febrile seizures. Several studies have found no association 
between viral infections and the occurrence of febrile seizures. One study described that the 
aetiology of infections (whether or not of viral origin) between children with a first febrile 
seizure and matched controls with fever caused by infections does not differ. 13 Accordingly, 
another study found no evidence for viral infections as the most important cause of fever in 
initial and recurrent febrile seizures. 12 In this study. however, viral isolations from 
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cerebrospinal fluid (CSF) were positive, which is contradictory to the definition of febrile 
seizures excluding children with infections of the central nervous system,I,14 More evidence 
has been presented about the role of Human Herpesvims-6 (HHV -6) infections in febrile 
seizures. These infections have shown to be frequently associated with initial febrile 
seizures, IS In a large study of young febrile children the general frequency of primo infections 
with HHV-6 was determined at 10%.16 This study described that of all febrile seizures 
occurring during the febrile course, 31% was associated with a primary HHV-6 infection. All 
seizures were initial febrile seizures. In a few CSF samples, also from children with febrile 
seizures, HHV-6 was detected by Polymerase Chain Reaction (peR), which may also be 
considered contradictory to the definition of febrile seizures. Recent primary HHV-6 infection 
was shown in sera of febrile children; in those with a recent primary HHV-6 infection, 30% 
experienced a febrile seizure. 17 Suggestions have been Illade for HHV-6 to invade the brain 
during the acute phase of exanthem subitulll. Recurrence of febrile seizures may be associated 
with vims reactivation. IS In children with roseola infantum, however, no increase in seizure 
recurrence frequency was shown; no laboratory tests were performed to confirm the clinical 
diagnosis.6 A recent study, in which the follow-up of children with a first febrile seizure with 
positive and with negative HHV-6 cultures was compared, confirmed these findings. 19 
Although beyond the scope of this thesis, the role of HHV -6 clearly needs to be fUither looked 
into to understand the pathogenesis of febrile seizures. 
A febrile seizure can only be diagnosed after exclusion of an underlying disease which may 
cause the seizure. Febrile seizures are to be differentiated from acute symptomatic 
convulsions, whether or not accompanied by fever, which are caused by intracranial infections 
(meningitis or encephalitis), trauma capitis, biochemical abnormalities (hyponatremia, 
hypoglycaemia or hypocalcemia) and intoxication. The major differential diagnosis in 
children presenting with a seizure associated with fever is bacterial meningitis. The reported 
overall prevalence of meningitis among children with seizures associated with fever varies 
between 1.2 and 7%.20-23 According to the Nllf Consensus (1980) and British and American 
recommendations published more recently a lumbar puncture is only indicated if there is a 
clinical suspicion of an infection of the central nervous system. 1.24.25 Tn most cases meningitis 
can be mled out on the basis of the clinical information, in which, in addition to the presence 
or absence of nuchal rigidity and petechiae, complex seizure characteristics play a 
differentiating role. 23 Lumbar puncture is recommended to be performed in young children 
because of eventually absent or just subtle clinical meningeal signs and symptoms « I year). 
Previolls treatment with antibiotics or diazepam may mask signs and symptoms of meningitis. 
Blood tests, i.e. glucose, calcium and sodium levels, aim to exclude an underlying metabolic 
disorder, which may have contributed to the seizure but which is not apparent in the patient 
history and physical examination. In the NIH consensus it has been stated that blood tests are 
rarely useful in the uncomplicated (simple) febrile seizure. I This has been confirmed by more 
recent guidelines, which state that blood laboratory evaluation is usually not required. 24,25 The 
guidelines have been based on previous studies in which it has been shown that young age 
(younger than 12 to 18 months of age), metabolic or gastrointestinal disease and complex 
seizure characteristics are imp0l1ant differentiating factors. 26-3o The evaluation of 
combinations of specific history Hnd physical examination characteristics, that might identify 
the individual child at risk for biochemical blood abnormalities or, inversely, identify those 
children for whom laboratory tcsts at presentation are unnecessary has not been addressed in 
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these studies. A prediction model for the exclusion of biochemical abnormalities as the 
underlying cause of the seizure may give a hand to decide whether or not metabolic blood 
tests are indicated in the individual patient with a febrile seizure: study aim I, chapter 1.2. 
In children presenting with febrile seizures measurement of erythrocyte sedimentation rate, C-
reactive protein level, peripheral leukocyte count and leukocyte differentiation are often 
performed to evaluate the source of the fever. 24 In clinical pediatric practice it is suggested 
that leukocytosis might be explained by the seizure duration itself rather than by the cause of 
the infection. The hypothesis is that increased leukocytes counts in febrile seizures are due to 
stress-induced redistribution of leukocytes. This concept of seizures changing the peripheral 
leukocyte count is based on extrapolation of previous findings in animal studies and in studies 
of human adults. 31-35 On the other hand, these findings have not been confirmed by other 
investigators who studied primates and human adults: changes in leukocyte counts after 
prolonged seizures were neither demonstrated in the cerebrospinal fluid nor in the blood.36,37 
We have not found any study providing evidence that febrile seizure duration is associated 
with an increased leukocyte count. It seems that the diagnostic value of peripheral 
leukocytosis in children with a long lasting febrile seizures is unclear: study aim 2, chapter 
1.2, 
Impact of febrile seizures on parents 
Most parents who witness their child's febrile seizure are extremely frightened and may even 
think that their child is dying,38'40 Although febrile seizures generally are harmless to the child 
41-43 they have substantial impact on its family life. Consequences for parents were assessed in 
a previous study on psychological sequelae of having a child affected by febrile seizures: 
parental sleeping problems were a predominantly existing problem, worsening with the 
frequency of the child's seizure recurrences.39 Despite the fact that these studies have shown 
the problem of parental fear it is not known whether the current provision of infonnl.ltion to 
parents about fever and febrile seizures has a positive effect on the parents' attitude: study aim 
3, chapter 1.2, 
Prognosis 
The prognosis of febrile seizures relates to three issues: the risk of brain damage, the risk of 
developing epilepsy later on and the risk of a febrile seizure recurrence. 
There has been a historic debate about the connection between febrile status epileptic us and 
mesial temporal sc}erosis. 41 ,44.46 Based on calculations on the data of a large epilepsy cohort, 
febrile status epilepticus followed by mesial temporal sclerosis does not occur in more than I 
in 150,000 children,41,42,47 and the associations found do not prove a causal relation.45 The 
evidence provided suggests that, if seizures cause damage, this seldom happens and that this 
depends on the underlying cause of the seizure which precludes febrile seizures. Hospital-
based and retrospective studies show a biased higher frequency of damage after febrile 
seizures compared to population-based studies which have collected their data prospectively. 
Prospective long-term follow up studies show that febrile seizures are not associated with 
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psychomotor developmental delay.48-50 If all studies are taken into account no clear 
association is found between febrile status epilcpticus and a higher risk of brain injury or 
impaired intellectual per[ormance,41,48,51,52 Neither are frequent recurrences of febrile seizures 
hmmful.42 ,43 
Epilepsy is defined by recurrent unprovoked (afebrile) seizures, at least two or more. 53 The 
risk of developing afebrile seizures or epilepsy in children who suffered from febrile seizures 
is only slightly higher compared to children not affected by febrile seizures. Children not 
affected by febrile seizures have a risk of developing epilepsy of 0.4 to 0.5%.54,55 
Retrospective studies of children with epilepsy showed that 15% of all children with epilepsy 
have a previous history of febrile seizures, which is substantially higher than the general 
prevalence of febrile seizures of 4%.47.55-57 Prospective follow-up studies of children with 
febrile seizures demonstrated that children with simple febrile seizures have only a slightly 
increased risk of developing recurrent afebrile seizures (epilepsy): between I and 1.5%.54.55 If 
febrile seizures are associated with complex seizure characteristics the risk of developing 
afebrile seizures or epilepsy later on increases. Febrile seizures cohort studies report 
probabilities of epilepsy of 6 to 10%.7,55.58 If focal characteristics are present this risk 
increases to 8% or higher.7,58 If two or three complex characteristics are present the risk may 
rise up to 30 to 40%.'·55.59 If one or both parents are affected by an epileptic disorder the child 
has an increased risk of 4% of developing afebrile seizures or epilepsy later 011.7,60 If the child 
has a family history of epilepsy and has suffered focal febrile seizures the estimated risk is 
13%.7 The number of febrile seizure recurrences do not affect the risk of epilepsy later on 
which implies that interventions to prevent recurrent seizures early in the courl'e of febrile 
seizures do not alter the natural course with respect to the risk of developing epilepsy.41,42 
Until recently children with febrile seizures underwent electroencephalographic tests (BEG), 
either to diagnol'e epileptic activity or to assess the risk of febrile seizure recurrence. No 
evidence exists, however, that an abnormal EEG after the first febrile seizure is predictive for 
either the risk of febrile seizure reCtllTenCe or the development of epilepsy.24,57,61.62 The EEG 
may be used as a diagnostic aid only in a few patients suspected of an epileptic disorder or of 
symptomatic convulsive abnormalities. The family history, the duration and the localisation of 
the seizure have more prognostic value than the EEG. 25,27 Therefore, the EEG has been 
abandoned as a prognostic indicator in children with febrile seizures. 1,25 
The risk of febrile seizure recurrences has been studied rather thoroughly.6-12,63,M The overall 
probability of a seizure recurrence is 30% within a 2 years' follow-up with a rapidly 
decreasing risk after the first six months following the previous seizure. Several risk factors 
have been determined, of which the major and most consistent are: young age at onset, family 
history of febrile seizures, previous recurrent febrile seizures, time lapse since previous 
seizure less than six months, a low body temperature at the first febrile seizure and a multiple-
type first febrile seizure. In a meta-analysis of a large data set comprising the pooled data of 
2496 individual participants of five febrile seizure cohort studies, including the study that was 
performed in the Sophia Children's Hospital,1O risk factors for I'eizure recurrence were 
investigatcd.64 The results of thil' study had an important impact on the design of the studies 
regarding febrile seizure recurrence, as reported in this thesis. 
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Additional to these risk factors evidence has been put forward that frequent febrile episodes 
are associated with an increased recurrence risk.65.66 These studies, however, contain some 
methodological flaws. One study evaluates retrospectively data on the frequency of fever 
episodes and seizure recurrences obtained by using a mailed questionnaire. This method may 
lead to recall bias and overestimation of the effect of fever episodes on seizure recurrence risk. 
Furthermore, no quantitative results, i.e. odds ratio or relative risk, were reported. 65 In the 
other study, in which the data were collected prospectively during one year, the frequency of 
fever episodes was divided into two categories: less than four versus four or more fever 
episodes per year.66 The highest risk of a febrile seizure recurrence, however, is within six 
months after the last previous seizure and the mean number of fever episodes per year in 
children with febrile seizures may be lower than four.65,66,?8.RO Therefore, assessment of 
seizure recurrence risk in a six months' follow-up may give a more concise view on the 
association between the number of fever episodes and febrile seizure recurrence: study aim 5, 
chapter 1.2. 
Furthermore, it is important to be able to predict a recurrent febrile seizure especially at the 
time the child is again feverish. The body temperature at the onset of the fever and during the 
fever episode plays an important role in the development of a febrile seizure.9,67,6l:i Age is an 
additional factor influencing the vulnerability of a child to develop a febrile seizure.64•69 The 
possibility to predict a febrile seizure recurrence in subsequent fever episodes using 
temperature and age as the main predictors has not been studied before: study aim 6, chapter 
1.2. 
Preventive treatment of reCUl'l'ent febrile seizures 
In recent years the prevention of recurrent febrile seizures has become a debatable issue: 
prevention may not be strictly necessary, because febrile seizures are benign and have a very 
good prognosis, even for children with long-lasting seizures or frequent recurrences.41 -43 
Prevention of febrile seizure recurrences, however, serves two useful purposes: meeting 
parental fear of recurrent febrile seizures and reducing the, very small, risk of a long lasting 
and eventually injurious recurrent seizure. One could consider either continuous or 
intermittent treatment to prevent febrile seizure recurrences. Continuous treatment is to be 
given every day during at least six months, while intermittent treatment means that medication 
is used only during fever. 
Children with recurrent febrile seizures used to be treated continuously with antiepileptic 
drugs, i.e. phenobarbitone or valproate, to prevent seizure recurrences. I ,70 Continuous 
anti epileptic treatment of children with febrile seizures is generally considered obsolete 
nowadays, because of the severity of negative side effects (phenobarbitone and valproate) and 
the questionable efficacy (phenobarbitone).71.77 
In one large clinical trial intermittent treatment with diazepam in a dose of 1 mg per kg 
body weight per 24 hours administered in 3 eight-hourly doses during fever has been proved 
efficacious in children with an increased seizure recurrence risk. 78 Accordingly, a smaller trial 
showed the preventive effectiveness of a lower dose, although one might comment on the 
possibility of bias due to the random allocation procedure using even and odd days.79 Other 
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treatment options were studied because of the side effects of diazepam and because of the less 
positive results in two smaller studies using a lower dose. We note here that any eventual 
efficacy of intermittent treatment of recurrent seizures is at least partly reduced due to the 
inherent problem of the recurrent seizure being the presenting symptom of fever. 78,80·82 
Several clinical studies support the assumption that there is a temperature level above which 
seizures will deveiop,9,M,68,69 From this we may expect that reduction of the body temperature 
is effective in the prevention of recurrences. Thus a rational alternative op~ion to prevent 
febrile seizure recurrences is intermittent treatment of the child with antipyretic drugs during 
fever. Until now no proper evaluation of the efficacy of antipyretic treatment in comparison 
with placebo to prevent febrile seizure recurrences has been carried out. Three studies 
investigated the preventive efficacy of antipyretics. None were antipyretic-placebo controlled 
° I ° I d dO d ° ° h d I 80 8384 I d I ° tna s WIt 1 a stan ar Ise antIpyretic treatment sc e u e. " n one stu y on y seIzure 
recurrence within the same fever episode was studied,84 Despite their methodological flaws 
all three studies drew the conclusion that antipyretics were not effective in preventing 
reclIrrent febrile seizures, 
Ibuprofen and acetaminophen are generally lIsed in febrile children, In several studies their 
antipyretic efficacy and the low risk of side effects have been proved.85-92 Some of the studies 
assessing the antipyretic efficacy and the risk of side effects of ibuprofen and acetaminophen 
in children have excluded children with febrile seizures,85,86,8s,89 In four studies only in-
hospital patients were studied.86,87,9o,91 Thus, before investigating the efficacy of antipyretics 
in the prevention of febrile seizure recurrence, it is necessary to assess the fever-reducing 
effect in children with febrile seizures, If antipyretics fail to reduce fever in children with 
febrile seizures it is unlikely that prevention of febrile seizure recurrences can be reached. 
Therefore, the antipyretic efficacy of ibuprofen 5 mg per kg bodyweight per dose versus 
acetaminophen 10 mg per kg per dose both to be administered six-hourly during fever was 
studied in a randomised clinical trial in outpatient children, who visited the Sophia Children's 
Hospital with febrile seizures in 1991 until 1993.93 Ibuprofen appeared to be a stronger 
antipyretic dmg especially in the first hours after starting the treatment. In the ibuprofen group 
0.5 °C more reduction of the temperature at 4 hours after fever onset was shown. These results 
are consonant with those of four other studies,85.87,88,9o The other studies showed no difference 
in antipyretic efficacy between ibuprofen and acetaminophen,86,91,92 These results, together 
with the inconclusive results and methodological flaws of earlier trials i.\ssessing the 
preventive efficacy of intermittent antipyretic treatment, are the rationale (0 perform a 
randomised placebo controlled trial of ibuprofen symp during fever to prevent febrile seizure 
recurrence: study aim 4, chapter 1.2. 
Genetics 
The precise eliciting mechanism of febrile seizures is still unknown, We still do not know, 
why one child develops a febrile seizure during fever, while another seemingly similar child, 
does not. In general; it is assumed that in young children the vulnerability to develop a seizure 
is related to the maturation phase of the child's nervous system and the severity of any acute 
cerebral dysfunction, Furthermore, children may have an inherited (genetically determined) 
susceptibility to convulsions, Environmental factors may contribute to susceptibility, It is 
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unclear how these factors interact.'J4 Genetic studies of febrile seizures may result in the 
discovery of predisposing genes. This may lead to an improved understanding of the 
pathophysiologic mechanisms in febrile seizures and eventually in other seizure disorders. 
Febrile seizures are known to aggregate in families. Of all children with febrile seizures, 18 to 
40% have affected relatives. 1I ,60,64,65,69 Twin studies of febrile seizures further supported a 
genetic contribution, although not all studies confirmed that the concordance rates of 
monozygotic twins were significantly higher compared to those in dizygotic twins.95.97 A 
polygenic aetiology in some families is suggested, an autosomal dominant inheritance pattern 
has been observed in others,97,98 One study found different inheritance patterns, depending 
upon whether or not the patients had suffered recurrent febrile seizures or only one.')9 
Several clinical studies support the role of genetic factors in febrile seizures, It is known that 
an affected first degree relative (parents/siblings) increases the risk of febrile seizure 
recurrence.8,IO,Il,64 A strong association was defined between the proportion of first degree 
relatives affected by febrile seizures and the two-years recurrence risk of febrile seizures. II 
The proportion was defined as the number of first degree relatives affected divided by the total 
number of first degree relatives. If there were no affected first degree relatives, the two-years 
recurrence risk was 27%; if one or more were affected, up to a proportion of 0.5, this risk was 
increased to 40%; if the affected proportion was higher than 0.5, e.g. the father and two 
siblings were affected while the mother was not, the risk to suffer a recurrent seizure within 
two years was 83%. In addition, this study showed that second and third degree relatives were 
uninformative. Other investigators have demonstrated that in children with febrile seizures 
either a first degree family history of febrile seizures or epilepsy or both were predictors of 
febrile seizure recurrence.6,I2,6-1 
Two studies have investigated the risk of seizure disorders among relatives of probands with 
febrile seizures.60,IOO Both studies have assessed the risk of siblings to develop febrile 
seizures, Further, they have investigated whether characteristics of the probands' febrile 
seizures and whether a history of febrile seizures in the parents are associated with the risk of 
the probands' siblings to develop febrile seizures, Both studies defined that this risk increases 
to 7-10% compared to the risk of 4% in the general population, Sibling risk increases further 
if the proband has recurrent febrile seizures, if the proband has febrile seizures with complex 
characteristics and if one or both parents has had febrile seizures.60,IOO Instead of addressing 
complex seizure characteristics one of these two studies defined young age at onset in the 
proband associated with increased sibling risk. 100 
These studies support the existence of a genetic predisposition in familial febrile seizures. 
Based on the results of the clinical studies, there is no doubt that frequent febrile seizure 
recurrences are genetically determined in familial febrile seizures. Further, complex febrile 
seizures may also include a familial predisposition. IOI The dissection of the heterogeneous 
group of children with febrile seizures into subgroups of patients with more homogeneous 
phenotypes is important. The definition of specific subgroups that are likely to be genetically 
determined may contribute to the localisation of genes involved in febrile seizures: study aim 
7, chapter 1.2. 
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Studies investigating a specific type of generalised childhood epilepsy called Benign Familial 
Neonatal Convulsions (BFNC) described that febrile seizures aggregate in BFNC families, 
which is considered suggestive for a hereditary common origin of both diseases. 102,103 In 1989 
BFNC has been linked to genetic markers on chromosome 20q, later in 1993 also on 
chromosome Sq.102-106 Morc recent linkage studies of febrile seizures, however, were unable 
to verify that BFNC-genes predispose for febrile seizures,IOJ,107 Another linkage study, 
however, provided suggestions of a gene on chromosome 8q13-21 involved in febrile 
seizures,108 A breakthrough in the research concerning the genetic basis of epilepsy has been 
the identification of mutations in two novel potassium channel genes (KCNQ2 on 
chromosome 20q and KCNQ3 on chromosome 8q), which co-segregate with the BFNC-
phenotype in a large BFNC family,I09,IIO The pathophysiologic basis of the idiopathic 
generalised epilepsy's may include disturbances in the electrolyte balance between the intra-
and extracellular space. These disturbances may be caused by a reduction in function of 
potassium channels, which may influence the excitability of the nervous system. 111,112 
The chance to find genes predisposing for febrile seizures is increased by searching gene 
localisations that have been demonstrated to be involved in clinically associated diseases or 
syndromes: the 'candidate regions'. Candidate regions for febrile seizures are localised genes 
predisposing for epileptic disorders. Because of the previously reported association between 
febrile seizures and BFNC and in view of the recent findings, candidate regions of major 
importance for febrile seizures comprise genes on chromosome 20q and Sq. Therefore, we 
focused on these chromosomes to study gene localisations involved in febrile seizures: study 
aim 8, chapter 1.2.102.106 
Aspects of informed consent 
The informed consent procedure plays a central role in clinical studies. \Vithout consent of the 
patient or his parents no participation of the patient and thus no study results will come about. 
The role of informed consent, however, has been explored only on a limited scale in pediatric 
studies.11J-115 Pediatric studies assessing socia-economic status of the parents who permitted 
their child to participate in clinical research showed conflicting results: they found a similar, 
higher and lower education and occupation leveI.89,113,114 Further, the informed consent 
information provided is often too difficult and the participants are in a varying degree aware 
of the details of the study. These results have been shown by questioning adult participants 
and their families only; comparable data of pediatric studies are lacking. The main motivation 
to participate in clinical research is to contribute to clinical sciencc.1I6-119 In pediatric studies 
it has been shown that a substantial number of parents is willing to participate, even without 
being adequately informed about the benefits and risks, and despite the fact that it will cost 
parents' time and efforL 113,114 With respect to this specific group of parents the role of 
informed consent is rather limited; they will participate anyway. One study questioned parents 
about whether or not they would participate with their (new-born) child in the hypothetical 
situation that such was asked, 114 The results described that 21 % of the parents was prcparcd to 
participate for the benefit of other children, contribution to clinical science and confidence in 
physicians. Of the parents questioned, however, 74% would refuse because of the risk of 
negative side effects and because of the fact that the study medication had not been proved 
efficaciolls. It is necessary that more of these data about pediatric studies become available. 
18 
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We may then be able to improve the quality of the procedures, which will be beneficiary to the 
participating patients, their parents and the study itself: study aim 9, chapter 1.2. 
1.2 Aims of the study 
The overall aim of this thesis is to contribute to our knowledge of febrile seizures and thus to 
the improvement of the quality of health care involving children with febrile seizures. The 
specific aims of this thesis are to define the diagnostic work-up at presentation of children 
with seizures associated with fever, to get insight in the impact of febrile seizures on daily Hfe, 
to improve the prediction of febrile seizure recurrences, to assess the efficacy of intermittent 
treatment of antipyretics to prevent febrile seizure recurrences, to study the genetic basis of 
febrile seizures and to evaluate the informed consent procedure in a randomised clinical trial. 
In this paragraph these aims are further specified. 
I. The evaluation of combinations of specific history and physical examination characteristics 
of children with febrile seizures, that might identify individual children for whom laboratory 
tests at presentation are unnecessary, has not been performed in previous studies. Such a 
prediction model for the exclusion of biochemical underlying causes of the seizures may help 
in the decision whether or not metabolic blood tests are indicated in the individual patient. We 
compiled prediction models for normal blood levels of calcium, sodium and glucose in 
individual children with seizures associated with fever, based on the specific combination of 
their clinical characteristics. The results are given in chapter 2.1. 
2. The diagnostic value of peripheral leukocyte count in children presenting with febrile 
seizures is not clear, because in clinical pediatric practice it is often suggested that increased 
leukocyte counts might be explained by the seizure duration itself. Therefore, the association 
between peripheral leukocytosis and febrile seizure duration was assessed (chapter 2.2). 
3. Earlier studies have shown the extent of parental fear as a result of febrile seizures affecting 
their child. It is not known, however, whether the current provision of information to parents 
regarding fever and febrile seizure positively changes the parents' attitude. Chapter 3 gives 
an current overview of parents' perceptions and beliefs about fever and febrile seizures. 
4. Neither continuous treatment with anti-epileptic dmgs nor intermittent treatment with 
diazepam during fever has been proved to be useful for the patient with respect to prevention 
of febrile seizure recurrences. Intermittent antipyretic treatment is a rational treatment option, 
but it has never been evaluated properly in a randomised placebo controlled trial. Therefore, 
we measured the efficacy of ibuprofen to prevent febrile seizure recurrence in a randomised 
double blind placebo controlled trial, as reported in chap tel' 4. 
5. Previous studies assessing the association between the frequency of fever episodes and 
febrile seizure recurrence contain methodological flaws. We assessed the risk of febrile 
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seizure recurrence as a function of the number of fever episodes in the first six months after a 
febrile seizure (chapter 5.1). 
6. It is of etiologic and practical value to predict a recurrent febrile seizure specifically at the 
time when children, who have suffered a previous febrile seizure, have got a febrile illness 
again. Prediction models using actual body temperature and actual age of the child have not 
been constmcted before. We constmcted a model using age and temperature at fever onset as 
predictors of febrile seizure recurrence in the corresponding fever episode. The results arc 
presented in chapter 5.2. 
7. Genetic studies of febrile seizures aim to increase etiologic knowledge. An important step 
in localising genes involved in febrile seizures may be the dissection of the heterogeneous 
group of children with febrile seizures into subgroups of more homogeneous patients with 
specific phenotypes. We studied whether children with familial febrile seizures have more 
complex seizure characteristics than children without familial febrile seizures (chapter 6.1). 
8. Identification of genetic localisation(s) of febrile seizures gains efficiency if 'candidate 
regions' are studied first, before a complete genomic search is carried out. Because of the 
suggested relations between febrile seizures and BFNC, major candidates to be studied are 
chromosome 8q and 20q, which have been associated with BFNC. There are suggestions of a 
major gene for familial febrile seizures mapping to chromosome 8q. We studied chromosome 
8q and 20q to localise genes involved in febrile seizures, using the affected sib pair method. 
The study results are reported in chapter 6.2. 
9. Details of informed consent procedures in pediatric studies have been studied only on a 
limited scale. We do not know why parents permit or refuse participation of their child in 
clinical research and how well they evaluate specific study details, such as random allocation, 
negative side effects of the treatment, the burden to their child, and practical issues as 
investigating time and effort. These data are necessary to improve the quality of the informed 
consent procedure in pediatric studies in general. We investigated parents' awareness of the 
study details, their evaluation of the informed consent procedure and their reasons for 
consenting to their child's participation in a randomised double blind placebo controlled trial 
of ibuprofen to prevent febrile seizure recurrence (chapter 7). 
1.3 Study populations 
Context of the febrile seizures study 
Febrile seizures have been registered prospectively in the Pediatric Department of the Sophia 
Children's Hospital Rotterdam since 1988.120,121 In 1994 collaboration started with the 
Pediatric Department of the Juliana Children's Hospital Den Haag and since then registration 
has taken place in both hospitals. In the Sophia Children's Hospital, a secondaJ)' and tertiary 
referral hospital, the outpatient clinic department includes mainly (93%) basic specialist 
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care.
ln The Juliana Children's Hospital is a secondary referral hospital. To both hospitals 
patients with febrile seizures are referred either by a general practitioner or they come in by 
themselves. The follow-up of children with febrile seizures has been centred around an 
outpatients' clinic set up for children with febrile seizures and their parents. Since the start of 
the registration three physician-investigators (MD) involved in the febrile seizures research 
project have consecutively mn the outpatient clinic hours supervised by two pediatricians 
(MD, PhD). All patients in the prospective follow up registration visited this outpatient clinic 
at least once, usually two to four weeks after the febrile seizure had occurred. In the follow-up 
the child was examined and oral and written information about fever and febrile seizures were 
provided. Furthermore, baseline characteristics with respect to the febrile seizures of the child, 
including the family history of febrile seizures and epilepsy were collected. Extra time was 
available to discuss participation in the running studies and to ask informed consent, if the 
child met the study requirements. 
Study popUlations of the present studies 
The two diagnostic studies described in chaptel' 2 comprised children with 11 seizure 
associated with fever who were seen at the emergency ward of the Sophia Children's Hospital 
between 1990 and 1992. All children were prospectively encoded according to the Problem 
Oriented Patient Classification System that was introduced in the Sophia Children's Hospital 
in 1988. 122 
Children who visited the Sophia Children's Hospital Rotterdam and the Juliana Children's 
Hospital Den Haag between 1994 and 1996 were the source population of the randomiscd 
double blind placebo controlled trial of ibuprofen symp to prevent febrile seizure recurrences. 
All children had visited the febrile seizure outpatient clinic hours (chapter 4). 
The children who had participated in the randomised controlled trial and had been allocated to 
the placebo group were included in a febrile seizure recurrence prediction study. To the study 
assessing the frequency of fever episodes as a risk factor for febrile seizure recurrence in the 
first six months after a febrile seizure, we added the 'cohort study' popUlation. This 
population was recruited from all children with a febrile seizure who visited the Sophia 
Children's Hospital Rotterdam and the Juliana Children's Hospital Den Haag in 1996 and 
1997. All children had visited the febrile seizure outpatient clinic hours. Participating children 
were prospectively followed during six months after the last previous seizure (chapter 5.1). 
The data of all children who had participated in the randomised controlled trial were also used 
for a study of the prediction of febrile seizure recurrence in subsequent fever episodes after the 
last febrile seizure, using temperature and age as predictors. For this study we included both 
the children who had been allocated to placebo and those who had been allocated to ibuprofen 
(chapter 5,2). 
All parents of the children who had participated in the randomised controlled trial of 
ibuprofen to prevent febrile seizure recurrence were included in a questionnaire study after the 
trial had been finished. These parents formed the population of the study of parental fear 
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regarding fever and febrile seizures (chapter 3) and aspects of informed consent in pediatric 
randomised controlled trials (chapter 7). 
Children were selected from the febrile seizure registration in the two participating hospitals 
between 1994 and 1996 for the study of the characteristics of familial febrile seizures. The 
case group consisted of children with a first degree family history of febrile seizures (an 
affected sibling or parent); the control group included the remaining children who had no first 
degree relatives affected by febrile seizures (chapter 6.1). 
For the affected sib~pair analysis of febrile seizures children were selected from the febrile 
seizure registration since the start in the Sophia Children's Hospital Rotterdam in 1988 until 
December 1997,10,11,93 In 1994 the registration started in the Juliana Children's Hospital Den 
Haag, where eligible patients were recruited until December 1997. Additionally, we selected 
children with a febrile seizure who visited the Juliana Children's Hospital Den Haag between 
1992 and 1994, which was two years before the registration was started there. Children with 
febrile seizures were only included, if they had one or more brothers or sisters who were also 
affected by febrile seizures. Because more pm1icipating families were required we started 
collaboration with pediatric departments of regional hospitals and regional general 
practitioners in January 1997. The pediatricians and general practitioners involved were asked 
to discuss the study with those parents who had two (or more) children with febrile seizures. 
In June 1997 we introduced the study in the monthly popular family magazine 'Guders van 
Nu'. The responding families which fulfilled the criteria were included. All children whose 
the parents had given informed consent to study participation, before November 1997, were 
included in this study (chapter 6.2). 
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2.1 Seizures associated with fever: clinical data as predictors for normal 
biochemical blood levels 
Margriet mil Stllijvellberg, Egbertiell N \'all Cijssel, ElI'Ollt W Stcycrberg, Karel GM Mool/s, Gemrda 
DerksclI-LubsclI (Jlld Henrie'tle A Moll 
Sunmlary 
We developed a predictive model to assess the probability of normal biochemical blood test 
results in children presenting with a seizure associated with fever. The models were based on 
various combinations of patient characteristics of the history and physical examination of 203 
children. The characteristics included gender, age in years, previous history of febrile seizures, 
family history of febrile seizures, fever previous to the seizure, vomiting and diarrhoea 
previous to the seizure. Further, clinical characteristics of the seizure were considered: focal 
seizure signs. multiple seizure, seizure duration and rectal temperature at seizure, The 
outcome was defined as normal test results of serum levels of sodium (n=115, 68%), calcium 
(n=149, 89%) and glucose (n=173. 100%). according to the hospital reference values. The 
prevalence of abnormal test results was rather low and the abnormalities were outside the 
morbidity range. We used logistic regression to relate the outcome to the several clinical 
characteristics. The discriminative ability of the models was 0.63 (area under the receiver 
operating characteristic curve of the model predicting normal sodium), 0.66 (normal calcium) 
and 0.66 (both normal) The score chart we constructed is an additional tool to a carefully 
performed patient history and physical examination and it may help to decide if a biochemical 
test is indicated for the individual patient. 
In children with seizures associated with fever, abnormal biochemical blood test results are 
rare and outside the morbidity range. The biochemical tests are generally not required. In 
children with a low probability of a normal result as calculated by the score chart, the test may 
be indicated. 
Introduction 
In children presenting with a seizure associated with fever biochemical blood tests aim to 
exclude an underlying disorder which may have contributed to the seizure but is not apparent 
on taking a patient history and physical examination. 17 If prediction of normal test results 
would be possible, the number of unnecessary tests may be reduced; only patients with a low 
probability of normal test results will need to be tested. Previous studies have shown that 
performing all standard biochemical tests as a routine is useless.6,7,11,12,16,17,20 
An association between biochemical abnormalities and complex seizure characteristics has 
been found 10-12,15, implying that children with complex seizure characteristics should be 
tested.7 Other patient characteristics studied include age and history of metabolic or 
gastrointestinal disease. 3,1l,12 Recently, recoIllmendations for the diagnostic evaluation of 
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children with simple febrile seizures have been published. I These guidelines are based on the 
available evidence and conclude that blood laboratory evaluation of the seizure is usually not 
required. 
In accordance with these guidelines, we aimed to study various combinations of patient 
characteristics to identify children with a low or high risk of normal test results. We llsed 
multi variable statistical techniques.s The aim of this study was to develop a predictive model 
to assess the probability of normal blood levels of calcium, sodium and glucose in children 
with simple and complex seizures associated with fever, based on clinical data available from 
the history and physical examination of the patient. 
Patients and Methods 
Patie1lts 
Between January 1, 1990 and December 31,1992,249 children with a seizure associated with 
fever were seen at the emergency ward of the Sophia Children's Hospital in Rotterdam. In this 
hospital a Problem Orientated Patient Classification System has been introduced since 1988, 
in which prospective encoded registration of reason of referral is carried out routinely.s 
Children between 3 months and 6 years of age were eligible. If the seizure was accompanied 
by major signs of meningitis such as petechiae, nuchal rigidity or coma, they were encoded as 
such and therefore did not enter this study. We excluded 46 children because of presentation> 
24 hours after the seizure, a history of epilepsy or transfer from another hospital. The study 
population consisted of 203 children. 
Definitions 
A febrile seizure was defined in accordance with the National Institutes of Health of 1980. 13 
Focal seizures were defined as partial seizures, seizures starting in one limb before secondary 
generalisation, seizures accompanied by an asymmetrical position of the head or the eyes, 
seizures accompanied by a Todd paralysis, or a combination of these. Multiple seizures were 
defined as seizures recurring within 24 hours. Complex seizures were defined as either focal 
or multiple seizures or seizures with a duration> 15 minutes, or a combination of these. 
Methods 
Individual clinical data were assessed by review of the patient charts: gender, age (in years), 
previous history of febrile seizures, family history of febrile seizures, fever previous to the 
seizure, vomiting and diarrhoea previous to the seizure and the clinical characteristics of the 
seizure: generalised or focal seizures, single or multiple seizures, seizure duration (in minutes) 
and rectal temperature at seizure (in °C). The obtained clinical data were linked to the 
computer-documented biochemical blood test results in the hospital information system by the 
patient identification code. 
The outcome parameters of the blood test results were defined as follows. Normal sodium 
level was defined as ~ 1351111110111, normal calcium level was defined as ~ 2.20 mmolll and 
normal glucose level was defined as ~ 2.5 mmoll1, according to the hospital reference values. 4 
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Results of lumbar punctures, which were performed in 69 (34%) cases, were not analysed. 
However, there were no positive viral or bacterial cerebrospinal fluid cultures. 
Statistical analysis 
The associations between each clinical characteristic and each outcome were quantified using 
univariable logistic regression analysis. In a multi variable model the outcome was predicted 
by several clinical characteristics. The probability of normal test results was modelled to the 
clinical characteristics by comparing patients with normal test results to patients with 
abnormal test results. As the aim of this analysis is prediction, in principle all clinical 
characteristics were candidates for inclusion in the multi variable analysis. 18 Model reduction 
was achieved by considering the plausibility of the predictors, the plausibility of the direction 
of the association and by considering the p-value «0.50).8 Odds Ratios (OR) and their 95% 
confidence intervals were calculated as the association measures. SPSS for \Vindows (version 
6.0, Chicago, Illinois, USA, 1993) and EGRET (statistical package, SERC, Seattle, 
Washington, USA, 1990) were used for the analysis. The cases with non-performed tests were 
initially excluded from the analysis. In a secondary analysis, non-performed tests were coded 
as normaL 
Evalllatioll of lIIodel pe/forlllallce 
Discriminative ability was assessed using receiver operating characteristic (ROC) analysis. 
The area under the ROC curve can be interpreted as the probability that the prediction model 
will a<;sign a higher probability of normal test results to a randomly chosen patient with 
normal test results than to a randomly chosen patient with abnormal test results. The area 
ranges theoretically from 0.5 (no discrimination) to 1.0 (perfect discrimination); the higher, 
the better. 
The internal validity of model performance was assessed with bootstrapping techniques. 
Random bootstrap samples were drawn with replacement from the full sample consisting of 
all patients (lOa replications). The model was estimated on these bootstrap samples and 
evaluated on the full sample. Moreover, bootstrap estimates were used to derive a ~hrinkage 
factor for the final predictive model. This factor corrects the logistic regression model for 
overoptimism.8,9 
Results 
Study populatioll 
Table 2.l.1 shows the distribution of the patient characteristics across the study population. 
The median age at presentation was 1.5 years and 62% were boys. A positive previous history 
of a febrile seizure WfiS present in 17% and 11% had a positive first-degree family history of 
febrile seizures. Fever previous to the seizure was present in 78% and 33% had vomiting and 
diarrhoea previous to the seizure. Of the children 58% had one or more complex seizure 
characteristics; focal signs (15%), multiple seizures (32%) and seizure duration >15 minutes 
(28%). The median rectal temperature at seizure was 40.0 0c, 
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Table 2.1.1 Distribution of patient characteristics 
(n=203) 
General characteristics 
Male 
Female 
Age in years! 
FebrHe seizures 
In patient history 
present 
absent 
In family historl 
present 
absent 
Previous symptoms 
Fever 
present 
absent 
Vomiting/diarrhoea 
present 
absent 
Seizure characteristics 
Focal 
Generalised 
Multiple 
Single 
Duration in ntinutesC 
~ 15 
15-30 
~30 
Temperature in °Ca 
a Median (25-75 percentiles) 
b First degree 
C Used as continuous variable in the model 
Laboralory lesl resllits 
n(%) 
125 (62%) 
78 (38%) 
1.5 (1.2-2.2) 
34 (17%) 
169 (83%) 
22(11%) 
lSI (89%) 
159 (7S%) 
44 (22%) 
67 (33%) 
136 (67%) 
31 (15%) 
172 (S5%) 
64 (32%) 
139 (6S%) 
147 (72%) 
26 (13%) 
30(15%) 
40.0 (39.4-40.4) 
Of all 203 children, 169 underwenl a sodium test, resulting in 115 (68%) normal sodium 
levels and 54 (32%) cases ofhyponatriaemia (range: 126-134 mmoVI) (Table 2.1.2). Three of 
them had a sodium level between 126 and 129 mmolII. Of the 167 children who underwenl a 
calcium test, 
149 (89%) had a normal calcium level and 18 (11%) children had hypocalcaemia (range: 1.90-
2.18 mmol/I) (Table 2.1.3). Of 173 who underwent a glucose test, all levels were in the 
normal range. 
36 
Diagnostic aspects 
UJlivariable and mliltil'ariable analysis 
In the univariable analysis, single seizures was the only significant predictor (OR>I) of a 
normal sodium level at p<0.05 (Table 2.1.2). The other six characteristics indicated a normal 
sodium level (OR> 1), but the association was weak: female gender, older age, previous 
history of febrile seizures, absence of vomiting or diarrhoea previous to the seizure, 
generalised seizures and longer seizure duration. The reduced multivariable model included 
four characteristics as predictors: female gender, previous history of febrile seizures, 
generalised and single seizures. This multivariable combination constituted a statistically 
significant model (p~0.004). 
In the univariable analysis, absence of vomiting or diarrhoea previous to the seizure and 
shorter seizure duration were the significant predictors (OR>1) of a normal calcium level at 
p<0.05 (Table 2.1.3).The other three characteristics indicated a normal calcium level (OR>I), 
but the association was weak: female gender, younger age and first degree family history of 
febrile seizures. These five characteristics were retained in the multivariable model (p=O.Ol). 
Because all glucose test results were in the normal range, only the combination of both normal 
sodium and calcium levels was analysed. Both a sodium and a calcium test was done in 163 
children, 98 (60%) cases were in the normal range and 65 (40%) had hyponatriaemia or 
hypocalciaemia (Table 2.1.4). Two characteristics were univariably significantly associated 
with the outcome (p<O.05): absence of vomiting or diarrhoea previous to the seizure and 
single seizures. The other five characteristics were associated with both nonnal sodium and 
calcium levels (OR> I), but the association was weak: female gender, previous history of 
febrile seizures, absence of fever previous to the seizure, generalised seizures and shorter 
seizure duration. In the multivariable analysis, absence of fever prior to the seizure was 
excluded and six predictors were included in the model (Table 2.1.4). The muHivariable 
combination was statistically significant (p::::O.Ol). 
In an additional analysis, in which the non-performed tests were counted as normal test 
results, two predictors, which initially were included in the multi variable models, were 
excluded: female gender in the model predicting normal calcium levels and previous history 
of febrile seizures in the model predicting both normal sodium and calcium levels. All other 
predictors were retained in the models, with a similar OR and confidence interval as described 
previously. 
The area under the ROC curve of the model to predict normal sodium levels, normal calcium 
levels and both normal sodium and calcium levels was 0.66, 0.73 and 0.70, respectively, when 
evaluated on the same data set used to derive the model. These estimates are generally 
overoptimistic. Using bootstrapping for internal validation of the models, the areas were 
reduced to 0.63, 0.66 and 0.66, respectively. 
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Table 2.1.2 Patient characteristics and nomlal sodium levels 
General cbaracterislics 
MaIe 
Age in years 
Febrile seizures 
in patient history 
in famjly historY' 
Previous symptoms 
Pever 
Vomiting/diarrhoea 
Seizure characterlstics 
Focal 
Multiple 
Duration in minutc{ 
S; 15 
15-30 
~ 30 
Temperature in °C 
~,b.c.,j See Table 2,1.4 
nomml 
n=1 15 (68%) 
66 
1.7(1.2-2.3/ 
23 
11 
89 
36 
16 
29 
80 
14 
21 
40.0(39.4-40.5)' 
sodium Jevels 
abnomlal 
n=54 (32%) 
37 
1.4(1.1-2.0)' 
6 
5 
44 
22 
II 
27 
41 
6 
7 
40.0(39.7-40.4)' 
OR (CI95%) 
univariablc 
0.62(0.3 I -1.23) 
1.28(0.85-1.93) 
2.00(0.77-5.23) 
1.04(0.34-3.18) 
0.78(0.34-1.78) 
0.66(0.34-1.29) 
0.63(0.27-1.46) 
0.34(0.17-0.68)d 
1.23(0.78-1.93) 
0.90(0.62-1.31) 
Table 2.1.3 Patient chtlfac(cristics and nonna! calcium levels 
calcium levels 
nomJai abnonnal OR (CI95%) 
n=149 (89%) n=18 (11%) univariable 
General characteristics 
Male 90 12 0.76(0.75-2.15) 
Age in years 1.5(1.2-2.2)' 1.7(1.2-2.6)' 0.78(0.47-1.30) 
Febrile seizures 
in patient history 26 3 1.06(0.29-3.94) 
in family historyb 12 4 0.31(0.09-1.09) 
Previous symptoms 
Pever 116 14 1.00(0.31-3.24) 
Vomiting/diarrhoea 46 10 0.36(0.13-0.98)' 
Seizure characteristics 
Focal 22 3 0.87(0.23-3.23) 
Multiple 49 7 0.77(0.28-2.09) 
Duration in minutesC 0.43(0.25-0.74)d 
$15 112 8 
15-30 17 2 
~30 20 8 
Temperature in °C 40.0(39.4-40.4)' 39.9(39.3-40.3/ 1.09(0.63-1.89) 
.. 6.c,d See Table 2.1.4 
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OR (CI95%) 
multi variable 
0.58(0.28-1.20) 
1.99(0.72-5.51) 
0.54(0.22-1.30) 
0.33(0.17-0.66)' 
OR (CI95%) 
multi variable 
0.63(0.21-1.93) 
0.75(0.44-1.27) 
0.30(0.07-1.28) 
0.38(0.13-1.10) 
0.43(0.24-0.76)' 
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Table 2.1.4 Patient characteristics and both normal sodium and calcium levels 
sodium and calcium Icvels 
norlllal abnormal OR (CI95%) OR (CI95%) 
11=98 (60%) n=65 (40%) univariable Illultivariable 
General characteristics 
Male 54 45 0.55(0.28-1.07) 0.47(0.23-0.95/ 
Age in years 1.6(1.2-2.2)' 1.5(1.1-2.1)' 1.08(0.74-1.57) 
Febrile seizures 
in patient history 20 9 1.60(0.68-3.79) 1.59(0.63-3.99) 
in family historyb 9 7 0.84(0.30-2.37) 
P('evious symptoms 
Fever 74 54 0.63(0.28-1.41 ) 
Vomiting/diarrhoea 27 29 0.47(0.24-0.92)' 0.54(0.27-1.09) 
Seizure characteristics 
Pocal 13 13 0.61(0.26-1.42) 0.68(0.27-1.71) 
Multiple 25 31 0.38(0.20-0.74)' 0.42(0.21-0.85)' 
Duration in minutesC 0.83(0.55-1.25) 0.81 (0.53-1.25) 
~ 15 72 45 
15-30 12 6 
~ 30 14 14 
Temperature in °c 40.0(39.4-40.6)' 39.9(39.4-40.4)' 0.98(0.69-1.39) 
a Median (25-75 percentiles) 
bPirst degree 
C Used as continuous varhtble in the model 
d Significant at p<O,05 
Score chari 
We presented the multi variable models in a score chart (Table 2.1.5). This chart is intended to 
facilitate the estimation of the probabilities of normal sodium and calcium levels in clinical 
practice. Scores for each predictor were derived from the logistic regression coefficients, 
which were reduced by a correction for overoptimism. This correction was assessed by 
bootstrapping, which resulted in a shrinkage factor of 0.81 in the model predicting normal 
sodium levels, 0.79 in the model predicting normal calcium levels and 0.80 in the model 
predicting both normal sodium and calcium levels. The scores were subsequently multiplied 
by 10 and rounded to whole numbers. The scores corresponding to the values of the predictors 
for the individual patient can be filled in on the score chart. The corresponding probabilities 
can be read from Figure 2.1.1. Alternatively, the exact probabilities can be calculated using 
formulas (see Appendix). 
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Table 2,1.5 Score chart to estimate the probability of normal biochemical blood lest results" 
General cimrllcferistics 
Female gender 
Age in years 
51.5 
1.5-2.5 
>2,5 
Febrile seizures 
Present in patient history 
Absent in family history 
Previous symptoms 
Absent vomiling/dimrhoca 
Seizure characteristics 
Generalised 
Single 
Duration in minutes 
S; 15 
15-30 
'30 
Sumscorc: 
(add variables that apply) 
normal sodium 
5 
6 
4 
9 
value 
normal calcium 
4 
5 
3 
o 
9 
8 
13 
7 
o 
normal sodium 
and calcium 
6 
4 
5 
3 
7 
4 
2 
o 
a We illustrate the use of the score chart with a hypothetical patient, a boy aged 2 years, presenting with a 
multiple seizure associated with fever, without focal signs, duration 5 minutes, without vomiting or diarrhoea 
previous to the seizure. The patient's history includes onc febrile seizure. TIle family history is negative for 
febrile seizures. The sumscores are 10 (6+4) for llonnal sodium, 33 (3+9+8+13) for normal calcium and 16 
(4+5+3+4) for both normal sodium and calcium. From Figure I it can be approximately seen that our patient has 
a probability of around 65% of a normal sodium level, 95% of a normal calcium level and 60% of both a normal 
sodium and calcium level, The exact probabilities (using the formulas) are 62%, 95% and 59%, respectively. One 
might suggest that no laboratory tests are indicated in this patient, since abnormal test results are unlikely. 
Discussion 
We confirmed earlier findings that severe hyponatriaemia, hypocalciaemia and 
hypoglycaemia, severe enough as to be considered the cause of seizures is rare. We have 
found only three cases of severe hyponatriaemia. All other abnormalities of sodium and 
calcium levels were mild and all glucose levels were within the normal range. Earlier studies 
showed that sodium, calcium and glucose blood tests in children with seizures associated with 
fever resulted in a very low number of abnormal results, in particular in children with 'simple' 
(non-complex) seizurcs,6,7,1I.12,16,17,20 However, some authors state that a glucose and calcium 
test should be done, because these are treatable conditions and the tests are relatively 
inexpensive. 21 Based on the results of earlier studies.6,2o they calculated the risk of abnormal 
glucose and calcium levels as 3 in 1000 and concluded that sodium tests are indicated only in 
case of suspicion of 
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INormal calcium I 
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Score 
Predicted probabilities corresponding to the sumscores as calculated with the score chart (see 
Table 5 and text) 
disturbances in the milieu interne?' Other authors concluded also that biochemical tests are 
useful, if they have been. performed on. indication. The indications they found were multiple-
type seizures, status epilepticus, history of metabolic or gastrointestinal disease and young 
age.3,7,IO,II.12,15,17 These indications, which imply an increased risk of abnormal test results, 
have been confirmed quantitatively by our analysis. 
In agreement with earlier studies, vomiting or diarrhoea previous to the seizure Was associated 
with biochemical abnormalities. 1I ,12,21 We included this characteristic in the model predicting 
normal calcium levels and in the model predicting both normal sodium and calcium levels. 
The presence of vomiting or diarrhoea previous to the seizure was not very important after 
inclusion of other predictors in the multi variable model predicting normal sodium levels. This 
means that other predictors were stronger associated with the outcome. In accordance with the 
results of earlier studies, we have found a rather strong association between complex seizure 
characteristics and abnormal sodium levels. IO•12,15 The absence of the predictor 'vomiting or 
diarrhoea' in the multivariable model predicting nonnal sodium levels may also be partially 
explained by our relalively mild definilion of Ihe predictor: if children had vomiled only once 
before the seizure occurred, it was counted as previous complaints of vomiting or diarrhoea. If 
we had defined it as a duration of at least two days we might have found the association. 
Lhnitatiolls 
A limitation of our study is that not all cases were biochemically tested, which might result in 
a selection bias. However, compared to the two other studies reporting the number of patients 
tested, our study included a similar or even larger percentage of children who were tested.7,17 
We have studied the data firsily by leaving the missing data oul of the model and secondly, by 
counting the missing data as normal test results. We found similar results for the prediction 
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models. We conclude that our results apply to the entire study population. Based on the aim of 
the study. which is to assess the probability of nomlai biochemical blood test results in 
children presenting with a seizure associated with fever, we have lost some information by 
analysing the laboratory test results as dichotomous variables (abnormal or normal) while the 
original laboratory test results were continuous. Furthermore, our sample size was limited and 
the statistical models we have constmcted require further validation. 
Practical application 
The multi variable models were presented in a score chart. For sodium test results, an 
individual patient can have a score between 0 and 24, corresponding with a probability range 
between 40% and 88%. For normal calcium levels, the score range is between 0 and 39, 
corresponding with probabilities between 38% and 95%. For both normal sodium and calcium 
levels the score range is between 0 and 29, corresponding with probabilities between 23% and 
85% (Table 2.1.5, Figure 2.1.1). The smaller mnge of predicted probabilities corresponds to 
the lower discriminative ability of the model predicting normal sodium levels (area under the 
ROC-curve 0.63) compared to the models predicting normal calcium and both normal sodium 
and calcium. These models have a wider probability range, which corresponds to a slightly 
larger area under the ROC-curve (both 0.66). 
The definition of a probability selection threshold in performing electrolyte and glucose tests 
in children presenting with a seizure associated with fever requires a weighing of the benefits 
and risks. The risks of a test include a short period of minor pain which will frighten the child, 
the time-delay before the child can be sent home, the low risk of a bone infection and the 
financial costs. However, if abnormal levels are present, the child will benefit from testing. 
The detected abnormalities will indicate start of intervention. In mild cases, intervention will 
comprise re-testing until the abnorrnal1evel has normalised. In the rare severe cases, further 
diagnostic procedures and treatment will be started. If the tests are not performed, 
hypocaJciaemia, hypoglycaemia and hyponatriaemia may be missed. In most cases the missed 
abnormalities will be outside the morbidity range. Severe biochemical disturbances may result 
in a long-lasting status epilepticus and cerebral damage. 2,3 In general, the advantages of 
performing biochemical blood tests may not balance the disadvantages. Decision analysis may 
help to find the optimal probability of the outcomes estimated using our prediction models, at 
which probability level the balance between the costs and benefits is most favourable. 14 
We have included patients with seizures associated with fever without any other serious 
condition, such as suspicion of meningitis or respiratory insufficiency for which hospital 
transfer is required. Thus, we had a patient group with a seizure associated with fever but 
without apparent symptoms or signs of an underlying disorder, which is exactly the patient 
group that is most difficult for cI inicians regarding the decision whether or not to perform 
biochemical blood tests. Our study complements the recommendations to refrain from routine 
determinations of serum electrolytes and calcium in children with simple febrile seizures, as 
stated by the American Association of Pediatrics in 1996. 1 Additionally, we have not only 
studied children with simple febrile seizures, but also children with complex seizure 
characteristics. We have confirmed and quantified that complex seizure characteristics include 
an increased risk of abnormal biochemical blood test results. Although the models are limited 
regarding their discriminative ability, in daily clinical practice the score charts give a hand, at 
least to the young and inexperienced physician, to decide whether or not biochemical tests are 
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indicated. However, it should also be clear that the score chart is only an additional tool to a 
carefully performed patient history and physical examination. 
Appendix 
The exact formulas to calculate the sUlIlscores arc: 
SUlI\score (normal sodium level): 
1.5-0.6(male gender)+O.7(febrile seizures present in patient historY)-O.5(focal seizure type)-l.I (multiple seizure 
type) 
SUlI\score (normal calcium level): 
4.1-0.5(male gender)-O.3(age)-1.2(febrile seizures present in family history)-O.5(previous symptoms of 
vomitingldiarrhoea)-O.8(seizure duration) 
Sumscore (normal sodium and calcium level): 
1.5-0.7(male gender)+O.5(febrile seizures present in patient history)-O.6(previous symptoms of 
vOll1ilingldiarrhoea)-O.4(focal seizure type)-O.9(multiple seizure type)-O.2(seizure duration) 
The variable 'gender' is 1 for males and 0 for females, the variables 'febrile seizures present in patient history', 
'febrile seizures present in family history', 'previous symptoms of vomiting/diarrhoea', 'focal seizure type', 
'multiple seizure type' arc I if true and 0 if false, the variable 'seizure duration' is 0 if S; 15, 1 if 16-29 and 2 if? 
30 minutes and for the variable 'age' (in years) the value can directly be filled in the formula. 
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2.2 The duration of febrile seizures and peripheral leukocytosis 
Margriet Will Stllijvenberg, Henriiftle A Moll, Ewollt IV Ste)'etberg, Egbertiell N vall Gijsset, Karel GM 
Moons alld Gerarda Derksen-Lubsell 
Summary 
In 203 consecutive children with febrile seizures, no clear association (Odds Ratio 1.0 [95% 
Confidence Interval 0.9-1.1], p~0.59) was found between seizure duration and blood 
leukocytosis (;0: 15.0* 10' cellsll). Increased leukocyte counts may be misinterpreted because of 
seizure duration. In children with febrile seizures, leukocyte counts should be used to evaluate 
the underlying cause of fever. 
Introduction 
In children with seizures associated with fever, peripheral leukocyte counts are often 
determined to evaluate the source of the fever,! However, in clinical pediatric practice it is 
suggested that an increased leukocyte count, without any other obvious clinical signs or 
symptoms indicating a bacterial infection, might be explained by the seizure duration itself 
rather than by the nature of the infection. 
The concept of seizures changing the peripheral leukocyte count is based on previous 
findings. Generally, stress mechanisms, which may result from the seizure, may increase the 
leukocyte count. In animal studies stress induced redistribution of leukocytes, resulting in 
increased blood leukocyte counts, has been demonstrated? In adult patients, long lasting 
convulsions without fever are associated with peripheral leukocytosis.3,4 However, other 
studies did not show changes in leukocyte counts after prolonged seizures.5 The diagnostic 
utility of peripheral leukocytosis in children with long-lasting febrile seizures is unclear. 
The aim of this study was to assess the association of the leukocyte count and the seizure 
characteristics in children with febrile seizures, irrespective of the underlying cause of the 
fever. 
Patients and Methods 
Patiellts 
We assessed the data of 203 consecutive patients, aged 3 months to 5 years, who visited the 
Sophia Children's Hospital Rotterdam between January I, 1990 and December 31, 1992, with 
a seizure associated with fever. In a previous study we developed a predictive model for 
biochemical blood test results in children with seizures associated with fever. 6 Febrile seizures 
were defined according to the National Institutes of Health Consensus of 1980.7 Children were 
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excluded if their seizures were accompanied by major signs of meningitis such as petechiae, 
nuchal rigidity, or coma. 
Methods 
The characteristics of the seizure were assessed by review of the patient charts: presence of 
focal seizure signs, multiple type seizure, seizure duration (in minutes), febrile stattls 
epilepticlIs, and temperature at seizure (in °C). These data were linked to the results of the 
peripheral blood leukocyte counts. In children with febrile seizures, leukocyte counts were 
used to be performed routinely to evaluate the fever. According to previous studies in children 
with febrile seizures, leukocytosis was defined as a leukocyte count of ~ 15.0*109 cells/1.8,9 
Results of lumbar punctures (n=69) were not analyzed; however, there were no positive 
cerebrospinal fluid cultures. In this analysis the underlying causes of fever were not addressed. 
Statistics 
Leukocyte counts are given in median values with the 25th and 75th percentiles between 
brackets. The relation between the seizure characteristics and leukocytosis was estimated 
using logistic regression analysis. Odds Ratios were used as the measure of association; 
associations were statistically significant (p<O.05) if the 95% Confidence Interval of the Odds 
Ratio did not include the value 1. The missing test results were initially excluded from the 
analysis; in a secondary analysis, they were counted as normal. In cases of febrile status 
epilepticus, leukocyte counts were analyzed by using a non-parametric test. 
Results 
The study population comprised 125 (62%) boys and 78 (38%) girls; they were median 1.5 
(25th-75th percentiles 1.2-2.2) years of age. The seizure characteristics are shown in Table 
2.2.1. 
Table 2.2,1 Seizure characteristics versus blood leucocyte count (n=203) 
Blood leucocyte count 
Seizure Total <15*109 cells/l ;;::15*109 cells!l 
characteristics n=t29 (64%) n=74 (36%) 
Focal typeJ 31 (15%) 19 12 
Multiple typeb 64 (32%) 40 24 
Duration in minutes 9(4-15) 10(3-15) 5 (4-15) 
FSE' 3D (15%) 20 10 
Temperature in o~ 40.0 (39.4-40.4) 40.0 (39.5-40.3) 40.0 (39.2-40.5) 
Durations and temperatures are given in median values with 25th to 75th percentiles. 
OR=Odds Ratio; FSE=Febrile status epilepticus 
a Focal onset and/or postictal Todd's paresis of facial muscles or limbs. 
b Seizure recurrence within 24 hours. 
e Seizure duration ;;::30 minutes. 
OR (CI95%) 
univariable 
1.1 (0.5-2.5) 
1.1 (0.6-2.0) 
1.0 (0.9-1.1) 
0.9 (0.4-1.9) 
0.9 (0.7-1.3) 
d Temperature measured closest to seizure time as documented in the emergency room or in the patient history. 
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p-vaJue 
0.78 
0.83 
0.59 
0.70 
0.68 
Diagnostic aspects 
Of all 203 children, 197 (97%) had a leukocyte count performed; the counts were 12.8 (8.5-
18.8)* 10' cells!l, leaving 6 (3%) missing test results. Leukocytosis was found in 74 (36%) 
children, with counts of 20.6 (17.8-24.2)*109 cells!1. This is similar to rates previously 
published.s" Normal leukocyte counts were found in 123 (61 %) children: 9. I (7.5-12.2)* 10' 
cells!1. 
\Ve did not find a significant association of any of the seizure characteristics and leukocytosis. 
Therefore, a multivariable analysis was not performed. If the 6 missing leukocyte counts were 
coded as normal, the same results were found (Table 2.2.1). 
In patients with febrile status epilepticus, leukocyte counts after seizures of more than 45 
minutes (n=14, 8.8 (6.7-20.3)*109 cells!l) were not significantly different (p=O.IO, Mann-
Whitney U test) from those after seizures of 30 to 45 minutes (n=16, 13.9 (11.3-19.5)*109 
cellsll). 
Discussion 
The results of this study demonstrated that the leukocyte count in the peripheral blood is not 
significantly related to the duration of the seizure or any other seizure characteristics. Besides 
assessing the underlying cause of the fever, leukocyte counts are rarely useful as a diagnostic 
tool in children with seizures associated with fever.1,7-9 Furthermore, in children with 
shigellosis, no relation was shown between an increased leukocyte count and the occurrence 
of a febrile seizure. \0 The major indication for performing a leukocyte count is the clinical 
suspicion of a bacterial infection that requires treatment, based on findings of the patient 
history and physical examination. I 
We conclude that it is unlikely that there is a clear association between seizure duration and 
blood leukocyte counts in children with febrile seizures. Leukocytosis should not be 
misinterpreted as due to a long-lasting febrile seizure. Similar to the diagnostic procedure in 
other children with fever, leukocyte counts should be used in the assessment of fever in 
children with a febrile seizure. 
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3 Parents' fear regarding fever and febrile seizures 
Margriel \'all Sfllijvellberg, Sal/dm de Vos, Gilbert CH Tjiallg, EII'Ollt lV Steyerberg, Gerart/a Derksell-
Lubsell and Hellriiitte A Moll 
Summary 
Objective To improve the effectiveness of information, we aimed to understand parents' 
perceptions and knowledge about fever and febrile seizures. \Ve determined how parents of 
children with febrile seizures perceive fever and febrile seizures affecting their child. 
~1etltods We carried out a questionnaire study among the parents whose children (0=230) 
participated in a randomised controlled trial of ibuprofen to prevent recurrent febrile seizures, 
Of the 230 parents, 181 (79%) responded to the questionnaire. 
Results Of all parents, 45% were afraid or very afraid of fever, which was strongly associated 
with being afraid of recurrent febrile seizures. Parents of children with a non-West European 
background were more nfraid. The consequences of parental fear included frequent 
temperature measurements (25% measured five times per day or more), sleeping in the same 
room (24%) and 13% remained awake at night during fever. Witnessing a febrile seizure is a 
very frightening experience for parents; a majority thought that febrile seizures are harmful, 
because they look dangerous and 47% thought their child was dying during the initial febrile 
seizure. On the other hand, reassuring information may be helpful: 21 % mentioned it as their 
reason to consider febrile seizures not harmful. 
Conclusioll We conclude that parental fear of fever and febrile seizures is a major problem 
with several negative consequences for daily family life. Adequate provision of information 
may reduce parental fear. We suggest that information about fever and febrile seizures should 
be provided to all parents, preferably during their contact with the preventive health care 
providers. The parents of children with a nOll-West European origin need extra attention. 
Introduction 
Young children are frequently affected by febrile illnesses, mostly due to infections without 
serious consequences. Fever in a young child is a frequent reason for parents to consult the 
general practitioner or the hospital emergency room, Many parents of young children are 
worried about fever; they fear a severe illness, adverse effects of the fever itself or, if they are 
known with the phenomenon, a febrile seizure,I,2,3 In general, febrile seizures are harmless to 
the ehild4, but any physician who has been involved, may know that the parents perceive the 
seizure as a very frightening event. 
Better understanding of parents' perceptions and beliefs about fever and febrile seizures may 
promote satisfactory communication and improve the effectiveness of the information 
provided,3 To determine how parents of children with febrile seizures perceive fever and 
febrile seizures affecting their child, we performed a questionnaire study among the parents 
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whose children participated in a raodornised controlled trial of ibuprofen to prevent recurrent 
febrile seizures. 
Patients and Methods 
Patients 
The study population consisted of the parents who had volunteered their child (n=230) for a 
randomised double blind placebo controlled trial of ibuprofen to prevent febrile seizure 
recurrences, of which the results have been reported elsewhere.s The trial protocol was 
approved by the relevant research ethics committees. The children were aged between one and 
four years old, they had an increased risk of febrile seizure recurrences and all parents were 
Dutch or English speaking. Each child had visited the emergency room of the Sophia 
Children's Hospital in Rotterdam or the Juliana Children's Hospital in The Hague, The 
Netherlands, because of a febrile seizure. 
Methods 
Two weeks after their febrile seizure, each child visited the special febrile seizure outpatients' 
clinic, where the investigator provided oral information about fever and febrile seizures to all 
parents. Additionally, an information leaflet was provided. The matters covered included the 
prevalence of febrile seizures, the risk of seizure recurrence, the benign nature of febrile 
seizures in general and the description of the typical attack. The parents of eligible children 
were informed about the trial and they were asked to give written informed consent; 230 
parents consented to participate in the trial. Median 1.4 (25-75 percentiles 1.1-2.0 years after 
entering the trial, these parents received a letter to introduce the questionnaire study. At that 
moment their participation in the trial had stopped. If they were willing to participate, we sent 
a questionnaire and written instmctions. The parents of 15 (7%) children were not contacted 
because they were lost to follow up (n=13), or they participated in another febrile seizures 
research project (n=2). Thirty-four (15%) did not respond to our announcement and request, 
without giving a reason. Two questionnaires were returned incomplete. The study popUlation 
consisted of the parents of lSI (79%) children. 
We compiled a questionnaire consisting of stl1lctured and semi-stl1lctured questions. The 
questions involved included the following issues: the parents' current perception of fever, the 
measures they currently take when their child has a febrile illness, and what they considered as 
their major source of information regarding fever. Furthermore we asked how they had 
perceived the initial febrile seizure of their child in the past, and how they cun'ently perceive 
their child's febrile seizures. The questionnaire comprised also several issues about the 
informed consent procedure and the parents' sociodemographic baseline characteristics; the 
results have been reported previously.6 Also baseline characteristics of the child and clinical 
characteristics of the initial febrile seizure were collected, 
Completed questionnaires were coded and analysed using SPSS version 6.0.7 The answers 
were categorised in groups. Sociodemographic characteristics were defined in categoriess,9, 
the details are described in the previous report.6 High occupation level included intermediate, 
higher or scientific profession. Low occupation level included elementary or lower profession 
and no profession/housewife. High education level was defined as higher general secondary or 
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pre-university education, intermediate or high level vocational training or university 
education. Low education comprised elementary school, lower general secondary education or 
lower level vocational training. Continuous variables (Le. age and temperature data) were 
reported in median values with 25 and 75 percentiles. 
Associations were studied using logistic regression models, Odds Ratios (OR) were given 
with their 95% confidence interval (CI95%). Associations were statistically significant, if the 
95% confidence interval of the OR did not include the value one. Multivariable analysis was 
performed using stepwise backward regression (p<O.IO) to identify the most important 
characteristics associated with the answers. The univariably significant variables were labelled 
in the tables, with the multivariable OR's given in the text. 
Results 
Fever 
Of all responding parents, 24 (13%) were not and 76 (42%) were a little afraid of fever, 43 
(24%) were afraid and 38 (21%) were very afraid. The answers were categorised in two 
groups: less afraid (n=IOO) and more afraid (n=81) of fever (Table 3.1). Table 3.1 also shows 
the baseline characteristics of the 181 responding parents and their children. To determine 
important characteristics of parents being more afraid, we analysed all baseline characteristics 
with respect to association with being more afraid of fever (Table 3.1). In the ffiultivariable 
model, non-West European origin of the child was the strongest characteristic (OR::::::4.4 
(CI95% 1.4-14.3), p=O.OI). 
Table 3.2 shows the parents' current perceptions of fever, including their expectations of 
further consequences of high fever. The temperature they considered to be high fever differed 
significantly: parents who were more afraid of fever considered high fever median 0.5 °C 
lower compared to the parents who were less afraid. 
The parents were asked to indicate the frequency of measuring their child's temperature and 
which other extra measures Ihey usually take when the child suffers fever (Table 3.3). In a 
multivariable model, we analysed which of all measures described in Table 3.3 were 
associated with being more afraid of fever. We found four: the frequency of temperature 
measurements per day during fever (OR=2.2 (CI95% 1.2-3.7), p=O.Ol), taking extra other 
measures if the child has fever (OR=9.0 (CI95% 1.1-71.1), p=0.04), sleeping in the same 
room (OR=2.2 (CI95% 1.0-4.9), p=0.04) and remain awake at night (OR=3.6 (CI95% 1.2-
11.0), p=O.03). 
We determined the parents' major source of information regarding fever by asking: 'In your 
view, who provided you the most important information concerning fever?'. Their responses 
were: the hospital, including the febrile seizure outpatient clinic (64%), the general 
practitioner (8%), the child health cenlre (2%) and other (26%). No clear differences were 
found with respect to West European or non-West European origin. 
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Table 3.1 Baseline characteristics of the parents and children versus being afraid of fevcr 
Total Less afraid More afraid OR (CI95%) 
l\'1others n=181 0=100 0=81 univariablc 
Age in years 32.6 (29.0-37.0) 32.9 (30.2-36.8) 32.4 (28.7-37.2) 1.0 (0.9-1.0) 
Non-West European origin 46 (25%) 11(11%) 35 (43%) 5.0 (3.3-10.0) 
Low education level 77 (43%) 35 (35%) 42 (52%) 2.0 (1.l-3.3) 
Low profession level 99 (55%) 44 (44%) 55 (68%) 2.5 (1.4-5.0) 
Fathers 0=155 n=87 11=68 
Age in years 35.6 (31.6-39.5) 35.6 (31.6-38.7) 35.6 (31.2-41.4) 1.0 (1.0-1.1) 
Non~West European origin 34 (22%) 6(7%) 28 (41%) 
Low education level 60 (39%) 29 (33%) 31 (46%) 
Low profession level 39 (25%) 22 (25%) 17 (25%) 
Children 0=181 0=100 11=80 
Single-parent family 26 (14%) 13 (13%) 13 (16%) 1.3 (0.6-2.9) 
Age in years 3.4 (2.7-4.3) 3.3 (2.7-4.2) 3.5 (2.7-4.3) 0.9 (0.7-1.3) 
Female gender 69 (38%) 38 (38%) 31 (38%) 1.0 (0.6-1.8) 
Non-West European origin 55 (30%) 12 (12%) 43 (53%) 10.0 (3.3-10.0)' 
First degree family history 36 (20%) 19 (19%) 17 (21%) l.I (0.5-2.4) 
of febrile seizures 
Initial febrile seizure: 
Multiple type 71 (39%) 36 (36%) 35 (43%) 1.3 (0.7-2.5) 
FSEb 16 (9%) 10 (10%) 6 (7%) 0.7 (0.3-2.1) 
a Significant in the muHivariable model (see text) 
b FSE Febrile status cpilepticus: seizure duration :?:30 minutes 
rc reference category 
Tnble 3.2 Parental perceptions of fever 
Total Less afraid l\-Iorc afraid OR (CI95%) 
(n=I8I) (0=100) (11=81) 
Level of temperature 
Considered high fevera 39.5 (39.0-40.0) 39.5 (39.0-40.0) 39.0 (38.5-40.0) 0.6 (0.4_1.0)' 
Maximum if untreated" 41.0 (40.5-42.0) 41.0 (40.5-42.0) 41.0 (40.0-42.0) 1.0(0.7-1.4) 
High fever harmful 
No 69 (38%) 43 (43%) 26 (32%) cc 
Yes 68 (38%) 32 (32%) 36(44%) 1.7 (0.9-3.9) 
Do not know 44 (24%) 25 (25%) 19 (23%) co 
Further consequences of 
high fever 
Febrile seizures 142 (79%) 74 (74%) 68 (84%) 1.8 (0.9-3.9) 
Othe{ 23 (13%) 17 (17%) 5 (6%) cc 
None 7 (4%) 5 (5%) 2 (2%) co 
Do not know 9 (5%) 4 (4%) 5 (6%) ce 
a temperature in 0C 
b significant at p<O.05 
C other consequences mentioned were: 
braindamage (n::::6), drowsiness (n::::6), cardiac sUffilenage (n::::3), dehydration (n=3), 
consequences depend on the cause of fever (n=3) and fever is useful (n::::l) 
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Table 3,3 Measures during the child's fever 
Total Less afraid More afraid OR (CI95%) 
(n~181) (n~100) (n~SI) univariable 
Temperature measurements3; 2.4 (1.4_4.0)' 
not more than once (1) 13 (7%) 8 (S%) 5 (6%) 
I\vo to four times (2) 122 (67%) 77 (77%) 45 (56%) 
five to eight time (3) 38 (21%) 14 (14%) 24 (30%) 
more than eight times (4) 8 (4%) I (1%) 7 (9%) 
Olher exira measures 163 (90%) 83 (83%) SO (99%) 16.4 (2.1-125.8)' 
Exira measuresc: 
use of the baby intercom 28 (16%) 15 (15%) 13 (16%) 1.1 (0.4-2.4) 
leave the door open 41 (23%) 24 (24%) 17 (21%) 0.8 (0.4-1.7) 
sleep in the same room 44 (24%) 15 (15%) 29 (36%) 3.2 (1.5_6.4)' 
sleep in the same bed 61 (34%) 26 (26%) 35 (43%) 2.2 (1.2-4.1) 
remain awake at night 23 (13%) 5 (5%) 18 (22%) 5.4 (1.9-15.4)' 
frequently look to check 80 (44%) 40 (40%) 40 (49%) 1.5 (0.8-2.6) 
put diazepam ready for use IO (6%) 6(6%) 4 (5%) O.S (0.2-3.0) 
keep the child cool 14 (8%) 8 (8%) 6 (7%) 0.9 (0.3-2.8) 
a Frequency of temperature measurements per 24 hours; analysed as a continuous variable; values between brackets; 
the OR represents the risk of being more afraid increasing 2.4 per temperature measurement category 
b remained significant in the multivariable analysis (see text) 
C more than one option possible 
Febrile seizures 
The parents described in their own words what they had thought at the moment their child had 
its first febrile seizure (Table 3.4). We determined if there were important characteristics of 
the parents who thought their child had been dying (n=85), using the characteristics given in 
Table 3.1. A negative independent association was found with initial febrile status epilepticus 
(OR=0.2 (CI95% 0.1-0.9), p=0.04), which implies that parents who have a child that suffered 
from an initial long lasting seizure, less frequently think their child has been dying. The 
parents who had recognised a febrile seizure (n=23), did not differ with respect to any baseline 
characteristics mentioned in Table 3.1. 
We investigated if parents had sought medical help after their child's initial febrile seizure: 
173 (96%) of the parents sought immediately for medical help: 100 (55%) dialled the national 
emergency alarm number, 44 (24%) parents called or visited a general practitioner and 29 
(16%) brought their child directly to the hospital. Eight (4%) parents did not seek medical 
help; they called their neighbours or bystanders for first aid. 
We asked the parents whether or not they currently thought, that febrile seizures were harmful. 
The results are given in Table 3.5. Seventy-four (41 %) parents said febrile seizures were 
harmful, because their child's seizures had looked very damaging; some parents mentioned 
the possible lack of oxygen during the seizure as harmful; their child had stopped breathing or 
got cyanotic and II (6%) said that after the seizure their child had looked injured. Among the 
parents who thought that febrile seizures were not harmful (n=79, 44%), 38 said so because 
they said to have had received convincingly reassuring information that febrile seizures are 
not harmful. 
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Table 3.4 Parental thoughts at the moment of their child's initial febrile seizure 
n=181 
Child is dying 
Recognition of a febrile seizure 
Something vcry dangerous 
Epilepsy 
Suffocation 
Child is playing a crazy trick 
Other3 
Do not know 
Number (%) 
85 (47%) 
23 (13%) 
20 (11%) 
15 (8%) 
15 (8%) 
5 (3%) 
4 (4%) 
7 (4%) 
a including paralysis (n-I), meningitis (n-I), sunstroke (n-I) and pain (n=l) 
All baseline variables mentioned in Table 3.1 were studied: low-level profession of the 
mother was significantly associated with considering febrile seizures as harmful (OR=2.2 
(CI95% 1.1-4.6), p~O.03). 
Finally. we asked the parents, whether or not they currently were afraid of recurrent febrile 
seizures affecling their child again: 102 (56%) parents were not or a little afraid and 79 (44%) 
were afraid or very afraid. Analysing all baseline characteristics from Table 3.1, being afraid 
or very afraid of new febrile seizures was associated in the multi variable model with low-level 
profession of the mother (OR~2.3 (CI95% Ll-5.1), p~0.03), non-West European background 
of the child (OR=6.8 (CI95% 2.7-17.4), p<O.OOI) and multiple type initial febrile seizure 
(OR~2.6 (CI95% 1.2-5.8), p~0.02). We found a very strong significant associalion between 
being afraid or very afraid of new recurrent febrile seizures and being afraid of fever: OR=82 
(CI95% 31-218), p<O.OOI. The number of discordant pairs in the Iwo-by-two table may 
illustrate this large OR: only 10 parents were more afraid of fever while less afraid of a 
recurrent seizure; 8 were less afraid of fever while more afraid of a recurrent seizure. 
Discussion 
Half of the responding parents was afraid or very afraid of fever affecting their child. The 
parents mentioned in 79% the risk of a seizure recurrence as the major consequence of fever 
and their fear of high fever was strongly associated with their fear of a febrile seizure 
recurrence. Being afraid of fever was clearly associated with a non-West European 
background of the child; being afraid of new recurrent seizures showed to be related to a low-
level profession of the mother, a non-West European background of the child and a multiple 
type initial seizure. The results of two other questionnaire studies about fever in children 
showed, that the occurrence of febrile seizures during high fever is a major issue for parents. 1,2 
One study investigated the fear of parents of children who visited a university-based walk-in 
clinic for several reasons: 15% mentioned a febrile seizure as the main consequence of high 
feveL' The other study included parents whose child was feverish meanwhile: 48% addressed 
the possibility of a febrile seizure as the principal danger. 2 
Only parents whose child had an increased risk of febrile seizure recurrence and had 
participated in a randomised controlled trial to prevent recurrences were included. Of the 
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Table 3.5 Parental thoughts about harmfulness of febrile seizures 
0=181 
Seizures are harmful 
seizures look damaging 
told so by others 
child looked damaged after a seizure 
Seizures are not harmful 
information provided was convincing 
own experience 
benign effect of a febrile seizure 
reassuring electroencephalogram 
certain without further specification 
Do not know 
Number (%) 
97 (54%) 
74 (41%) 
12 (7%) 
11(6%) 
79(44%) 
38 (21%) 
24 (13%) 
5 (3%) 
1 (1%) 
11 (6%) 
5 (3%) 
Pare1ltal perception and e.\perience 
parents of 275 children who initially fulfilled the criteria of the randomised controlled trial, 
the parents of 181 (66%) children participated in the questionnaire study. We may argue about 
how fearful the non-participating parents would have been. They may either have been 
relatively more afraid, and therefore have not participated, or less afraid and therefore have 
considered it not necessary to participate in the mndomised controlled trial and the 
questionnaire study. Therefore, it is justified to discuss the results of the questionnaire study 
with respect to parents of children with recurrent febrile seizures. 
The present questionnaire study population is different compared to studies that have 
addressed similar issues in questioning parents whose child had just suffered its initial febrile 
seizure lO-12; only one study questioned also parents later on, until 20 months after the initial 
seizure!! and one other included only parents who had witnessed the seizure. 10 In a recent 
study among parents of children with febrile seizures 40% reported full relief compared to 
what they had felt at the time of the acute event owing to reassuring information provided by 
the hospital after the seizure had occurred.!3 The parents of all these previous studies had not 
participated in a preventive trial and may have been provided reassuring information only 
once. Thus, the parents in the present questionnaire study may be considered relatively 
experienced, compared to the parents participating in the other studies: they have participated 
in a randomised controlled trial to prevent recurrences, implying that they have been 
repeatedly provided with reassuring information regarding fever and febrile seizures and their 
child has likely suffered from recurrent seizures; they might have become used to it. Thus, it is 
surprising that they are afraid of fever and seizure recurrence at a level not clearly different 
compared to the other studies. IO-13 \Ve might have expected that the information repeatedly 
provided would have reduced their fear, but clearly it has not completely countervailed their 
fear. 
The parents in the present questionnaire study had no clear misconceptions about what they 
defined as high fever or how high fever could rise if untreated, which is in contrast with 
parents who were not educated about fever. 1,2 Furthermore, 21 % of the parents mentioned the 
information provided as their reason for considering febrile seizures not harmful. Thus, in the 
'general population', parents with a child affected by febrile seizures may be even more 
frightened about fever and febrile seizures, because they probably have received less 
information. 
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Parental fcar includes several negative consequences: fearful parents frequently repeat rectal 
temperature measurements, which is not beneficiary to the child: 25% measures five times or 
morc during fever. Furthermore, 24% sleeps in the same room as the child Of stays up all night 
(13%), to be alarmed in time if a febrile seizure might occur. These measures certainly have 
negative implications for daily family life. Parents' restless sleep is a major problem, which is 
even worsening with the frequency of febrile seizures recurrences in their child. II The 
consequences of being frightened by a febrile seizure arc expensive and redundant: at the 
initial febrile seizure of their child, 55% of the parents call the national emergency number for 
an ambulance. 12 Other parents drive by car to the hospital (16%), which is a stressful and 
dangerous event with a child of whom they think is dying. The best thing to do is contact the 
general practitioner for further advice. In our study, 24% of the parents called or visited a 
general practitioner at the initial seizure affecting their child. Although this is a substantial 
percentage of adequate acting, we should try to increase this number in future parents. 
The fact that parents think their child is dying, in our study in 47% at the initial febrile seizure, 
indicates a lack of information. The prevalence of febrile seizures is 4%14; since they are so 
commonly occurring, it would seem useful to provide more information about febrile 
seizures. IO-13 If parents receive information before the first seizure of their child occurs, a 
substantial number of them may remember the information and recognise a febrile seizure, 
which will reduce the fear and increase adequate acting. II The efficacy of health education to 
parents may be illustrated by the improvement of parental confidence after education about 
fever, demonstrated by a subsequent decrease in emergency hospital visits because of fever 
affecting their child. IS Negative effects of providing information may entail increasing fear of 
fever; the fact that something so strange and frightening as a seizure may happen to the child 
during fever may induce an increase in parental fear and medical consumption of parents, who 
otherwise would not have contacted their general practitioner or the hospital. Balancing 
qualitatively the positive and negative effects, we advocate providing information to any 
parent when they visit the primary health care centre. The relatively high prevalence and the 
substantial parental fear, may be the strongest motive for febrile seizures to provide 
information about in primary health care centres. 
In the present questionnaire study the parents' major source of information was the hospital 
(64%), likely due to several hospital visits and participation in the febrile seizures trial; the 
first line health care and the child health centres provided information to just a minority of 
these parents (10%). In the Netherlands, generally more than half of all children affected by 
febrile seizures will never visit a hospital after a febrile seizure. 16 Therefore, the preventive 
care and first line health care providers may be considered a major source of information 
regarding fever and febrile seizures. 
Furthermore, general practitioners and pediatricians may be unaware of the stresses that 
parents of children with febrile seizures expericnce. IO·11 The results of our study show that 
parental fear is a substantial problem: 44% of the parents said to be afraid of recurrent seizures 
affecting their child again. The parents' fear should be discussed after the initial febrile 
seizure. Specific information is needed by parents who have watched their child during a 
febrile seizure to avoid long term adverse reactions." \Ve have demonstrated that specifically 
mothers with a low level profession and parents of children with a non-\Vest European 
background and a multiple type initial seizure need extra attention regarding their fcar. They 
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will benefit from information about the benign prognosis of febrile seizures. In nOll-West 
European parents, cultural differences regarding feverish diseases may play a role in 
understanding the information provided. Further, from the fact that all participating parents 
had to be Dutch or English speaking, we may derive that Ihis does not exclude Ihe possibility 
of subtle linguistic distinctions as a complicating factor in the communication. These issues 
require specific attention. 
Conclusions 
At least half of the parents of children affected by febrile seizures is afraid of fever, because 
they are afraid of febrile seizures. Parents fear' implies substantial negative consequences for 
daily family life. Adequate provision of information may reduce parental fear. Extra attention 
is necessary for the parents of children with a non-West European origin. 
We gratefillly acknowledge Mrs.L.W.A. vall Suijiekom·Smil, MD, PhD alld Mrs.M.H. SllIlr, MSeN for reviewillg 
the manuscript. 
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4 Randomized controlled trial of ibuprofen to prevent febrile seizure 
recurrences 
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Sumnmry 
Objectives Febrile seizures frequently recur. In daily practice, children with febrile seizures 
are often treated with antipyretics during fever to prevent febrile seizure recurrences. So far, 
no randomized placebo controlled trial has been performed to assess the efficacy of 
intermittent antipyretic treatment in the prevention of seizure recurrence. 
Methods We performed a randomized double blind placebo controlled trial, in which 230 
children, aged 1-4 years, with risk factors for febrile seizure recurrence, were enrolled. They 
were randomly assigned to either ibuprofen syrup, 20 mg per ml, 0.25 ml (=5 mg) per kg body 
weight per dose (Ill children) or matching placebo (119 children), to be administered every 
six hours during fever (temperature C: 38.5°C). The primary outcome was the first recurrence 
of a febrile seizure. Kaplan-Meier curves and Cox regression were used for the statistical 
analysis. 
Reslllts Median follow up time (25-75 percentiles) was 1.04 years (0.7-1.8 years) in the 
ibuprofen group and 0.98 years (0.7-1.6 years) in the placebo group. The two-year recurrence 
probabilities were 32% and 39%, respectively (p=0.70). The recurrence risk in the ibuprofen 
group was 0.9 (0.6-1.5) times the recurrence risk in the placebo gronp (,intention-to-treat'). 
Adjustment for baseline characteristics did not affect the risk reduction estimate. A 'per-
protocol' analysis showed similar results. 
Conclusion We found no evidence that ibuprofen administration during fever prevents febrile 
seizure recurrence. 
Introduction 
Febrile seizures are the most common type of seizures in childhood, with a cumulative 
incidence of 4% I and an average recurrence risk of 30% in two years. Factors increasing the 
risk of febrile seizure recurrences include young age at onset, family history of febrile 
seizures, previous recurrent febrile seizures, time lapse since previous seizure less than six 
months, temperature lower than 40.0 °C at the initial febrile seizure, multiple type initial 
febrile seizure and frequent febrile illnesses.2-8 
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In recent years, the prevention of recurrent febrile seizures has become a debatable issue: 
prevention may not be necessary because almost all febrile seizures are not injurious to the 
h'ld 9. II H 'f ' , C I. owever, preventIOn 0 seizure recurrences serves two useful purposes: meetmg 
parental fear of recurrent febrile seizures in generaI 12,13 and reducing the (small) risk of a long 
lasting and eventually injurious recun"ent seizure.9•11 
Intermittent treatment with diazepam during fever is associated with adverse effects and has 
not been proven efficacious to prevent febrile seizure recurrences. 14 Intermittent treatment of 
the child with antipyretic dmgs is likely to be a rational alternative, Although children with 
febrile seizures are often treated with antipyretics in daily practice, until now no proper 
evaluation of the efficacy of antipyretic treatment in comparison with placebo to prevent 
febrile seizure recurrences has been carried out. 15·17 The aim of this study is to assess the 
efficacy of ibuprofen to prevent febrile seizure recurrence in children with an increased risk 
for recurrence. 
Patients and Methods 
Patiell/s 
Children who were seen for a febrile seizure at the Sophia Children's Hospital in Rotterdam 
and the Juliana Children's Hospital in The Hague, The Netherlands, between April I, 1994 
and April I, 1996 were considered for inclusion. These hospitals have pediatric emergency 
wards which are open twenty-four hours per day. 
A febrile seizure was defined according to the NIH consensus as 'an event in infancy or 
childhood, associated with fever but without evidence of intracranial infection or defined 
cause' .IS Criteria for inclusion were: febrile seizure within the last six months, between one 
and four years of age; and presence of one or more risk factors for febrile seizure recurrence. 
Risk factors were defined as: a positive first degree family history of febrile seizures; an initial 
febrile seizure of the multiple type; a temperature below 40.0 °C at the initial febrile seizure; 
and previous febrile seizure recurrence(s). All parents had to give written informed consent 
for participation of their child in the study. Criteria for exclusion were: previous seizures 
without fever; known allergy for ibuprofen; current use of anti-epileptic drugs; no telephone 
connection; non-Dutch and non-English speaking parents. 
The study protocol was approved by the ethical review boards of both institutions. 
Study medication 
Study medication consisted of either ibuprofen symp, 20 mg per ml, 0,25 ml (=5 mg) per kg 
body weight per six·hourly dose, or matching placebo, to be given by the parents during fever. 
Parents were instructed to take the rectal temperature of the child immediately when the child 
seemed ill or feverish, and to start promptly with administering of study medication when the 
temperature was 38.5 °C or higher. Each dose was to be administered every six hours until the 
child was afebrile for twenty-four hours. The parents were instructed not to administer any 
other antipyretic dmg to their child, 
According to a computer generated randomization schedule, which was stratified by center, 
each child was assigned at study entry to either the ibuprofen or to the placebo arm of the 
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study. Only the biostatistician and the hospital pharmacists knew the actual treatment 
allocation. 
Procedures 
Baseline characteristics, including demographic characteristics, characteristics of the initial 
seizure and previous seizure recurrences, were recorded at study entry. Parents were instructed 
to record the precise timing of administering of the study medication and the height of the 
temperature in a standardized patient form. For measuring rectal temperature, a digital 
thermometer (Philips HP53l6) was distributed, On the first day of fever onset, the child 
visited the outpatient clinic for assessment of the clinical condition, rectal temperature, 
compliance to the study protocol and registration of concomitant therapy. No laboratory tests 
were done, unless indicated by the clinical condition of the child. Antibiotic treatment was 
prescribed, jf necessary. During subsequent treatment of the fever episode, parents had to call 
the investigator at least once per day. They had to notify the investigator in case of a febrile 
seizure recurrence. The investigator could be contacted by the parents twenty-four hours per 
day. If no fever had been reported after three months, the investigator contacted the parents to 
assure participation and to check the occurrence of fever or febrile seizure recurrence. Also, 
parents were instructed every three months about the dose of study medication to be used in 
order to account for bodyweight gain. 
Statistical allalysis 
The outcome was the first recurrent febrile seizure. Follow-up time 'at risk' for this event was 
considered as terminated at the planned date of study termination (Le. October I, 1996), or 
when: any seizure (Le. febrile or non-febrile) had occurred; the patient had left the out-patient 
clinic follow~up; further participation was refused; any medical condition occurred that 
precluded use of study medication to treat a .fever episode. The cumulative probability over 
time 'at risk' of a first febrile seizure recurrence was estimated using the Kaplan-Meier 
method. 19 The two study medication groups were compared by Cox proportional hazards 
analysis,20 using study medication allocation as the only covariate. Risk reduction by 
ibuprofen relative to placebo with its 95% confidence interval (CI95%) was estimated from 
the Cox model. Next, Cox proportional hazards modeling was used to assess whether 
correction for differences in baseline characteristics between the two study medication groups 
influenced the result. 
Two analyses were performed. In an 'intention~to-treat' analysis, all first recurrent febrile 
seizures over the follow-up time 'at risk' defined earlier were considered, irrespective of study 
medication compliance by the parents of the child. A 'per-protocol' analysis was limited to 
those febrile seizure recurrences which occurred in the context of study medication 
compliance, defined as administration of study medication during an episode of fever 
according to the protocol before any febrile seizure recurrence had occurred. The definition of 
follow-up time 'at risk' was the same in both analyses. 
The treatment effect on the temperature at 6 (±2) hours from fever onset was assessed using 
analysis of covariance, with temperature at fever onset as covariate. 21 Analysis of covariance 
was also used to assess the difference between temperature at seizure recurrence and 
temperature at fever onset and to assess the treatment effect on the temperature at seizure 
recurrence. Calculations were performed with SPSS for \Vindows, version 6.0.22 
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Power calculatioll 
The two-year probability of seizure recurrence was assumed to be 40% in the placebo group. 
This relatively high figure was assumed because of the inclusion criterion of having at least 
one risk factor for febrile seizure recurrence. The required power was set at 80% (13=0.20) to 
detect a halving of the recurrence risk by ibuprofen (hazard ratio 0.5) with a type I error (a) of 
0.05. Using the Egret Size package the required sample size was found to be 220 (110 in each 
study medication group).23 
Results 
Study population and protocol compliance 
In total 478 children were considered for inclusion. Between October I, 1994 and April I, 
1996,230 of these were randomized (Figure 4.1); III to the use of ibuprofen and 119 to the 
use of placebo to treat any fever episode that might occur. Baseline characteristics are given in 
Table 4.1. The median follow-up time was 1.04 years (25 - 75 percentiles: 0.7-1.8 years) for 
ibuprofen and 0.98 years (0.7-1.6 years) for placebo. 
Table 4.1 Baseline characteristics by treatment group 
ibuprofen 
n=l1\ (100%) 
Demographic characteristics 
Female gender 41 (37%) 
Age at study entrya 1.9 (1.4-2.4) 
First degree/amity histoT}' affebrile seizures 27 (24%) 
Family history of any seizures 44 (40%) 
Daycarc attendance 39 (35%) 
First horn 70 (63%) 
Cauca<;lan origin 67 (60%) 
Immunization completcdb 85 (77%) 
Initial seizure characteristics 
Age at onsela 
FSEc 1.4 (1.1-1.9) 
Focal typed 8 (7%) 
MlIltiple typee 16 (14%) 
Rectal temperatllre below 40.0°C 47 (42%) 
Previous recurrent febrile seizures 55 (50%) 
Previous recurrcllt/ebrile seizllres 
Time lapse between last seizure and study entry *' 39 (35%) 
Number of risk factors 0.10 (0.05-0.21) 
} 66 (60%) 
2 33 (30%) 
~3 t2(1I%) 
a in years, median (25th-75th percentiles) 
b according to the national guidcline-s for immunization in the Netherlands 
C febrile status epileptic us (FSE): seizure duration 30 minutes or more 
d focal onset of the seizure Of postictal Todd's paresis 
C seizure recurrence within 24 hours 
placebo 
n=119 (100%) 
49 (41%) 
1.9 (1.4-2.7) 
32 (27%) 
49 (41%) 
49(41%) 
59 (50%) 
78 (66%) 
88 (74%) 
1.5(1.0-2.1) 
12 (10%) 
10 (8%) 
40 (34%) 
66 (56%) 
45 (38%) 
0.07 (0.04-0.18) 
66 (56%) 
44 (37%) 
9 (8%) 
CIUlYacteristics prillted ill italics are the four riskfdclorsforfebrile seizure recurrence mentioned ill the 'Patients' 
section 
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Reasons for temlination of follow-up arc shown in Figure 4.2: 67 children had a first febrile 
seizure recurrence. 
During follow-up, 555 fever episodes were reported in 194 children distributed as follows 
over the treatment groups: 94 children allocated to ibuprofen (85% of Ill) had a total of 271 
fever episodes; 100 children allocated to placebo (84% of 119) had a total of 284 fever 
episodes. Table 4.2 shows that in 377 of all 555 fever episodes (68%), study medication was 
administered according to the protocol. Also the reported use of concomitant medication is 
given. 
ill 67 children (31 ibuprofen, 36 placebo; Figure 4.2), a first recurrent febrile seizure occurred 
during a fever episode. In the 'intention-ta-treat' analysis, these 67 children were considered 
as having reached the outcome studied. Of these, 30 first febrile seizure recun'cnces occurred 
in the context of study medication compliance (13 ibuprofen, 17 placebo). The 'per-protocol' 
analysis was limited to these events. 
Effect of ibuprofell 011 febrile seizure recurrellce 
The cumulative probability over time of a first febrile seizure recurrence by treatment group us 
estimated by the Kaplan-Meier method based on 'intention-to-treat' (Le. 31 events on 
ibuprofen, 36 on placebo) is shown in Figure 3. The two-year estimated recurrence probability 
was 32% for ibuprofen and 39% for placebo (p = 0.70). The recurrence risk in the ibuprofen 
group was 0.9 times the recurrence risk in the placebo group (CI95%: 0.6-1.5). The risk 
reduction estimate was similar when the analysis was adjusted for baseline characteristics. A 
'per-protocol' analysis (i.e. using the 13 events on ibuprofen and 17 on placebo for which 
study medication was used) showed similar results (risk reduction 0.8, CI95%: 0.4-1.7). 
Table 4.2 Compliance and concomitant medication per fever episode by treatment group 
Feyer episodes without febrile seizure recurrence: 
Fully compliant 
Not fully compliant 
Parents did not give the study medication and did not 
timely report fever 
Parents deviated from the prescribed dose 
-and gave additional acetaminophcn 
-and gave diazepam rectal solutiona 
Fever episodes with febrile seizure recurrence: 
Fully compliant 
Not fuUy compliant 
Parents did not give the study medication, because fever 
was not recognized previously to the seizure 
Parents did not give the study medication, because of olher 
reasons 
a of the parcnts' own accord to prevent febrile scizure recurrence 
ibuprofen 
n~27t (100%) 
t64 (6t%) 
17 (6%) 
54 (20%) 
4 (t%) 
1«1%) 
t3 (5%) 
t t (4%) 
7 (3%) 
placebo 
n~284 (t 00%) 
183 (64%) 
6(2%) 
56 (20%) 
3 (t%) 
t7 (6%) 
11 (4%) 
8 (3%) 
Antibiotic treatment for suspected bacterial infection of the respirMory tract was prescribed to 8 children 
(I in (he ibuprofen group and 7 in the placebo group); 2 children received continuous antibiotic prophylaxis 
because ofprc~existing vesica-ureteral reflux (1 in the ibuprofen group versUs I in the placebo group), 
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Table 4.3 shows that the median temperature at fever onset was similar in both treatment 
groups. A significant reduction of the temperature at 6 (±2) hours after fever onset in the 
ibuprofen group compared to the placebo group was demonstrated, if all 555 fever episodes 
were considered (0.7 °C, p<O.OOI). In the fever episodes with a first febrile seizure recurrence, 
a temperature increase from fever onset until seizure recurrence was shown (p<O.OO 1); the 
increase was not significantly different in the ibuprofen group compared to the placebo group, 
neither in the intention-to-treat analysis nor in the per-protocol analysis (in both analyses 
p>O.20). 
Discussion 
The present study failed to demonstrate a preventive effect of intermittent antipyretic 
treatment with ibuprofen during fever on the number of febrile seizure recurrences in children 
with an increased recurrence risk. The possibility of antipyretic treatment to reduce the risk of 
febrile seizure recurrence has been addressed beforeY-17 Table 4.4 summarizes the 
characteristics 
of these studies. None were placebo controlled trials with a standardized antipyretic treatment 
schedule; hence, it is difficult to draw conclusions from these studies, with respect to the 
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Table 4.3 Temperature by trcutment group 
ibuprofen placebo 
group group 
All fever episodes: 271 284 
At fever onset 39.1 (38.7-39.4) 39.0 (38.7-39.3) 
At 6(±2) hours after fever onset 38.2 (37.3-39.0) 38.9 (38.2-39.3) 
Feyer episodes with recurrence: 
Intention-to·treat analysis 31 36 
At fever onset 39.0 (38.7-39.7) 39.4 (38.8-39.7) 
AI febrile seizure recurrence 39.9 (39.0-40.3) 39.6 (39.1-40.0) 
Per-protocol analysis 13 17 
At fever onset 39.0 (38.6-39.1) 39.5 (38.7-39.8) 
At febrile seizure recurrence 40.1 (39.9-40.4) 40.0 (39.4-40.3) 
Median temperatures in "c (25th-75th percentiles) 
effkacy of antipyretic treatment to prevent febrile seizbre recurrence. As the present study is 
the first placebo controlled trial of antipyretics to prevent febrile seizure recurrences, one can 
not be completely convinced that ibuprofen does not make a difference. The results, however, 
indicate that it is unlikely that intermittent antipyretic treatment reduces the number of febrile 
seizure recurrences. 
We considered ibuprofen to be a pronllslllg dmg to reduce the risk of febrile seizure 
recun-ence_ Both ibuprofen and acetaminophen administered orally have shown to be safe and 
effective antipyretic dmgs in children with fever. 24-26 Because in these studies children with 
febrile seizures were excluded, we assessed the antipyretic efficacy of ibuprofen symp, 5 mg 
per kg per six-hourly dose, versus acetaminophen symp, 10 mg per kg per six-hourly dose, 
during fever in children with febrile seizures in a previous study?7 The results indicated that 
antipyretics administered orally reduce fever in children with febrile seizures safely. In the 
first hours after the initial dose, ibuprofen showed a stronger temperature reducing effect 
compared to acetaminophen. We used a similar six-hourly dose of ibuprofen of 5 mg per kg in 
the present study. We confirmed the temperature reducing effect of ibuprofen at six hours 
after administering of the first dose, when the second dose was to be administered. The 
temperature lowering effect of ibuprofen could not be demonstrated in those fever episodes in 
which a recurrent febrile seizure occurred, neither in the intention-to-treat analysis, nor in the 
per-protocol analysis (Table 4.3). Some faclors might have played a role in the reported 
inability of ibuprofen to reduce fever in those fever episodes. 
The timing of temperature measurement was unfavorable to demonstrate the maximum 
antipyretic efficacy of ibuprofen; if the temperature had been measured earlier, we might have 
found a stronger antipyretic effect. 27 However, for the convenience of the study participants 
and their parents, the temperature measurements were not taken more frequently than every 
six hours, when the next dose of the study medication was administered. 
70 
Randomized controlled trial of ibuprofen 
Further, the parents may have taken the temperature under some stress due to their fear of a 
recurrent seizure resulting in a less than optimal reliability of the measurements. Since this has 
probably occurred equally in the ibuprofen group and the placebo group it is unlikely that the 
reported inability of ibuprofen to reduce fever in those fever episodes with a recurrence is due 
to unreliable measurements. 
While discussing factors influencing both the inability of the present study to show fever 
reduction and prevention of seizure recurrences by ibuprofen, non-compliance of the parents 
of the child to the study protocol and unreported additional use of antipyretics should also be 
addressed. Compliance was ensured by using a standardized patient form in which 
administration of the study medication had to be written down by the parents. We neither used 
any marker of medication nor performed measurement of ibuprofen and acetaminophen blood 
levels to assess the compliance. The analysis of the temperature measurements in the total 
study group showed a clinically relevant and statistically significant temperature reduction in 
the ibuprofen group. Therefore, substantial compliance failures and unreported use of 
antipyretics are rather unlikely the cause of the inability of our study to show temperature 
reduction in those fever episodes in which a recurrence occurred and are also unlikely the 
cause of the inability of the study to show preventive efficacy on seizure recurrences. 
If adequate reduction of fever prevents seizure recurrences, prevention may only be possible 
with the use of a much stronger temperature reducing agent, such as a higher dose of 
ibuprofen or other temperature reducing methods. For instance a dose of 10 mg ibuprofen per 
kg might be administered, which is twice the dose we have used, and which has been 
recommended in children with high fever. It is unknown, however, whether stronger fever 
reducing methods are able to lower the temperature in children with febrile seizures 
sufficiently to prevent febrile seizure recurrences. 
In addition, specific conditions may affect the child's susceptibility to febrile seizure 
recurrence, such as conditions determined by the underlying cause of the feverish illness. The 
underlying cause of the fever may either be responsible for antipyretic treatment to fail in 
lowering the body temperature and therefore being ineffective to prevent seizure recurrences, 
or may provoke a febrile seizure, regardless of resistance to any fever reducing treatment. 
In the present study, the 'per-protocol' analyses showed similar results as the 'intention-to-
treat' analyses. Thus, a strong preventive efficacy of ibuprofen is unlikely, even when it has 
been administered in compliance with the study protocol. Nevertheless, it should be made 
clear that even if ibuprofen would be effective, then recurrences would occur frequently 
before an upcoming feverish illness is recognized. This is a problem inherent to any 
intermittent preventive treatment of febrile seizure recurrences, because it reduces the 
preventive efficacy. We found a recurrent febrile seizure as the presenting sign of fever in 22 
(33%) of all 67 recurrences (Table 4.2). Likewise, in a study comparing intermittent diazepam 
administered rectally during fever and no preventive treatment, the fever was not recognized 
previously to 7 (33%) of the 21 recurrences in the intermittent diazepam group.28 In another 
study of oral intermittent diazepam versus placebo, the seizure was the first manifestation of 
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Table 4.4 Previous randomised controlled studies of prevention of febrile seizure recurrcnces 
including antipyretic treatment 
Treatment groups 
(number of children) 
Temperature measurements 
Outcome measure 
Maximum study duration 
Patient inclusion 
Major difficulties in the evaluation of 
the results 
Rcsults 
Efficacy of antipyretic prc\'cnthre 
Camfield, 1980 
single daily dose of phenobarbital per as 5 mglkg plus 
antipyretic instruction of the parents (0=39) versus 
antipyretic instruction including oral antipyretics only 
(n~O) 
oral and rectal measurements by the parents at home 
first febrile seizure recurrence in the same or following 
fever episodes 
12 months 
simple initial febrile seizure 
-no standardization of the lmlipyrelic treatment' 
-no placebo control group of antipyretic treatment 
2 or tile 39 patients using phenobarbital plus anti-
pyretic instruction and 10 of the 40 patients with only 
instruction had a recurrent febrile seizurec 
not effective 
a all parents received instructions about fever control; no standardized dosis per kg bodyweight was administered 
b all parents were allowed to administer extra antipyretics, whenever they believed they should 
C survival analysis was performed to compare seizure recurrence in the phenobarbital plus instruction group and the 
instruction only group (p<O.02, log-rank) 
J survival analysis was performed to compare seizure recurrence in the diazepam group and the placebo group 
(p=O.4I, log-rank) 
fever in 42%(14/33) of all seizure recurrences.29 In a study comparing diazepam with valproic 
acid, both administered rectally during fever only, there were no signals of an upcoming 
feverish illness in 31 % (11/36) in all seizure recurrences. 30 In a study comparing oral 
diazepam with placebo during fever, 60% (68/113) febrile seizure recurrences occurred 
without the child receiving the study medication, in part because the seizure was the first sign 
of illness. 31 
Until the recent past, children with recurrent febrile seizures were used to be treated by 
continuous antiepileptic dmgs to prevent further recurrences. Because of the severity of 
negative side effects and the debatable efficacy, continuous anti epileptic treatment of children 
with febrile seizures nowadays is considered obsolete in general, unless there are strong 
indications. 14 Accordingly, intermittent preventive treatment with diazepam during fever is 
associated with adverse effects and has not shown to be effective in a meta-analysis 14; 
exclusively children with a high risk of febrile seizure recurrence may benefit from 
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prophylaxis of acetaminophen orally 15-20 mglkg per 
4-hourly dose (n=53) versus sporadic usage of 
acetaminophen of a similar oral dose contingent at 
fever above 37.9 °C (n=51) 
rectal measurements by nurses or parents during 
hospitalization 
-first febrile seizure recurrence in the same fever 
episode (multiple type) 
-body temperature 
one fever episode 
simple initial febrile seizure 
-no placebo control group of antipyretic treatment 
-non-comparable outcome measure 
4 of the 53 children using ongoing prophylaxis versus 
5 of the 51 children in the sporadic usage group had a 
recurrent seizure in the same fever episode 
not effective 
Randomized controlled trial of ibuprofen 
Uhari, 1995 
diazepam 0.2 mglkg 8-hourly during fever 
above 38.5 °C (n=81), of which the first dose to 
he given rectally and further doses per as, 
versus placebo (n=80); 
additional: cross-over per feyer cpisode with 
acetaminophen 10 mglkg 6-hourly during fever 
above 40.0 °C (route of administration not 
reported) versus placebo 
(oral or rcctal) measurements by the parents at 
home 
-number of febrile seizure recurrences in any of 
the following feyer episodes 
-body temperature 
two years 
simple or complex initial febrile seizure 
-no standardization of the antipyretic treatmentb 
9 of the 173 fever episodes were associated 
with a recurrence in the acetaminophen group 
vcrsus 14 of the 170 fever episodes in the 
placebo groupd 
not effective 
intermittent diazepam in an oral dose of 0,33 mg per kg to be administered every eight hours 
during fever,3! The decision to prescribe it should be made in consultation with the parents, 
because of its negative side effects, the necessity of regular medical check ups and the 
difficulty of early recognition of a feverish illness, Negative consequences of focusing on 
prevention of seizure recurrence may entai1 an iatrogenous fear of the parents unwittingly 
encouraged by the pediatrician.32 Probably the most important issue in treating children with 
febrile seizures is to make efforts to reduce parental anxiety by providing information about 
the excellent prognosis of febrile seizures,9-11,33 
We conclude there is no evidence supporting intermittent antipyretic treatment to prevent 
febrile seizure recurrences, Antipyretics may be given during a febrile illness, with the aim to 
make the child feel more comfortable. Consultation with the parents should emphasize the 
generally benign character of febrile seizures, 
We thank the Emergency and Outpatient Clinic Department employees and the hOllse slah- of Ihe Pediatric 
Deparlmellf of the Sophia Children's Hospital al/{I Juliana Children's Hospila/ for Iheir assislance with patient 
el'llllltllion and M. Offrillga, MD, PhD, and A. ~'ml ESc/I, MD, PhD, for Iheir colltrilmtioll 10 the design of the 
study. 
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5.1 The ft'equency of fever episodes related to febrile seizure recllrrence 
Margriet vall Stuijl'ellberg, Nicoline E Jansen, EII'OIlI W Stc),erberg, Gerarda Derksen-Lllbsell alld 
Hellrielte A Mol! 
SUIlunary 
Objective To assess the number of fever episodes as a risk factor for febrile seizure recurrence 
during the first six months after the last previous febrile seizure. 
Methods Six months follow-up study of ISS children, aged 3 months to 5 years, with a first or 
a recurrent febrile seizure. The occurrence of fever episodes and febrile seizure recurrences 
was prospectively documented. With logistic regression analysis we studied the association 
between the baseline characteristics and the number of fever episodes and the outcome: a 
febrile seizure recurrence, 
Results We registered 260 fever episodes. 29 children experienced one or more febrile seizure 
recurrences during follow-up. We identified two factors associated with febrile seizure 
recurrence: number of fever episodes (OR= 1.8 (CI95%: 1.4-2.4)) and age at study entry 
(OR=0.6 (CI95%: 0.3-1.1)). In a multivariable model, only the number of fever episodes 
remained significant. 
Conclusion The number of fever episodes increases the risk of a febrile seizure recurrence 
with a factor 1.8 per fever episode in the first six months after a febrile seizure. 
Introduction 
With a cumulative incidence of 4%, febrile seizures are the most common type of seizures in 
children aged three months to five years. I,2 The two-years probability of a febrile seizure 
recurrence has been estimated as 30% on average; 10 to 20% of the seizures recur within six 
months, with a decreasing risk after the first six months following the previous seizure. 3,4 
The risk of febrile seizure recurrences has been studied rather thoroughly.3 0 9 The major and 
most consistent risk factors are: young age at onset, family history of febrile seizures, previous 
recurrent febrile seizures, a low temperature at the initial febrile seizure, a multiple type initial 
febrile seizure and short time lapse since the previous seizure. 
Additionally, it has been demonstrated that frequent fever episodes are associated with an 
increased recurrence risk,9,10 Children have the highest recurrence risk in the first six months 
after the last previous febrile seizure. We aimed to assess the incidence of fever episodes in 
relation with febrHe seizure recurrence in this high risk period for febrile seizure recurrence. 
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Patients and Methods 
Patients 
Children aged 3 months to 5 years, who were seen for an initial or a recurrent febrile seizure at 
the Sophia Children's Hospital in Rotterdam and the Juliana Children's Hospital in The Hague 
between April I, 1994 and July I, 1997 were considered for inclusion. Both outpatients' 
cHnics include mainly basic specialist care. Eligible children were either enrolled in a 
randomised placebo-controlled trial of ibuprofen symp to prevent febrile seizure recurrences 
(1994-1996), of which the results will be reported elsewhere, or in a cohort study, in which 
the OCCUlTcnce of fever episodes and febrile seizure recurrence during six months were 
registered (1996-1997). We adopted the definition of febrile seizure of the National Institutes 
of Health Consensus Meeting,2 The parents of all participating children gave their written 
informed consent. The study protocol was approved by the relevant local ethical review 
boards. 
Additional inclusion criteria for the children in the randomised controlled trial were: aged 
between I and 4 years, presence of one or more risk factors for seizure recurrence, defined as: 
a positive first degree family history of febrile seizures; an initial seizure of the multiple type; 
a temperature below 40°C at the initial febrile seizure; and one or more previous febrile 
seizure recurrences. 
Exclusion criteda for the present study were: more than two months time lapse between the 
last previous febrile seizure and study entry; current use of anti-epileptic dmgs; no telephone 
connection; non-Dutch and non-English speaking parents. Of the randomised controlled trial 
we included the children who were allocated to placebo only. 
Method" 
After the children had visited the emergency room of the hospital with a febrile seizure, they 
received an appointment for special febrile seizure outpatients' clinic hours, where they were 
examined and the parents were provided infOlmation regarding fever and febrile seizures. The 
parents were advised against giving their child antipyretics during fever. 
Baseline characteristics were recorded and checked at study entry, including age, gender, 
family history of febrile seizures and epilepsy, date and characteristics of the initial febrile 
seizure, the number of previous recurrent febrile seizures and the date of the last previous 
febrile seizure, Of the initial febrile seizure, the temperature and the presence of complex 
characteristics were documented, Complex charactedstics were defined as seizure duration of 
15 minutes or more and/or recurrence of the seizure within 24 hours (multiple type) and/or a 
focal onset of the seizure or a postictal Todd paresis of facial muscles or limbs (focal 
characteristics),11,12 
If parents consented to participate in the randomised controlled trial, they were instmcted to 
take the rectal temperature of the child immediately when the child seemed ill or feverish and 
to start promptly with administering of study medication when the temperature was 38,5 °C or 
higher. They were instmcted to record the precise timing of administering of the study 
medication and the height of the temperature in a standardised patient form, They had to 
notify the investigator of each fever episode and recurrent febrile seizure, If no fever had been 
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reported after three months, the investigator contacted the parents to assure participation and 
to check the occurrence of fever or febrile seizure recurrence. When a febrile seizure 
recurrence occurred, follow-up time was considered as terminated for the randomised trial; 
however, the parents were asked to continue to list all subsequent fever episodes and seizure 
recurrences until the planned date of study termination (October 1996). 
Parents who consented to participate in the cohort study were provided six diaries. They were 
instmcted to use subsequently one diary per month of follow-up to register the occurrence of 
fever episodes and recurrent febrile seizures. The parents were instmcted to document every 
day whether or not their child was feverish. \Vhen the child seemed ill or feverish, the parents 
took the child's rectal temperature; when the rectal temperature was 38.5 °C or more, they 
were asked to mark that day with 'yes' and when the rectal temperature was lower than 38.5 
°C, with 'no', Accordingly, the occurrence of one or more febrile seizure recurrences was 
documented. After every month of follow-up, the parents sent the diary to the investigator. If 
the diary was not received promptly or if data were not filled in, the parents were contacted to 
assure participation and to check the occurrence of fever or febrile seizure recurrence. 
Statistical allalysis 
The outcome was defined as the occurrence of a febrile seizure recurrence in six months 
follow-up time at risk. If follow-up time was terminated before six months, children were 
excluded from the analysis. Early termination of follow-up was defined as: development of 
afebrile seizures; starting the use of intermittent prophylactic diazepam; and refusal of further 
study participation. 
We used logistic regression analysis to assess the association between baseline characteristics, 
the number of fever episodes and the outcome. Baseline characteristics included the following 
risk factors for febrile seizure recurrence: a first degree family history of febrile seizures, age 
at onset under one year, temperature at the initial febrile seizure below 40°C, multiple type 
initial febrile seizure and one or more previous recurrent febrile seizures. An characteristics 
with p<O.lO in the univariable analysis were entered in a multivariable model, to adjust for 
their interrelation. Odds Ratios (OR) were used as measure of association. Associations were 
statistically significant (p<O.05), if the 95% confidence interval (CI95%) of the OR did not 
include the value one. SPSS for Windows was used for the analysis. 
To assess any difference between the randomised controlled trial group and the cohort study 
group, we performed univariable regression analyses in both groups separately. If different 
OR's for baseline characteristics were found, a study-interaction term, indicating the original 
study (randomised controlled trial or cohort study), was introduced in the model and was 
multiplied with the baseline characteristics involved, to assess whether differences were likely 
due to chance. 
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Results 
Study population 
The study population consisted of 171 children; 89 (52%) children allocated to the use of 
placebo in the randomised controlled trial and 82 (48%) children in the cohort study. Sixteen 
children of the cohort study were excluded from the analysis, because of early termination. Of 
these, two children developed afebrile seizures, one child received intermittent prophylactic 
treatment with diazepam; and 13 parents refused after informed consent had initially been 
given. Thus, the data of 155 children were used for the analysis; 89 children from the 
randomised controlled trial and 66 children from the cohort study. 
Febrile seizure recurrence during follow-lip 
Of all 155 children, 29 (19%) children had one or more febrile seizure recurrences and 126 
(81%) had no febrile seizure recurrence during six months follow-up. Forty-one febrile 
seizures occurred; 20 children suffered one recurrence, 6 children had two recurrences and 3 
children had three recurrences. 
A total of 260 fever episodes was counted in 155 children; the mean number of fever episodes 
per child was 1.7. Of all 155 children, 42 (27%) had no fever episodes and 113 (73%) had one 
or more fever episodes. Among those 113, 29 children had a febrile seizure recurrence who 
had 89 fever episodes (mean nllmber of fever episodes per child: 3.1, mediall 2.0). The 126 
children without a recurrence had 171 fever episodes (mean: lA, median 1.0). 
Table 5.1.1 Ba<;eline characteristics, fever episodes and febrile seizure recurrence 
Recurrence Univariable analysis Multivariable analysis 
Yes n::::29 No n::::126 OR(CI95%) p-value OR(CI95%) p-value 
(100%) (100%) 
Baseline 
characteristics 
Female gender 13(45%) 43(34%) 1.6(0.7-3.6) 0.28 0.89 
Age at study entrya 1.6(l.3-2.l) 1.8(1.42.6) 0.6(0.3-1.1 ) 0.09 1.0(0.5-1.8) 
Number of febrile 2.0(2.0-4.0) 1.0(0.0-2.0) 1.8(1.4-2.4) <0.001 1.8( 1.4-2.4) <0.001 
episodesh 
a median age and 25th-75th percentiles in years 
h median and 25th-75th percentiles 
As shown in Table 5.1.1, in the univariable analysis age at study entry (OR=0.6) and number 
of fever episodes (OR~ 1.8) were associated with febrile seizure recurrence (p<O.IO). The 
other baseline characteristics, including the risk factors for febrile seizure recurrence, were not 
associated with febrile seizure recurrence. In a multi variable model, the number of febrile 
episodes was significantly associated with febrile seizure recurrence. The risk of a febrile 
seizure recurrence was increased with a factor of 1.8 per fever episode in the first six months 
after the last previous febrile seizure. Age at study entry had 110 additional effect on the 
outcome in the multi variable model (OR= t .0). Figure 5. t.1 illustrates that children at young 
age experienced more fever episodes. It can be read from this figure that children with a 
recurrence during follow-up experience more fever episodes. For a given number of fever 
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The number of fever episodes in relation to the age at study entry and febrile seizure 
recurrence, The open cubes show the cases without a febrile seizure recurrence during follow-
up and the black dots represent the cases with a febrile seizure recurrence during follow-up. 
episodes, the risk of recurrence shows no clear association with age. Children at young age 
have more recurrences due to the high number of fever episodes at young age. 
In separate analyses of the randomised controlled trial and the cohort study, no statistically 
significant differences were found in the OR of baseline characteristics with febrile seizure 
recurrence. We also assessed the separate probabilities of febrile seizure recurrence in six 
months follow-up: 21 % in the randomised controlled trial and 15% in the cohort study (X2 , 
p=O.33). 
Discllssion 
The present study demonstrates that the number of fever episodes was a factor independently 
associated with a febrile seizure recurrence in the first six months after the last previous 
febrile seizure. The risk of a febrile seizure recurrence was increased with a faclor 1.8 per 
fever episode; children with febrile seizures who suffer frequently from feverish illnesses have 
a high recurrence risk. Two follow-up studies of children who had had an initial febrile 
seizure found similar results.9,10 Rantala et al. evaluated retrospectively the frequency of fever 
episodes and febrile seizure recurrences, using a mailed questionnaire. After a mean follow-up 
period of 3.8 years, they found that the number of fever episodes was a significant risk factor 
for recurrence of febrile seizures. Unfortunately, no quantification of the relative risk was 
reported.9 Knudsen et al. demonstrated that in the year after an initial febrile seizure, children 
who suffer few fever episodes (defined as less than four per year) had 0.06 times the risk of 
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febrile seizure recurrence of children suffering four or more fever episodes per year (OR 
I: 16),10 Concordantly, when we categorised the number of fever episodes in our study (less 
than two episodes versus two or more episodes per six months) we found a comparable risk 
reduction of 0.09 in the group of children with less than two fever episodes per six months. 
In the present study the mean number of fever episodes per child was 1.7 in six months 
foHow-up. Children with one or more febrile seizure recun'ences had a mean of 3.1 versus 1.4 
in children who experienced no febrile seizure recurrence, illustrating a higher frequency of 
febrile episodes in children with febrile seizure recurrence. In other febrile seizure studies, the 
mean number of fever episodes per child per year has been reported as 3.010 or was calculated 
from the presented data as 1.5 to 1.99,13.14 All these studies had a median follow-up time 
longer than six months. The relatively high estimate of 1.7 fever episodes per six months in 
the present study is likely due to the fact that the risk over time may not be constant, since 
increasing age decreases the incidence (Figure 5,1.1).10 
In the present study the combination of the data of the randomised controlled trial and the 
cohort study is justified, because both are prospective fonow-up studies, which have been 
carried out in the same hospitals, by the same investigators, within a ongoing study period of 
three years (1994-1997). All parents had received similar instructions regarding the use of 
antipyretics and children had not received a standardised dose of ibuprofen during fever. All 
children had a similar follow-up time at risk of six- months. Further analysis of the two 
original studies separately showed no difference with respect to association of baseline 
characteristics with febrile seizure recurrence. 
We reported the six months probdbiJities of febrile seizure recurrence of both studies 
separately (21% and 15%, respectively). The fact that the children who had been participating 
in the randomised controlled trial had one or more risk factors at study entry may explain the 
slightly higher recurrence risk. Further, the recurrence risk of 15% per six months in the 
cohort study is in accordance with previous reported average probabilities of 10 to 20%.3,4 
The association between the number of fever episodes and seizure recurrence may suggest that 
the factor 'chance' plays an important role in the pathophysiology of febrile seizures. The 
more fever episodes a child experiences, the higher will be the probability of another recurrent 
seizure, independent from other risk factors of febrile seizure recurrence. 
Further, the results of the present study may have consequences for the provision of 
information to the parents. If their child usually suffers from frequent fever episodes, they may 
be acquainted of a probably increased risk of seizure recurrence in the first six: months after a 
febrile seizure. If intermittent preventive treatment (Le. diazepam during fever, 1 mglkg body 
weight per day, given in three doses) is considered necessary. because of a very high 
recurrence risk or very frightened parents. the frequency of fever episodes may play a 
additional role in this decision. 14 However, parents may also be reassured because the number 
of fever episodes will decrease if their child grows older; thus, febrile seizure recurrence risk 
will decrease accordingly. 
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Conclusion 
The number of fever episodes is independently assoc'iated with febrile seizure recurrence. 
During the first six months after a febrile seizure the recurrence risk is increased with a factor 
1.8 per fever episode. 
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5.2 Temperature, age and febrile seizure recurrence 
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Summary 
Objective Prediction of a recurrent febrile seizure during subsequent fever episodes. 
Design We studied the data of the temperatures, seizure recurrences and baseline patient 
characteristics, that were collected at a randomized placebo controlled trial of ibuprofen syrup 
to prevent febrlIe seizure recurrences, 
Setting Two pediatric hospitals in the Netherlands. 
Patients 230 children with an increased risk of febrile seizure recurrence. 
Main outcome measure Seizure recurrence during a subsequent fever episode. 
Results We registered 509 fever episodes with 67 recurrences; 35 (52%) recurrences within 
the first two hours after fever onset had a lower median temperature (39.3 0c) than 32 (48%) 
after more than two hours of fever (40.0 °C, p<O.OOI). 
Poisson regression analysis resulted in three univariably significant (p<O.05) predictors of a 
seizure recurrence during [t subsequent fever episode. In a multivariable model, they were 
corrected for their correlation: time interval between the last previous seizure and fever onset 
less than six months (RR~1.3 (CI95%: 0.8-2.4)), age at fever onset (RR~0.7 (CI95%: 0.5-1.0) 
per year increase) and temperature at fever onset (RR~1.7 (CI95%: 1.1-2.8) per 'C increase). 
Analysis of seizure recurrence per six hours time period of fever resulted in sim.ilar 
associations. If we included the temperature at onset of each six hours time interval, the 
prediction showed to be more accurate: a larger relative risk and smal1er p-value. 
Conclusion Half of the recurrent seizures occur in the first two hours after fever onset of a 
subsequent fever episode. If seizure recur at a later time, the temperature at seizure is higher 
compared to recurrences occurring in the first two hours of fever. Young age at fever onset, 
high temperature at fever onset, and high temperature during the fever episode are associated 
with an increased risk of a recurrent febrile seizure at the moment that a child with a history of 
febrile seizures has fever again. 
Introduction 
The last decade, several risk factors for seizure recurrence in children affected by febrile 
seizures have been defined. These include young age at onset, family history of febrile 
seizures, previous recurrent febrile seizures, time lapse since previous seizure less than 6 
months, a low temperature (lower than 40.0 °C) at the initial febrile seizure and a multiple 
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type initial febrile seizure.1-6 Furthermore, frequent fever episodes have shown to be 
associated with an increased risk of recurrent febrile seizures.7,8 However, it is also of 
practical interest to predict a febrile seizure recurrence during subsequent fever episodes. To 
our knowledge, this has never been investigated before. A fever episode is, in fact, the only 
time that the child is at risk to suffer from a recurrent febrile seizure.9 The body temperature 
during a fever episode has been reported to play a role in the development of a febrile 
, 10 11 F h' , k d ' h 46 I h' d ' selzure,' urt er, seIzure recurrence fiS cereases wit age·' ntis stu y we mm to 
clarify the effects of these and other previously reported risk factors for seizure recurrence. 
Therefore, we have examined the temperatures during fever and the baseline patient 
characteristics of 230 children with febrile seizures who participated in a randomized double 
blind placebo controlled trial of ibuprofen to prevent febrile seizure recurrences. 12 We report 
the analysis of factors that predict a seizure recurrence during subsequent fever episodes. 
Patients and Methods 
Patients 
We used the prospectively collected data of 230 patients who participated in a randomized 
controlled trial of ibuprofen to prevent recurrent febrile seizures. To be eligible for the study, 
children had to be between I and 4 years of age and had to have an increased risk of febrile 
seizure recurrence as defined by presence of one Of more of the following characteristics: first 
degree family history of febrile seizures, temperature below 40.0 °C at the initial seizure, 
multiple-type initial febrile seizure and previous recurrent febrile seizures. I ,2,5,6 Children 
currently using anti-epileptic drugs, including intermittent diazepam, were excluded. Children 
were assigned to either ibuprofen 20 mg per ml, 0,25 ml per kg body weight per dose to be 
administered every 6 hours at the time of fever (11= 111), or placebo (n= 119), 12 A febrile 
seizure was defined according to the N.I.H. consensus.9 The study protocol was approved by 
the relevant institutional review boards and the parents of aU participants had given written 
informed consent. 
We used the data of aU patients who experienced one or more fever episodes during follow-
up, as reported by the parents. Data of children that had not yet reached the temperature of 
fever according to our definition (> 38.4 °C), but were recognized by the parents as feverish 
and had a temperature of ~ 38.1 °C were included in the analysis. Furthermore, although 
treatment with ibuprofen influences the course of the temperature, we included the patients 
who either had been allocated to the placebo group or to the ibuprofen group, since the trial 
showed that ibuprofen syrup in this dose was not effective in the prevention of recurrent 
febrile seizures. 12 
Procedures 
According to the protocol, the parents were instructed to take the rectal temperature 
immediately when their child seemed ill or feverish and to start with administering of the 
study medication if the temperature exceeded 38.4 °C. In the present study this moment has 
been defined as fever onset. All temperatures were rectally measured with the Philips HP5316 
thermometer. They were instmcted not to administer any other antipyretic dmg, to continue 
with administering the study medication and to measure the temperature every six hours until 
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the child was afebrile for 24 hours and to measure the temperature at seizure recurrence. If a 
child had a first febrile seizure recurrence after study entry, the study was stopped for that 
child and any subsequent fever episodes were not taken into account. At the first day of fever 
onset and after a recurrent febrile seizure, the child was physically examined. No laboratory 
tests were performed nor antibiotic treatment was started unless indicated by the clinical 
condition of the child. 
Statistical analysis 
The outcome was a febrile seizure recurrence during a subsequent fever episode. 
The analysis only included data from patients having at least one fever episode. Therefore we 
ascertained first if there was any difference in the distribution of baseline patient 
characteristics between the group of children with and the group of children without at least 
one fever episode during foHow-up with logisti~ regression. 7,8 
Temperatures are given in median values, with their 25 and 75 percentiles between brackets. 
We used unpaired and paired non-parametrical tests to analyze differences in temperature at 
fever onset and at seizure recurrence. 
For the analysis of seizure recurrence during subsequent fever episodes we used three types of 
data. 
First, we analyzed the baseline characteristics known at study entry, including gender, age and 
the presence of the known risk factors for seizure recurrence as demonstrated by previous 
studies. I ,2,5,6 
Second, we considered patient characteristics that were unique for each fever episode: age at 
fever onset, the time interval between the last previous seizure and fever onset and the 
temperature at fever onset. 
Third, the data of the temperatures that were measured every six hours during fever were used. 
This analysis considered seizure recurrence in each time period of six hours of fever, using the 
most up to date temperature data available. 
\Ve used Poisson regression analysis to assess the risk of seizure recurrence. 13 For the first and 
second type of data the unit of analysis was a fever episode. For the third type of data the unit 
of analysis was a time period of six hours of fever (a stratum). Follow up time from fever 
onset through 24 hours was divided in four strata of six hours of fever each. The strata 
included the patient characteristics (such as age, gender and temperature), the outcome (=the 
first febrile seizure recurrence for each child after entry into the study) and number of patients 
at risk (=number of patients still having fever). If patients had a fever duration of more than 24 
hours, we constructed a fifth time period including the remaining hours of fever. We also 
analyzed seizure recunence in a time period of six hours of fever. 
We consider the Poisson model suitable, because we study a relatively rare event (=first 
febrile seizure recurrence) in a time interval which has a different duration for each individual 
patient and which consists of one or more separate time periods (=subsequent fever episodes). 
Univariable and multivariable Poisson regression analysis related patient characteristics to 
seizure recurrence. Associations were expressed as rate ratios, which we interpret as relative 
riskS.13 The level of statistical significance was set at 0.05. Calculations were performed with 
SPSS and EGRET. l4•I ' 
89 
Chapter 5 
We report the results of the analyses using data of all randomized patients. However, we 
repeated the analyses using only the data of the patients randomized to placebo to assess 
whether the patients randomized to ibuprofen biased the results in any way. 
Results 
Table 5.2.1 shows the patient characteristics at study entry of all 230 children. There were no 
clear differences in patient characteristics in the 182 (79%) children with at least one fever 
episode compared to the 48 (21 %) children without a fever episode during follow up. 
The parents reported 555 fever episodes. 46 (8%) of the fever episodes were excluded from 
the analysis, because the parents had not registered any of the temperature data during follow 
up. No recurrences occurred in these excluded fever episodes. We further analyzed the 509 
fever episodes, in which 67 (13%) recurrences occurred, Thirty-five (52%) recurrences 
occurred within the first two hours after fever onset compared to 32 (48%) occurring after 
more than two hours of fever. The risk of a recurrence was 7% (35/509) in the first two hours 
after fever onset and 7% (32/(509-35» after more than two hours of fever. 
We analyzed the relation between the temperature and the first febrile seizure recurrence using 
all temperature measurements in the 509 fever episodes. The temperature at seizure recurrence 
was variably and relatively low (39.3 'e (39.0-39.8 'e)) in recurrences occurring in the first 
two hours compared to recurrences occurring after more than two hours of fever (40.0 °C 
(39.6-40.4 'e), p<O.OOI, Mann-Whitney U test). 
Additionally, we analyzed all temperatures measured in the fever episodes in which a seizure 
recurrence occurred at two hours or more after fever onset (n=23 with complete temperature 
data). In those fever episodes the temperature at seizure recurrence (39.6 'e (39.1-40.1 'C) 
was higher compared to the temperature at fever onset (39.3 'e (38.8-39.7 'C), p<O.OI, paired 
Wilcoxon test). 
Table 5.2.2 shows the results of the Poisson regression analysis of seizure recurrence per fever 
episode. Three univariably signific'ant predictors were: time interval between the last previous 
seizure and fever onset, age at fever onset and temperature at fever onset. Age and 
temperature at fever onset had similar effects (RR=O.7) after adjustment for the correlation 
between these three characteristics; age at fever onset lost its statistical significance (p=0.06). 
The analysis was repeated llsing only the data of the fever episodes of the children randomized 
to placebo and showed similar results. 
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Table 5.2.1 Baseline patient characteristics of the study population at study entry (n-230) 
Baseline characteristics: 
Female gender 11=90 (39%) 
Age at initial seizure 1.4 (l.1~1.9? 
First degree family history of febrile 
seizures 11=59 (26%) 
Initial seizure characteristics: 
Temperature<40.0°C 11=121 (53%)h 
Multiple type 11=87 (38%) 
Recurrences before study elltr{: 
o recurrences 11=146 (64%) 
1 recurrence 1l=61 (27%) 
2 or more reCUrrences 1/=23 (10%) 
Risk factors for recllrrenced: 
I or 2 risk factors 11=209 (91%) 
3 or 4 risk factors 1l=21 (9%) 
Age at study entry 1.9 (1.4~2.5? 
Follow-up 0.8 (O.4~l.4t 
a Median in years (25th-75th percentiles) 
;::>: 1 fever episode 
during folIow~up 
n=182 
(79%) 
71 (39%) 
1.4 (1.0-1.9) 
44 (24%) 
93 (51%) 
74 (41%) 
111(61%) 
53 (29%) 
18 (10%) 
163 (90%) 
19 (10%) 
1.9 (1.4-2.4) 
0.8 (0.3-1.5) 
no fever episodes 
during follow-up 
n=48 
(21%) 
19 (40%) 
1.6 (1.2-2.2) 
16 (33%) 
28 (58%) 
13 (27%) 
35 (73%) 
8 (17%) 
5 (10%) 
46 (96%) 
2 (4%) 
1.9 (1.4-2.8) 
0.7 (0.5·1.3) 
OR (CI95%) 
1.0 (0.5-1.9) 
0.7 (0.5-1.1) 
0.6 (0.3-1.2) 
0.7 (0.4-1.4) 
1.8 (0.9-3.7) 
cc 
0.8 (0.5-1.2) 
1.6 (0.9-2.9) 
cc 
2.7 (0.6-11.9) 
0.8 (0.5-1.2) 
1.1 (0.7-1.8) 
p-value 
0.94 
0.17 
0.17 
0.37 
0.09 
0.24 
0.15 
0.20 
0.31 
0.76 
b Temperature measured at time closest to seizure time (documented in the emergency room or in the patient history) 
C Initial seizure not counted a~ recurrence 
d As described in the Patients section 
rc reference category 
Table 5.2.2 Patient characteristics and febrile seizure recurrence per fever episode (n=509) 
univariable analysis multi variable analysis 
RR (CI95%) p-value RR(CI95%) p-value 
Patient characteristics known at study entry 
Female gender 1.5 (0.9-2.5) 0.09 
First degree family history of febrile seizures 0.8 (0.4-1.4) 0.42 
Initial seizure characteristics: 
Temperature < 40.0 °C 1.1 (0.7-1.8) 0.65 
Multiple type 1.6 (1.0-2.5) 0.06 
One or marc recurrences before study entry 0.9 (0.6-1.5) 0.76 
Number of risk factors for seizure recurrence 1.2 (0.9-1.7) 0.28 
Characteristics unique for each feYer episode 
Time interval': 
> 0.5 year rc rc 
:-::; 0.5 year 1.8 (1.1-2.9) 0.02 1.3 (0.8-2.4) 0.32 
Age at fever onsel (in years) 0.7 (0.5-0.9) O.Ot 0.7 (0.5-1.0) 0.06 
Temperature at fever onset (in 0c) 1.7 (1.1-2.8) 0.02 1.7 (1.1-2.8) 0.02 
a time period between last previous seizure and fever onset in years 
rc reference category 
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Table 5.2.3 Patient characteristics and febrile seizure recurrence pcr six hours time period of fever (0-193l) 
univariable analysis 
Patient characteristics known at study entry 
Female gender 
First degree family history of febrile seizures 
Initial seizure characteristics: 
Temperature < 40.0 °C 
Multiple type 
One or more recurrences before study entry 
Number of risk factors for seizure recurrence 
Characteristics unique for each feycr episode 
Time interval"; 
> 0.5 year 
:S 0.5 year 
Age at fever onset (in years) 
Temperature at fever onset (in 0c) 
Characteristics unique for each six hours time period of fever 
Temperature at onset of each six hours (in 0c) 
a time period between last previous seizure and fever onset in years 
RR (CI95%) 
1.5 (0.1-1.5) 
0.8 (0.5-1.5) 
1.1 (0.7-1.8) 
1.7 (1.1-2.8) 
0.9 (0.5-1.5) 
1.3 (0.9-1.7) 
rc 
1.9 (1.1-3.1) 
0.7 (0.5-0.9) 
2.0 (1.2-3.2) 
2.8 (2.0-3.9) 
p-value 
0.10 
0.54 
0.69 
0.02 
0.64 
0.17 
0.01 
0.01 
om 
<0.001 
b variables included in the multivariable model: time interval, age and temperature at fever onset 
C variables included in the multi variable Glodel: time interval, age at fever onset and temperature at onset of eaeh six 
hours time interval of fever 
rc reference category 
Figure 5,2,1 shows the relation between age and temperature at fever onset versus the risk of a 
febrile seizure recurrence in the corresponding fever episode, The figure illustrates that the 
risk of a recurrence increases with temperature at fever onset and decreases with age, The 
lines indicate four arbitrarily chosen recurrence risks: 5%, 10%, 20% and 30%, For example, 
if the temperature at fever onset is 40.0 °C, a child aged one year has a 30% recurrence risk in 
Ihe corresponding fever episode. This risk is between 5% and 10% for a 4-year-old child. 
". 
". 
Figure 5.2.1 
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Prediction of recurrence 
multivariable analysisb multi variable analysisC 
RR (CI95%) p-value RR (CI95%) p-valuc 
rc rc 
1.4 (0.8-2.5) 0.28 1.9 (1.0-3.5) 0.04 
0.7 (0.5-1.0) 0.05 0.8 (0.5-1.1) 0.19 
2.0 (1.2-3.2) om 
2.9 (2.1-4.0) <0.001 
Table 5.2.3 shows the results of the Poisson regression of seizure recurrence per six hours 
time period of fever. The associations were similar to the associations in the model predicting 
seizure recun'ence per fever episode (Table 5.2.2). In a multivariable analysis we included the 
three characteristics that were univariably significant in all analyses. If we included the 
temperature at onset of each six hours time period of fever, in stead of the temperature at fever 
onset, the multi variable relative risk was higher (2.9 versus 2.0) and the p-value smaller 
(p<O.OOI versus p=O.OI). The analysis using only the data of the children randomized to 
placebo gave similar results (RR=2.5(1.7-3.9), p<O.OOOI, for the temperature at onset of each 
six hours time period of fever). 
Discussion 
The present study shows that half of the febrile seizure recurrences during a subsequent fever 
episode occur within the first two hours of fever. Accordingly, other febrile seizure studies 
show that a substantial part of the seizure recurrences occur early in the fever episode and that 
febrile seizure recurrences are often the presenting symptom of a feverish illness. 16-18 
However, previous studies have not demonstrated that the temperature at seizure recurrence in 
the first two hours after fever onset is clearly lower compared to the temperature at 
recurrences more than two hours after fever onset. These findings suggest a seizure provoking 
effect of either the temperature increase, or the high temperature level that has been reached. 
Furthermore, it might be that febrile seizures occurring after a short duration of fever are 
occurring in a different (more vulnerable) type of patients than seizures occurring later on. 
Follow up studies may give insight in the consistency of this pattern in the individual patient. 
At least, initial febrile seizures occurring after a short duration of fever are associated with an 
increased risk of recurrence.4 
93 
Chapter 5 
Age plays an important role in the susceptibility of febrile seizures; the risk of seizure 
d I· . I . Id 126 19 20 If h . . d··d I h h recurrence ec mes Wit 1 groWlI1g 0 er."" t ere IS an III IV! ua temperature t res old 
level above which a febrile seizure will develop, this threshold is influenced by age: the older 
the child grows, the higher the threshold, the lower the risk. The results of our study are in 
accordance with these hypotheses and findings: age showed to be associated with a seizure 
recurrence, although in the multivariable model the level of statistical significance was not 
reached (p~0.06). Independently from either being longer at risk, or getting higher 
temperatures during fever, young age is associated with an increased recurrence risk, 
The other predictor of recurrent febrile seizures is the temperature: per degree increase in 
temperature at fever onset, the risk of a febrile seizure increases with a factor 1.7 and per 
degree increase in temperature measured every six hours, the risk is increased 2.9 times. To 
address any difficulty regarding the interpretation of these findings with respect to the 
inclusion of children who had been using antipyretic treatment during their fever episodes, we 
have repeated the Poisson analyses using only the data of children randomized to placebo. No 
differences were found. Clinical studies in children with febrile seizures have shown that a 
relatively low temperature (below 40.0 °C) at the initial seizure is associated with an increased 
risk of recurrent febrile seizures.6,10 Accordingly, in a matched case-control study risk factors 
for developing an initial febrile seizure have been investigated; the height of the temperature 
as a characteristic of the acute illness showed to be an independent risk factor. 21 These studies 
suggest that a febrile seizure temperature threshold exists and that a higher risk of febrile 
seizures is related to a lower threshold level. The results of our study support this hypothesis. 
In our data set, multiple type initial febrile seizures was the only baseline characteristic and 
known risk factor that predicted a febrile seizure recurrence at the time the child has fever 
(Table 5.2.3). In contrast with this finding, other studies concerning risk factors for recurrence 
show that multiple type initial febrile seizures is a relatively weak factor compared to a 
positive first degree family history of febrile seizures, a low (below 40.0 0c) temperature at 
the initial seizure, one or more previous recurrences and time lapse since previous seizure not 
exceeding six months. 3,4,6.8 The absence of association between the known risk factors and 
seizure recurrence in the present study should not be interpreted as lack of importance of these 
risk factors. Only children with an increased risk of febrile seizure recurrences have been 
included. Selection based on high risk criteria reduces the power of the study to identify these 
criteria as high risk factors. If also children with a lower recurrence risk had been included, 
the relative risks might have been different and the known risk factors might have been found 
associated with seizure recurrence. Further, we have studied recurrent seizures in a different 
way, i.e. the prediction of recurrences specifically at the time the child has fever, which might 
explain the different results. 
One might argue that we found the temperature the most important predictor of febrile seizure 
recurrence, because some temperature data were missing; high temperatures might have been 
measured more frequently than low temperatures. However, it is not very likely that this 
mechanism has caused a bias in our analysis, because it is unlikely that measuring the 
temperature is related to the occurrence of a seizure recurrence. However, the main limitation 
of our study is that the data can not be used to analyze the influence of the rapidity of 
temperature increase on the risk of seizure recurrence. For the convenience of the participants 
in the study, the temperature measurements during fever were scheduled at every six hours, 
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simultaneously to the administering of the study medication, without measurements in 
between. If continuous data had been available, we might have clarified whether the 
temperature itself, the rapidity of increase, or both, are the main febrile seizure eliciting 
factors. 
This study was performed mainly to contribute to the scientific insight regarding fever and 
febrile seizures. The findings may also have practical implications for the information 
provided to parents of children affected by febrile seizures. It might be reassuring information 
for parents to hear that half of the febrile seizure recurrences occur within the first two hours 
of fever. Thus, after two hours of fever, the risk of a recurrent seizure is substantially lower. 
The older the child grows, the lesser the recurrence risk, even when suffering from fever. The 
high temperature at fever onset and during the course of the fever episode is a more difficult 
thing to discuss. Prevention of fever rising high may only be reached by undressing and 
uncovering of the child. The number of fever episodes might be reduced by eliminating 
sources of infection. Antipyretic treatment of the child has not been shown effective in 
preventing febrile seizure recurrences.12.22-24 The underlying cause of the fever may playa role 
in the ineffectiveness of antipyretics to prevent seizure recurrence. The cause of the fever 
either may give rise to a resistance to fever reducing treatment or may have an inherent 
provoking effect on a febrile seizure recurrence. 
Conclusion 
We conclude that approximately half of the recurrent seizures occur in the first two hours after 
fever onset. If the recurrent seizure occurs at a later moment, the temperature at seizure will be 
higher compared to occurrence of the seizure in the first two hours of fever. Furthermore, the 
risk of a febrile seizure recurrence, at the moment that a child with a history of febrile seizures 
has fever again, decreases with age and increases with temperature at fever onset and 
temperature during fever. 
References 
1. Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics 1978;61:720-727. 
2. Verity CM, Butler NR, Golding J. Febrile convulsions in a national cohort followed up from birth. I: 
Prevalence and recurrence in the first year of Hfe. DMJ 1985;290:1307-1310. 
3. Berg AT, Shinnar S, Hauser WA, Leventhal JM. Predictors of recurrent febrile seizures: a metaanalytic 
review. J Pediatr 1990;116:329-337. 
4. Berg AT, Shinnar S, Hauser WA, Alemany M, Shapiro ED, Salomon ME, Crain Er. A prospective 
study of recurrent febrile seizures N Engl J Med 1992;327: 1122-1127. 
5. Esch A van, Steyerberg EW, Berger MY, Offringa M, Derksen-Luhsen G, Habbcma JDF. Family 
history and recurrence of febrile seizures. Arch Dis Child 1994;70:395-399. 
6. Offringa M, Bossuyl PMM, Luhsen J, Ellenberg JH, Nelson KB, Knudsen FU, Annegers JF, EI-Radhi 
AS, Habbema JDF, Derksen-Lubsen G, Hauser WA, Kurland LT, Banajeh SMA, Larsen S. Risk factors 
95 
Chapler 5 
for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data of 
five studies. J Pediatr 1994;124:574-584. . 
7. Knudsen PU. Frequent febrile episodes and recurrent febrile cOIlYulsions. Acta Neural Scand 
1988;78:414-417. 
8. Rantala H, Uhari M, Risk factors for recurrences of febrile convulsions. Acta Neurol Scand 
1994;90:207-210. 
9, National Institutes of Health Consensus Statement. Febrile Seizures. Pediatrics 1980;66: 1009-1012. 
10, EI-Radhi AS, Banajeh S. Effect of fever on recurrence rate of febrile convulsions. Arch Dis Child 
1989;64:869-870. 
11. Berg AT. Arc febrile seizures provoked by a rapid rise in temperature? AlOe 1993;147: 1101-1103. 
12. Stuijvenberg M van, Derksen-Lubsen G, Sleyerberg EW, Habbema JDF, Moll HA Randomized 
controlled trial of ibuprofen to prevent febrile seizure recurrences, Accepted in Pediatrics, 1998, 
13. Frome EL, Checkoway H. Use of Poisson regression models in estimating incidence rates and ratios. 
And Epidem 1985;121:309-323. 
14. SPSS version 6.0 for Windows, SPSS Incorporated, Chicago, Illinois, USA, 1993. 
15. EGRET statistical package, Statistics and Epidemiology Research Corporation, Seattle, Washington, 
USA,1990. 
16. Rosman NP, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye EM, Bennekom van C, Winter MR. A 
controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile 
seizures. N Engl J Med 1993;329:79-84. 
17, Daugbjerg P, Brems M, Maj J, Ankerhus J, Knudsen FU. Intermittent prophylaxis in febrile 
convulsions: diazepam or valproic acid? Acta Neurol Scand 1990;82(1): 17-20, 
18. Knudsen FU. Effective short term diazepam prophylaxis in febrile convulsions. J Pediatr 1985; 106:487-
490. 
19. Shirts SB, Annegers JF, Hauser WA. The relation of age at first febrile seizure to recurrence of febrile 
seizures. Epilepsia 1987;28:625. 
20. Berg AT, Shinnar S, Darefsky AS, Holford TR, Shapiro ED, Salomon ME, Crain EF, Hauser AW. 
Predictors of recurrent febrile seizures, A prospective cohort study. Arch Pediatr Adolesc Med 
1997;151(4):371-378. 
21. Berg AT, Shinnar S, Shapiro ED, Salomon ME, Crain EF, Hauser WA. Risk factors for a first febrile 
seizure: a matched case-control study. Epilepsia 1995;36(4):334-341. 
22. Camfield PR, Camfield CS, Shapiro SH, Cummings C, The first febrile seizure-antipyretic instruction 
plus either phenobarbital or placebo to prevent recurrence, J Pediatr 1980;97:16-21. 
23. Schnaidermann D, Lahat E, Sheefer T, Adjalem M. Antipyretic effectiveness of acetaminophen in 
febrile seizures: ongoing prophylaxis versus sporadic usage. Eur J Pediatr 1993;152:747-749,' 
24. Uhari M, Rantala H, Vainionptiti L, Kurttila R. Effect of acetaminophen and of low intermittent doses of 
diazepam on prevention of recurrences of febrile seizures. J Pediatr 1995; 126:991-995. 
96 
6 
Genetic aspects 

6.1 Characteristics of the initial seizure in familial febrile seizures 
Margriet vall Stuijvellberg, Eline vall Beijerell, Nathalie H Wi/s, Gerarda Derksen-Lubsell, Cornelia AI 
~'alJ Duijn alld HelJriiHle A Moll 
Summary 
We studied complex seizure characteristics in patients with a positive family history to define 
familial phenotype subgroups of febrile seizures. Fifty-one children with one or more affected 
first degree relatives and 177 without an affected first degree relative were compared 
regarding history of complex characteristics of the initial febrile seizure. No difference was 
found in the frequency of febrile status epilepticus (OR=l.l (0.3-4.3)), multiple type (OR=0.6 
(0.3-1.2)) and focal characteristics (OR=O.4 (0.2-1.2)). The presence of any complex 
characteristic (OR=0.5 (0.3-1.0)) was higher in those without an affected first degree relative, 
although differences did not reach the level of statistical significance. The familial type of 
febrile seizures is not associated with complex characteristics of the initial febrile seizure. 
Complex seizure characteristics are unlikely to help in discriminating phenotype subgroups 
for genetic studies of febrile seizures. 
Introduction 
Although the genetic basis of febrlle seizures is still unknown, several findings suggest a 
genetic origin of febrile seizures. Febrile seizures are known to aggregate in families; 18 to 
40% of affected children have affected relatives and monozygotic twin concordance varies 
between 19% and 69%, depending on the sampling method of the study.'·6 A polygenic 
aetiology is suggested in some families, in addition to an autosomal dominant inheritance 
pattern observed in others.6.7 One study found different inheritance patterns, depending upon 
whether the patients had suffered recurrent febrile seizures.8 A positive family history of 
febrile seizures is one of the major risk factors for febrile seizure recurrence; if first degree 
relatives are affected, the recurrence risk is increased and may rise up to 80%.2-5,9 Clearly, the 
frequency of febrile seizure recurrences is an important phenotype feature of children with a 
familial type of febrile seizures. An increasing number of genes are identified for epileptic 
disorders but no genes for febrile seizures specifically have been localised up until now. An 
important step into the localisation of genes involved in febrile seizures will be the dissection 
of the heterogeneous group of children with febrile seizures into subgroups of patients with a 
more homogeneous phenotype. 
We examined whether familial febrile seizures can be characterised by complex seizure 
characteristics. Characteristics of the initial febrile seizure were compared between children 
with one or more affected first degree relatives and children without an affected first degree 
relative. 
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Patients and Methods 
Paliellis 
Children who consecutively visited the Sophia Children's Hospital Rotterdam Of the Juliana 
Children's Hospital The Hague between 1994 and 1996 with a febrile seizure were considered 
for inclusion. They were selected from the prospective febrile seizure registration, established 
at the paediatric department of the Sophia Children's Hospital Rotterdam since 1988. The 
paediatric department of the Juliana Children's Hospital The Hague joined this registration in 
1994. All patients in this registration visited the febrile seizure outpatient clinic within two to 
four weeks after a febrile seizure. In addition to routine patient follow-up, baseline 
characteristics of the patients were registered, including the family history. A febrile seizure 
was defined according to the NllI-consenslls for febrile seizures, excluding any seizure caused 
by an underlying abnormality and excluding any seizure occurring after a previous non-febrile 
seizure. 10 Children with an unknown family history were excluded from the analysis. Children 
with a non-Caucasian origin were excluded to obtain a genetically homogeneous study 
sample. 
Children were included in the case group, if they had one or more first degree relatives 
affected with febrile seizures: parents, brothers and sisters. The referent group consisted of all 
children who had no first degree relatives affected by febrile seizures. 
Data collection 
The following data were studied: baseline characteristics, including age at the initial febrile 
seizure (age at onset), gender, and the presence of complex characteristics of the initial febrile 
seizure. A seizure was defined as complex, if the seizure lasted 30 minutes or longer (febrile 
status epilepticus) andlor if the seizure recurred within 24 hours (multiple type) andlor if the 
seizure had a focal onset or a postictal Todd's paresis of facial muscles or limbs (focal 
characteristics).I,II,12 Seizure characteristics were determined based on the history given by 
the parents or other witnesses of the seizure, or on the documentation in the patient chart. If 
characteristics of the initial seizure were unknown, these were considered missing values. 
For the analysis, the status affectus of the second and further degrees was not taken into 
account. Siblings and parents with epileptic disorders but without a history of febrile seizures 
were considered not affected. 
Statistical analysis 
The relation between the characteristics of the initial febrile seizure (febrile status epilepticus, 
multiple type and focal characteristics) in the case group and the control group was estimated 
using logistic regression analysis. Odds Ratios (OR) were used as the measure of association; 
associations were statistically significant (p<0.05) if the 95% confidence interval of the OR 
did not include the value one. SPSS 6.0 for Windows was used for the analysis. 
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Results 
Of all 478 children who had visited one of the two participating hospital because of a febrile 
seizure betweell 1994 and 1996, 240 children were of non-Caucasian origin. In 10 of the 
remaining eligible children, the family history was unknown. Thus, 228 children entered the 
study. 
Of them, 51 (22%) children had at least one affected first degree relative and were included in 
the case group: 14 (27%) of the 51 children had one or more affected siblings, 3 I (61 %) had 
one affected parent and 6 (12%) had one affected parent and one or more affected siblings. 
The referent group comprised 177 (78%) of 228 children without a first degree relative 
affected by febrile seizures. 
Table 6.1.1 shows the baseline characteristics and the characteristics of the initial febrile 
seizure of the cases and the referents, Using logistic regression, no difference was shown in 
age at onset and gender. Febrile status epilepticus did not differ between the two groups; 
multiple type and focal characteristics were counted more frequently in the referent group; the 
presence of any complex characteristic was observed more frequently in the referent group, 
although differences did not reach the level of statistical significance (p=O.07). The number of 
complex characteristics per seizure neither showed a difference between the case and the 
referent group. 
Table 6.1.1 Baseline characteristics and characteristics of the initial febrile seizure 
Baseline characteristics 
Age at onseta 
Female gender 
Initial seizure characterislics 
Febrile status epilepticusb 
MUltiple typcC 
Focal characteristicsd 
Any complex characteristic 
Number of complex characteristicse 
0 
I 
2 
3 
a median and 25th~75th percentiles (years) 
b missing values: 3 (6%) versus 19 (11%) 
C missing values: 3 (6%) versus 14 (8%) 
d missing values: 12 (23%) versus 72 (41%) 
Cases 
11=51 
1.3 (1.0·2.2) 
19 (37%) 
3 (6%) 
II (22%) 
5 (10%) 
14 (27%) 
36(71%) 
9 (18%) 
5(10%) 
e analysed as a continuous variable: OR=0.7 (0.4-1, I), p=O.14 
rc reference category 
Referents 
n=l77 
1.5 (1.2·2.2) 
73 (41%) 
9 (5%) 
56 (32%) 
27 (15%) 
72 (41%) 
97 (55%) 
52 (29%) 
20 (11%) 
OR (95%Cl) p-value 
Univariable 
0.8 (OS!.!) 0.19 
0.8 (0.4-1.6) 0.61 
l.l (0.3-4.3) 0.89 
0.6 (0.3-1.2) 0.14 
0.4 (0.2·1.2) 0.11 
0.5 (0.3·1.0) 0.07 
r.c. 
1.5 (0.9·2.4) O.ll 
0.7 (0.4·1.2) 0.21 
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Discussion 
This study demonstrates that the familial type of febrile seizures is not likely associated with 
complex characteristics of the initial seizure. Thus, defining a phenotype subgroup associated 
with complex seizure characteristics Illay be unhelpful in genetic studies to localise genes 
involved in febrile seizures. The study results suggested even higher frequencies of complex 
seizure characteristics in the referent group, although differences were not statistically 
significant. These results are supported by a study that showed no difference in 'seizure 
severity' in familiar versus non-familiar febrile seizures. In the previous study, no further 
specification was made on how seizure severity was defined and whether or not complex 
seizure characteristics were considered,13 Another familial febrile seizures study suggested 
that the proportion of complex febrile seizures was higher among multi-case (familial) 
compared to single-case (non-familial) probands. Statistical signit1cance, however, was not 
reached,6 The results of the present study are in accordance with these previous studies, 
A large population-based study of 2609 relatives (parents, siblings, children, nieces, nephews 
and half-sibs) of 421 children with febrile seizures investigated the risk for the development 
of febrile seizures in siblings. Besides frequent recurrent seizures, complex seizures in the 
proband showed to be associated with an increased risk of febrile seizures in siblings, which 
may suggest that complex seizures are associated with a familial predisposition. I In a recent 
study of 398 first degree relatives of 129 children with febrile seizures, the risk of febrile 
seizures in siblings was studied. This risk was increased when the proband had had recurrent 
febrile seizures. Unfortunately, complex characteristics were not considered in the analysis.'4 
These two previous studies have used a different strategy to investigate phenotype subgroups 
which may be helpful to study the hereditary basis of febrile seizures. Their approach has been 
based on studying a sample of the relatives of the proband. Thus, their results can not easily 
be compared with ours. Both previolls studies provided evidence for recurrent febrile seizures 
and one of them also for complex seizure characteristics', to be interesting phenotype 
subgroups in studying the hereditary basis of febrile seizures. I ,14 
The limitation of the present study is the high number of missing values regarding focal 
seizure characteristics. This is likely to be due to the relative difficulty of recognising a focal 
seizure feature. In a study assessing the accuracy of the classification of complex 
characteristics of febrile seizures, experienced paediatric neurologists showed most often 
disagreement regarding assessment of focal seizure characteristics. Their disagreement 
concerning multiple and prolonged characteristics was clearly 10wer.11 
In conclusion, we provided no evidence for association between the familial type of febrile 
seizures and complex characteristics of the initial febrile seizure of the proband. This does not 
exclude the existence of other clinical features, i.e. characteristics of the seizure, specific for 
patients with fan~i1ial forms of febrile seizures. Complex febrile seizure characteristics, 
however, are unlikely to help in discriminating phenotype subgroups for genetic studies of 
febrile seizures. 
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6.2 No evidence for febrile seizures linked to genetic markers on 
chromosome 8q and 20q 
Margriel mil StllijveniJerg, Peler Heflfillk, Leoll Testers, Lodewijk A Sandkuij/, Dick Lil/cllIO/tt, Gerarda 
Derkscn-LubsclI, Cornelia At \'all Duijll and Henriette A Moll 
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SUl1l1nary 
illtroductioll Familial clustering indicates a genetic contribution to the predisposition of 
febrile seizures. One previous study on a large family with multiple affected persons has 
provided a suggestion for a gene 011 chromosome 8q for febrile seizures. For benign familial 
neonatal convulsions (BFNC) evidence for linkage on chromosome 8q and 20q has been 
described. Because of the clinical association of BFNC with febrile seizures both loci are 
candidate regions for febrile seizures in the general population. 
Patients We have studied markers of chromosome 8q and 20g surrounding the two loci in 72 
affected sib pairs with febrile seizures. Of these pairs 55 were of Caucasian origin and 17 
were of other origins including Turkey, Morocco, the Philippines and Surinam. 
Ale/hods Affected sib-pair analysis was performed on genotypes from five microsatellite 
markers (DSS 1132, DSS592, DSS 1179, D20S IOS5 and D20S171). 
Results \Ve found no evidence for linkage between febrile seizures and the chromosomes 
studied. In the Caucasian sib-pairs linkage to chromosome 20q (52 sib-pairs tested) and Sq (30 
sib-pairs tested) could be excluded (Iod score -2). The maximum percentage of alleles shared 
between affected siblings was 68% in the non-Caucasian population on chromosome 20 
(multipoint maximum lad score 0.63). This observation, however, is based on 12 sib-pairs. 
Conclusions The present study provides no evidence for involvement of loci on chromosome 
20g and 8q in febrile seizures. A wide search of the genome and enlargement of the sample is 
necessary to localise genes predisposing for febrile seizures. 
Introduction 
Febrile seizures is a common seizure disorder with a prevalence of 3.9% in Dutch 
schoolchildren.' In the United States and Great Britain approximately 2 to 5% of all children 
has been affected?,3 These seizures occur in association with fever during childhood, without 
an underlying defined cause:~ There is some evidence for a genetic origin, but the specific 
contribution of genetic factors as well as the mode of inheritance are still unclear.5~7 
Suggestions for a genetic loclls on chromosome 8q13-21 linked to febrile seizures have been 
found recently in one large family with multiple affected persons.8 Febrile seizures are 
prominent in some families with benign familial neonatal convulsions (BFNC).9,10 A lOCHS for 
BFNC has been identified on chromosome 20g, later another locus for BFNC has been 
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reported on chromosome 8q.9,ll-13 Other linkage studies failed to confirm that these BFNC-
genes on chromosome 8 Of 20 are implicated in febrile seizures. IO,14 Recently, mutations in a 
novel potassium channel gene on chromosome 20q13.3 (KCNQ2) were found to co-segregate 
in large BFNC families, IS In one BFNC family a mutation in a novel potassium gene in co-
segregation with the BFNC phenotype was identified on chromosome 8q24 (KCNQ3).'6 
Chromosome 8q locus and perhaps also the BFNC locus on chromosome 20q arc candidate 
regions for febrile seizures in the general population. We have studied several polymorphic 
markers flanking the loci on chromosome 8q and 20q in 72 sib pairs with febrile seizures. 
Patients and Methods 
Patiellis 
Families (11::::;68) were selected using the available clinical data of the patients who had visited 
the Sophia Children's Hospital Rotterdam between 1988 and 1997 or the Juliana Children's 
Hospital Den Haag between 1992 and 1997 for a febrile seizure. Two families were included 
in collaboration with regional hospitals (n=1) and general practitioners (n=1). After an 
announcement in a popular monthly magazine (1997) 10 additional families were recruited. 
Written informed consent was obtained from all 80 participating families according to the 
international guidelines and national legislation. The study protocol was approved by the local 
ethical review boards. 
Families were eligible if there were two or more siblings or half~siblings with febrile seizures 
in the family. A febrile seizure was defined according to the NIH Consensus Meeting as 'an 
event (sudden loss of consciousness, eventually accompanied with tonic-clonic muscular 
contractions) in infancy or childhood, usually occurring between 3 months and 5 years of age, 
associated with fever but without evidence of intracranial infection or defined cause. Seizures 
with fever in children who have suffered a previous nonfebrile seizure are excluded'.4 All 
participants were interviewed by one of us (MvS). By means of a standard questionnaire the 
diagnosis was verified according to these criteria. Additional or diagnostic information was 
asked from the patients' general practitioner, neurologist or paediatrician. Eight families were 
excluded from the present analysis because the diagnosis could not be verified. Thus, the 
present study included 72 families. 
Familes were defined non-Caucasian if one of the two parents or both parents were of non-
Caucasian origin. Otherwise, families were defined of Caucasian origin. 
DNA silldies 
Genomic DNA was isolated from peripheral blood as described by Miller et al. 17 Microsatel-
lite markers were tested in multiplex reactions essentially as described by Weber and Mayl8 
using AmpHtaq Gold™ according to the manufacturers protocol. peR reactions were 
performed in 96 well plates in a Perkin-Elmer-Cetus 9600 Thermocycler. Initial denaturation 
was 15' at 95°C followed by 32 cycles of 30" denaturation at 95°C, 301t annealing at 57°C and 
90" extension at 72°C. After 25 cycles a final extension time of 51 at 72°C was used. Primers 
were labelled with three different fluorescent dyes; 6-carbofluorescein (FAM), 4,7,2',4' ,5',7'-
hexachloro-6-carbofluorescein (HEX), and 4,7,2' ,7'-tetrachloro-6-carboxyfluorecein (TET) 
and visualised on the ABI PRISM'" 377 as blue, green, and yellow respectively. 
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Information for microsatellite markers D8S 1132, D8S592, D8S 1179 (chromosome 8), 
D20S 1085 and D20S 171 (chromosome 20) was obtained from the Genome DataBase 
(GDB).19 Marker order was also obtained from GDB. 
Slatislieal analysis 
Relative population frequencies of marker alleles were estimated from all observed genotypes, 
with correction for family relationships20, using the ILINK option of the LINKAGE program 
package, version 5.D3?1 The following marker order and intermarker distances were used in 
the multipoint sib-pair analysis: D8S1132 - 6 centiMorgan (cM)- D8S592 - II cM - D8SI179 
and D20SI085 - 13 cM - D20S17!. In addition to the multipoint analysis a single-point 
analysis was performed. 
Affected sib-pair analysis was performed using the MAPMAKERISIBS programme", 
simultaneously including marker information for all markers in a given chromosomal area, 
using the 'dominance variance' (non-restrictive) model. To assess whether any discrepancy 
existed, in addition a 'no dominance variance' (additive) model was used. Using this 'no 
dominance variance' model we considered a strict function of the number of alleles shared to 
estimate the risk of disease in siblings. The 'dominance variance' model does not include this 
restriction; only a higher lad score significance threshold (3.3) has to be defined. When more 
than two affected sibs occurred in a single sibship weighted scores were computed according 
to Suarez and Hodge.23 
Tn a sib-pair analysis the sharing of parental marker alleles between sibs is evaluated. 
Normally 25% of sib-pairs share their marker alleles from both parents, 50% share one marker 
allele from one of their parents, while the remaining 25% share no parental allele. Deviations 
from this pattern towards increased sharing and consistent with the constraints of Holmans' 
possible triangle are explained as linkage and expressed as maximum lod score (MLS).24 
In addition, exclusion analyses were performed for which we used the 'no dominance 
variance' model. The A-sib was defined as 2.7, which means that siblings of patients with 
febrile seizures have a 2.7 times increased risk of developing febrile seizures?5 
Not all of the 72 families were analysed for both chromosome 8q and 20q. We started with 
genotyping and analysing a sample of 45 families including both Caucasian and nOI1-
Caucasian families for chromosome 8q and 2Dq. In the next phase of the study 27 families of 
Caucasian origin were genotyped and analysed for chromosome 20q; of them, 19 were also 
genotyped and analysed for chromosome 8q. 
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Results 
Study population chm'acleristics 
Of the 72 participating families 55 (76%) were of Caucasian origin. In 4 families only I parent 
was available for genotyping. In 14 families there were more than two affected siblings: 13 
had three and I had five affected siblings. The characteristics of the study population are 
shown in Table 6.2.1. The median time interval between the initial seizure and study entry 
was 5.0 (2.3-10.0) years. 
Table 6.2.1 Characteristics of the study population (affected siblings) 
Characteristics 
Female gender 
Age at study entry in yearsa 
History of recurrent febrile seizures 
Initial seizure characteristics: 
Age in yearsa 
Multiple typeb 
Febrile status epilepticusC 
Focal featuresd 
a median (25-75 percentiles) 
b one or more recurrent seizures within 24 hours 
C seizure duration of ~30 minutes 
Total n= 160 (100%) 
77 (48%) 
6.2 (3.8·9.2) 
91 (57%) 
1.4 (1.1·2.1) 
40 (25%) 
24 (15%) 
7 (4%) 
d focal onset of the seizure and/or postictal Todd's paresis of facial muscles or limbs 
Idelttity by desceltt 
The results of the total sample are shown in Table 6.2.2. The percentages of alleles shared 
were generally not higher than 50%, suggesting that a febrile seizure locus is unlikely 
localised in the regions studied. 
Table 6.2.3 and 6.2.4 show Ihe results of separate analyses for the Caucasian and the non-
Caucasian families. In the Caucasian families the percentage alleles shared remained close to 
50%, with the exception of the multipoint results of chromosome Sq (alleles shared 5S%, Iod 
score 0.29, 30 pairs), which was also shown by the overall analysis. Single-point analysis of 
the D8S 1132 marker gave similar results compared to the multipoint analysis. In the 
Caucasian sib-pairs linkage to chromosome 20g (52 sib-pairs tested) and Sq (30 sib-pairs 
lestcd) could be excluded (Iod scores lower than -2). The non-Caucasian families showed 
increased allele sharing on chromosome 20q to 68%, which implies a slight suggestion of 
linkage (Iod score 0.63). Single poinl analysis for marker D20S IOS5 resulted in an increased 
number of alleles shared (75%) with a lod score of 0.S7. 
lOS 
Genetic aspects 
Table 6,2,2 Allele sharing in sib-pairs (overall)" 
i\larkers No dominancc variance Dominance variancc % informativcness 
allele sharing lodscorc allele sharing lodscore 
Chromosome 8 
DBSI132 0.55 O.IS 0.55 0.18 0.74 
DSS592 0.50 0 0.50 0 0.42 
DBSI179 0.55 0.11 0.55 0.11 0.65 
Hflpiotypc/multipoint 0.57 0.34 0.57 0.34 0.64·0.83 
Chromosome 20 
D20S1085 0.54 0.12 0.55 0.14 0.50 
D20S171 0.50 0 0.50 0 0.55 
Haplotype/multipoint 0.51 0 0.51 0.01 0.49·0.64 
a Number of families tested: n=45 (chromosome 8) and n:::64 (chromosome 20) 
Table 6,2,3 Allele sharing in sib-pairs (Caucasian subpopulalion)a 
Markers No dominance variance Dominance variance % informativeness 
alleles shared lodscore alleles shared lodscore 
Chromosomc 8 
D8S1132 0.58 0.3 0.58 0.3 0.72 
D8S592 0.50 0 0.50 0 0.41 
D8S1179 0.55 0.09 0.55 0.09 0.71 
Haplotype/multipoint 0.58 0.29 0.58 0.29 0.67·0.80 
Chromosome 20 
D20SI085 0.50 0 0.50 0 0.45 
D20SI71 0.50 0 0.50 0 0.66 
Haplotype/multipoint 0.50 0 0.50 0 0.49·0.72 
a Number of families te.sted: n-30 (chromosome 8) and n-52 (chromosome 20) 
Table 6,2,4 Allele sharing in sib-pairs (non-Caucasian sUbpopulation/ 
Markers No dominance variance Dominancc variance % informativeness 
alleles shared lodscore alleles shared lodscore 
Chromosome 8 
D8S1132 0.50 0 0.50 0 0.78 
D8S592 0.58 0.09 0.58 0.09 0.46 
D8S1179 0.54 0.11 0.59 0.17 0.53 
Haplotype/multipoint 0.55 0.07 0.59 0.29 0.60·0.88 
Chromosomc 20 
D20S1085 0.75 0.87 0.75 0.B7 0.71 
D20SI71 0.50 0 0.50 0 0.07 
Hflpiotype/multipoint 0.69 0.59 0.68 0.63 0.29·0.74 
a Number of families tested: n-15 (chromosome 8) and n-12 (chromosome 20) 
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Discussion 
In a previous study a suggestion for linkage of febrile seizures to a locus on chromosome 
8q13-21 in one large family with multiple affected persons has been found,' BFNC is a 
seizure disorder occurring in newborns. These seizures have been observed to be followed by 
febrile seizures in some families. 9,JO A locus for BFNC has been identified on chromosome 
20g and later also on chromosome 8q.9,11-13 The role of these chromosomes in BFNC was 
confirmed by the finding of co-segregating mutations 011 chromosome 20q13.3 and 
chromosome Sq24. 15 ,16 The localisation of these mutations reveals the implication of 
potassium channel genes (KCNQ2 and 3) in BFNC. Possibly, these mutations may also be 
involved in other inherited 
types of epilepsy and in febrile seizures. Other linkage studies, however, have failed to 
confirm that BFNC-genes on chromosome 8 or 20 are implicated in febrile seizures. 1O,14 
Accordingly, one other recently published study of one large family with multiple subject 
affected by febrile seizures excluded linkage to the chromosome 8 locus in an extended family 
with febrile seizures·26 
The present study failed to show linkage between febrile seizures and the loci studied, 
Findings were consistent in the families of Caucasian and non-Caucasian origin. The separate 
analysis of the Caucasian families showed no evidence for linkage of chromosome 8q and 
20q. The results of the genotyping of chromosome 20q in the Caucasian families have been 
not suggestive for a gene on this region of the chromosome. Although a slightly higher 
percentage of alleles shared (58%) of chromosome 8 was seen in multipoint and single point 
analysis, the exclusion analysis in the Caucasian sib-pairs showed clearly that linkage to 
chromosome 20g and 8 could be excluded. The chance to localise a gene has been highest in 
this sample since this is genetically the most homogeneous group of families. The sample size 
of the Caucasian families is substantially larger compared to the non-Caucasian sample, which 
makes the results of the Caucasian families more reliable. The nOll-Caucasian families showed 
increased allele sharing on chromosome 20g implying a slight non-significant suggestion of 
linkage in the multipoint analysis, The single point analysis of marker D20S 1085 resulted in 
an even higher percentage (75%) allele-sharing with a lod score of 0,87, The small non-
Caucasian sample consisted of families from a variable origin: Turkey, Morocco, The 
Philippines and Surinam, These families contributed approximately equally to the results, 
which makes the presence of linkage less likely, Most important is that the suggestive 
observation was based on a limited number of informative families and remains to be 
confirmed. 
The suggestion provided by a previous study for a febrile seizures gene localised on 
chromosome 8q has been based on an analysis of one large family with 19 subjects with 
febrile seizures,8 Three of them developed afebrile seizures, Of these three, one subject had 
temporal lobe epilepsy with hippocampal sclerosis. Although families with such phenotype 
features were not present in our study this may not explain the contradictive finding, because 
only one subject had this different type of predisposition. Further, since the patients in our 
study are children we do not know their precise type of predisposition yet. Our inability to 
find a significant role of BFNC-genes on chromosome 20q and 8q in the risk of developing 
pure febrile seizures, however, may be explained by the fact that BFNC did not occur in our 
popUlation. 
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Previous work on familial aggregation in febrile seizures suggest that siblings of patients with 
febrile seizures have a 2,7 to 3,7 times increased risk of developing febrile seizures,25,27 This 
suggests that genetic factors play an important role, There is little evidence in our study that 
the loci on chromosome 8q and 20q involved earlier in febrile seizures and BFNe play an 
impol1ant role in the occurrence of febrile seizures in the general population, Further 
searching of the genome will be necessary to identify predisposing genes for febrile seizures, 
To increase the power of the present study to detect linkage, the sample size of the study 
population needs to be enlarged. Recently provided evidence for a gene for familial febrile 
seizures on chromosome 19p requires confirmation in other families with febrile seizures 
including ourS.26 
The present study provides no evidence for involvement of loci on chromosome 20q and 8q in 
febrile seizures, A wide search of the genome and enlargement of the sample is necessary to 
localise genes predisposing for febrile seizures, 
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7 Informed consent: parental awareness and reasons for participating 
in a randomised controlled study 
Margriet Will Stuijvellberg, Marja H Suur, Sal/dra de Vos, Gilbert CH Tjiallg, EwolIl \V Steyerberg, 
Gerarda DerksclI·LlIbsell and Henriette A Moll 
Sununal'Y 
Background The informed consent procedure plays a central role in randomised controlled 
trials but has only been explored in a few studies on children. 
Aim To assess the quality of the infonned consent process in a paediatric setting. 
Methods A questionnaire was sent to parents who volunteered their child (n=230) for a 
randornised, double blind, placebo control1ed trial of ibuprofen sYI11P to prevent recurrent 
febrile seizures. 
Rest/Its 181 (79%) parents responded. On average, 73% of parents were aware of the mf\jor 
study characteristics. A few had difficulty understanding the information provided. Major 
factors in parents granting approval were the contribution to clinical science (51 %) and 
benefit to the child (32%). Sociodemographic status did not influence initial participation but 
West European origin of the father was associated with willingness to participate in future 
trials. 89% of participants felt positive about the informed consent procedure; however, 25% 
stated that they felt obliged to participate. Although their reasons for granting approval and 
their evaluation of the info1TIled consent procedure did not differ, relatively more were 
hesitant about participating in future. Parents appreciated the investigator being on call 24 
hours a day (38%) and the extra medical care and information provided (37%) as advantages 
of participation. Disadvantages were mainly the time consuming aspects and the work 
involved (23%). 
Conclusions Parents' understanding of trial characteristics might be improved by designing 
less difficult informed consent forms and by the investigator giving extra attention and 
information to non-West European parents. Adequate measures should be taken to avoid 
parents feeling obliged to participate, rather than giving tme informed consent. 
Introduction 
Informed consent issues relating to clinical research involving children are increasingly 
attracting professional interest,I-] The informed consent procedure plays a central role in 
randomised controlled trials. However, studies of the issues in clinical trials involving 
children are limited. Understanding parental comprehension and their reasons for approval 
may lead to changes in the procedure that could enhance its quality. Based on the information 
provided, parents decide whether or not to penn it their child to participate; therefore we 
should aim to provide adequate information about the study. Understanding how parents 
perceive the different aspects of research procedures could lead to improved quality of 
comfort for children and parents participating in future studies. In addition, compliance might 
increase and withdrawal might he reduced, factors that would benefit the study itself. 
Chapter 7 
We assessed how parents who had given infonned consent for their children to participate in a 
randomised controlled trial of ibuprofen to prevent recurrent febrile seizures evaluated the 
information presented. We determined their sociodemographic status, their awareness of 
major study characteristics, their reasons for granting approval, their perception of the 
informed consent procedure, the perceived advantages and disadvantages of participation and 
their willingness to participate in future studies. 
Patients and Methods 
Patiellts 
The study population consisted of parents or guardians who had volunteered their child for a 
randomised double blind placebo controlled trial of ibuprofen to prevent febrile seizure 
recurrences.4 All children were between I and 4 years old, with a recognised risk of febrile 
seizure recurrence, and parents were Dutch or English speaking. Each child had visited the 
emergency room of the Sophia Children's Hospital in Rotterdam or the Juliana Children's 
Hospital in Den Haag because of a febrile seizure. Children (n=230) were included in the trial 
between I October 1994 and I April 1996 and followed up until 1 October 1996. The trial 
procedures complied with Dutch national legislation and international guidelines.5 The trial 
protocol was approved by the institutional review boards of the hospitals involved. 
Illformed consent procedure 
Two weeks after their febrile seizure, each child visited the special febrile seizure outpatients' 
clinic. If children were eligible, the trial was explained verbally after which the informed 
consent form was presented. Matters discussed included the rationale, design and procedures, 
medication, risks, possible negative side effects and parents' freedom to withdraw the child at 
any time. If the parents requested, they received a copy of the signed informed consent form to 
take home. If they needed time to consider the invitation to participate, a new appointment 
was made. They were asked to telephone the investigator at fever onset (24 hours a day), to 
start promptly and to continue administering the study medication every six hours until the 
child had been afebrile for 24 hours, and to notify the investigator in the event of seizure 
recurrence. If no fever had been reported, the investigator contacted parents every three 
months. At every contact parents were reminded of the study details. 
Methods 
\Ve compiled a questionnaire consisting of structured and semiNstructured questions about the 
sociodemographic status of the parents, how they evaluated the information presented about 
the study, their awareness of major study characteristics, their reason for granting approval, 
their perception of the informed consent procedure, the advantages and disadvantages of 
participation, and their willingness to participate in future studies.6, 7 
In May 1996, we decided to send the questionnaire to the parents of the children whose 
participation in the trial ended before April 1996. In May 1997, the remaining parents were 
sent questionnaires. All parents were unaware of the results of the trial and the treatment to 
which their child had been randomly allocated. Two investigators who had not yet been 
involved in the trial sent a letter of introduction to parents to introduce the questionnaire and 
116 
Illformed consent ill pediatric studies 
request their consent. The questionnaire and written instructions were sent two weeks later. 
The parents of 15 (7%) children were not contacted because: (I) they were lost to follow up 
during the trial (n=5), (2) they were lost to follow up after completion of the trial (n=8), or (3) 
they had participated in another febrile seizure research project (n=2). Of the remaining 215 
(93%) eligible parents, 32 did not respond to our announcement and request, without giving a 
reason. Two questionnaires were returned incomplete. Thus, the study population consisted of 
the parents of 181 (79%) children. 
Statistical analysis 
Completed questionnaires were coded and analysed.s The answers were categorised in groups. 
Sociodemographic details were defined in categories.9,10 The association between socio-
demographic data and the answers was studied using logistic regression. The significance 
level was set at 0.05. Multivariable analysis was done with backward regression (p=O.lO). 
Odds Ratios (OR) are given with their 95% confidence interval (CI95%). 
Results 
Baseline characteristics 
The study population consisted of 181 mothers and 155 fathers. There were 26 (14%) single 
parent families. Table 7, I summarises the sociodemographic baseline characteristics. 
Table 7.1 Sociodemographic baseline characteristics 
Median age in years (25th-75th percentiles) 
West European origin 
Occupation 
Unknown 
Low 
High 
Elementary profession 
Lower profession 
No professionlhousewife 
Intermediate profession 
Higher profession 
Scientific profession 
Education 
Unknown 
Low 
High 
Elementary school 
Lower general secondary education 
Vocational tmining (lower level) 
Higher general secundary education! 
pre-university education 
Vocalionailraining (intermediate level) 
Vocational tmining (higher level) 
University education 
mothers (n=18l) 
32.6 (29.0-37.0) 
t35 (75%) 
2 (1%) 
5 (3%) 
2t (t2%) 
7t (39%) 
59 (33%) 
20(tt%) 
3 (2%) 
2(1%) 
23 (t3%) 
2t (t2%) 
3t (17%) 
23 (1370) 
46 (25%) 
29 (t6%) 
6 (3%) 
fathers (n=155) 
35.6 (31.6-39.5) 
t t8 (77%) 
4 (3%) 
3 (2%) 
36 (23%) 
2 (1%) 
73 (47%) 
33 (2t%) 
4 (3%) 
3 (2%) 
13 (8%) 
13 (8%) 
34 (22%) 
t7 (I 1%) 
3t (20%) 
34 (22%) 
to (6%) 
117 
Chapter 7 
Comprehellsibility oj illjormatioll 
Parents of 176 cases (97%) evaluated the verbal information as easy to understand and four 
(2%) thought that it was difficult to understand, The general information leaflet about fever 
and febrile seizures and the informed consent form were evaluated as easy to understand by 
parents of 171 (95%) cases and as difficult to understand by seven (4%), including four 
parents who evaluated the verbal information as difficult. All seven mothers were of a 000-
West European origin and the parents of six children were of unskilled occupation and limited 
education level. 
Table 7.2 Awareness of six major trial characteristics 
Aim of fhe study 
Assessment of efficacy of antipyretic treatment 
or ibuprofen to prevent febrile seizures 
Increase understanding of febrile seizures 
Test or invent a new drug in children 
Study of ibuprofen to provoke febrile seizures 
Do not remember 
Reason for signing the informed consent fonn 
Indication of being completely infonned and 
approval of participation 
Protectional rights: 
for the investigator 
for themselves and their ehild 
for both 
Do not remember why they had signed il 
Do nol remember that they had signed it 
Possible negative side effects 
50% chance of being assigned a placebo 
Random allocation procedure 
Possibility of withdrawing 
A JVarelless of six major trial characteristics 
number (%) of 
parcnt~ (0:::181) 
95 (53%) 
63 (35%) 
t7 (9%) 
3 (2%) 
3 (2%) 
t36 (75%) 
14 (8%) 
12 (7%) 
t (1%) 
16 (9%) 
2 (1%) 
73 (40%) 
160 (88%) 
9t (50%) 
t65 (9t%) 
We asked parents to describe in their own words the aim of the trial. We used a multiple 
choice question to determine why they thought they had to sign the informed consent form. 
We assessed the knowledge of the other four trial characteristics (Table 7,2), 
Of the three parents who did not remember the aim of the trial, two were not aware why they 
had signed the informed consent form. Nonetheless, the two parents who did not know that 
they had signed it understood the aim of the trial. 
As expected, all parents who knew about the random allocation procedure (n=91) were also 
aware of the 50% chance for the child to be assigned a placebo, Eighty two (45%) of the 
parents were aware of five to six major trial characteristics. This high level of awareness was 
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associated with two-parent family (OR=3.2(CI95% 1.2-8.4), p=0.02), high education level of 
the mother (OR=2.3(CI95% 1.3-5.0), p=O.OI) and West European origin of the mother 
(OR=8.6(CI95% 3.4-21.7), p<O.OI) and father (OR=6.3(CI95% 2.4-16.7), p<O.OI). In the 
multivariate model, West European origin of the parents was retained, 
None of the parents who evaluated either the verbal or the written information as difficult 
(n=7) could remember more than three of the six major trial characteristics, They had most 
difficulty with remembering the aim of the trial, the reason for signing the informed consent 
form, and the random a1location procedure, 
Major reasons for grallting approval 
The major reasons for parents for granting approval are shown in Table 7,3, The largest group 
consisted of parents whose major reason for participation was to contribute to clinical science 
(51 %). We asked parents if they had feIt obliged to participate in the trial; 45 (25%) parents 
answered affirmatively, We compared the reasons for approval of those parents who had felt 
obliged to participate with the reasons of those who had not; no significant difference was 
found. 
Table 7.3 Major reasons for approval versus feeling obliged to participate 
Felt obliged to participate 
No (n=136) Yes (n=45) 
Contribution to clinical science n=92 (51 %) 
BeneHt for their own child n=58 (32%) 
Benefit for other children in future n=5 (3%) 
Benefit for the parent n=6 (3%) 
Give something in return for the care of their 
child n=12 (7%) 
The doctor askcd n=6 (3%) 
No major reason n=2 (1%) 
Table 7.4 Perception of the informed consent procedure 
Evaluation of itwitation to participate 
Negative n=4 (2%) 
Positive n=165 (91%) 
Positive, but objections n=5 (3%) 
No evaluation n=7 (4%) 
Sufficient time to decide 
Yes n=174 (96%) 
No n=7 (4%) 
Sufficient explanation 
Yes n=174 (96%) 
No n=7 (4%) 
67 (49%) 
46 (34%) 
4 (3%) 
5 (4%) 
9 (7%) 
4 (3%) 
1(1%) 
25 (56%) 
12 (27%) 
1(2%) 
1(2%) 
3 (7%) 
2 (4%) 
1(2%) 
Felt obliged to participate 
no (n=136) yes (n=45) 
2(1%) 2 (4%) 
123 (90%) 42 (93%) 
4 (3%) 1(2%) 
7 (5%) 0(0%) 
132 (97%) 42 (93%) 
4 (3%) 3 (7%) 
131 (96%) 43 (96%) 
5 (4%) 2 (4%) 
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Perception of fhe ill/ormed COllsent procedure 
Table 7.4 shows how parents perceived the informed consent procedure when they attended 
the febrile seizure outpatients clinic. We asked them how they had felt about our invitation to 
volunteer their child for a clinical research project. Most felt positive (n= 165, 91 %) and 
thought it was efficiently planned or they felt the time was convenient for them to consider the 
invitation. Five parents felt positive but had objections: they had been taken by surprise (n=2) 
or they felt the invitation was an extra problem to think about (n=3). Four (2%) parents felt 
ncgative, bccause they felt that they had been taken by surprise: two of them felt obliged to 
participate. Their major reason for approval was to contribute to clinical science. Forty two of 
the 45 parents who felt obliged to participate (93%) felt positive about the invitation. 
Of the seven parents who thought that they did not have sufficient time to decide whether to 
participate or not, four felt positive and three negative about the invitation, because they felt 
taken by surprise. There were also seven parents who considered they had not received 
sufficient explanation; six of them had received sufficient time. Of the 13 parents who had 
either not received sufficient lime or explanation, four felt obliged to participate. Their 
reasons for approval were: contribution to clinical science (n=3) and benefit of their own child 
(n=I). 
Perceplioll ojparlicipalioll 
The major advantages and disadvantages of participation are shown in Table 7.5. The parents 
answered this question in their own words. One hundred and fifty six (86%) mentioned an 
advantage and 65 (36%) mentioned a disadvantage of participation. 
All parents were asked whether they were concerned or not about possible negative side 
effects of antipyretic drugs for their child in general: 75 (41 %) parents were concerned while 
105 (58%) were not. 
lViIIillglless 10 participale ill jllillre sludies 
The results of the questions about the willingness and reasons for future participation in 
another study resembling our clinical tdal are shown in Table 7.6. More than half of the 
parents (n=109, 60%) were willing to participate in a similar future study. We found 
willingness to participate again associated with \Vest European origin of the father 
(OR=2.0(CI95% 0.9-4.2), p=0.08), although the results were not significant. The level of 
awareness of major trial characteristics did not playa role. 
We compared the reasons for being prepared to participate in the future to the initial reasons 
for approval. Of the 44 parents who were willing to contribute to clinical science, 32 (73%) 
had initially given this as the main reason for approval. The reason for participating in future 
studies being the benefit of their own child or other children (n=32) was mentioned initially 
by 14 (44%) of these parents. 
We defined four groups of parents (Table 7.7): (I) those who mentioned an advantage only 
(n=96), and had the highest percentage willing to participate again (68%); (2) those who 
mentioned both advantages and disadvantages (n=60), and had a slightly lower percentage 
wil1ing to participate (58%); (3) those parents who did not mention either an advantage or a 
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Table 7.5 Advantages and disadvantages of participation 
Advantages 
Invcstigator on call 24 hours a day 
Extra medical care and information 
The possible efficacy of thc study medication 
No advantages 
Disadvantages 
Temperature measurements and administering 
of study medication during a fever episode 
Hospital visits at fever onset 
Time consuming aspect and work involved in general 
The possible inefficacy of the study medication 
Other: 
Bad ta<;te of the study medication 
Possible side effccts 
Not allowed to administer acetaminophen 
Uncertainty about administering placebo or 
ibuprofen 
Enlering lite medical circuit 
No disadvantages 
Informed cOl/sent if! pediatric studies 
number (%) of 
parcnts (n= 181) 
68 (38%) 
66 (37%) 
22 (12%) 
25 (14%) 
21 (12%) 
10 (6%) 
10 (6%) 
4 (2%) 
3 (2%) 
6(3%) 
4 (2%) 
6(3%) 
1 (1%) 
116 (64%) 
Table 7.6 Willingness and reasons for participation in a similar future study 
Willing to participate 
Contribution to clinical science 
Benefit for their O\\ln child and other children 
Extra medical care and support 
No motive 
Not willing to participate 
Time and work involved 
No benefit for their own child 
Uncertainty about receiving placebo or 
active treatment 
No reason 
Do not know 
It depends on the study 
Reluctance to be involved with the hospital 
No reason 
number (%) of 
parents (n=181) 
109 (60%) 
44 (24%) 
32 (18%) 
19 (10%) 
14 (8%) 
14(8%) 
7 (4%) 
4 (2%) 
1 (1%) 
2(1%) 
58 (32%) 
4 (2%) 
1 (1%) 
53 (29%) 
disadvantage (n;::20), and had an even lower percentage (35%) willing to pal1icipate again; 
and (4) parents who mentioned a disadvantage only (n;::5), and had the highest percentage not 
willing to participate again, although the number was small (n;::2). The third group included 
the highest percentage not knowing whether or not they would participate. 
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Table 7.7 Willingness to participate in a similar future study versus advantages and disadvantages of participation 
Willing to participate in a similar future study 
Only advantage (0=96) 
Advantages and disadvantage (0=60) 
Neither advantage nor disadvantage (0=20) 
Only disadvantage (0=5) 
No 
(0"14) 
3 (3%) 
7 (12%) 
2 (10%) 
2 (40%) 
Yes 
(0"109) 
65 (68%) 
35 (58%) 
7 (35%) 
2 (40%) 
Do not know 
(0"58) 
28 (29%) 
18 (30%) 
11(55%) 
1(20%) 
Table 7.8 Willingness to participate in a similar future study versus initially feeling obliged to participate 
Willing to participate in a similal' future study 
Felt initially obliged to participate 
No n"136 (75%) 
Yes 0=45 (25%) 
No 
(0"14) 
11(79%) 
3 (21%) 
Yes 
(n"I09) 
88 (81%) 
21 (19%) 
Do not know 
(n"58) 
37 (64%) 
21 (36%) 
Table 7.8 shows an association between willingness to participate in a future study and feeling 
obliged to participale. Parenls who did not know whether they would participate or not 
included a relatively higher number who had felt obliged initially (n=2I, 36%) compared with 
the parents who were certain about whether or not to participate, 19% and 21 %, respectively 
(OR=2.3(CI95% 1.2-4.7), p=O.02). 
Discussion 
The levels of education and occupation of the responding parents are similar to the Dutch 
national data for 1996 on educational and occupation levels. lI Similar studies have shown 
varying results: parents who permit their child to participate in clinical research can have the 
same, a higher, Of a lower education or occupation level than those who do noL l ,2,12 There is a 
relatively open and easy accessible health care system in the Netherlands, which makes 
selection bias unlikely with respect to socia-economic status. 
The informed consent form may have been difficult to read,l3 However, only a few parents 
evaluated the written information as difficult to understand. In addition, verbal information 
was evaluated as difficult by a few parents. In general, studies concerning the level of 
difficulty of informed consent forms conclude that investigators should keep the form simple, 
use short words and sentences, and avoid medical jargon. 14-17 Although language difficulty 
was an exclusion criterion for the febrile seizures trial, the linguistic usage was clearly too 
difficult for non-West European parents. The problem might, at least in part, be resolved by 
using informed consent forms in native languages. 
The degree of awareness of the major trial characteristics was generally sufficient; 45% of 
parents were aware of five or six trial characteristics. A high level of awareness was 
associated with West European parental origin. Parents who had mentioned difficulties with 
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understanding the information provided also had difficulties with recalling the trial 
characteristics, In general, parents understood the details of the trial, despite the difficult 
informed consent form, Detailed and repeated explanation of the study by the investigator 
might have played a positive role,18 In non-West European parents, cultural differences 
regarding health might also have contributed to difficulties in understanding the information 
provided. 
Half the participants (53%) correctly expressed the aim of the trial. In adult trials these 
percentages vary between 60% and 87% 18-20 compared with 97% in a paediatric study,21 In 
our study we asked parents to describe the aim of the study in their own words, This is a more 
difficult task, which might explain our relatively low percentage, In future, we will ask parents 
to describe the aim of the trial in their own words at the time that they are invited to 
participate and informed consent is discussed, 
In our study, all parents were aware that they had participated in a clinical trial, although we 
are doubtful about the two parents who knew neither the aim of the study nor the reason for 
signing the informed consent form, Studies involving adult participants show a similar 
awareness of between 86% and 98%,18,19 
A signed informed consent form is a legal requirement instituted for the protection of 
participants, In our study, 75% of participants knew why they had to sign the informed 
consent form, which indicates a minor inadequacy in this respect. Another paediatric study has 
shown that only 19% knew the reason for signing; a larger group thought it was to protect the 
doctors. 21 
The information about possible negative side effects was recalled by 40% which, in our 
opinion, is low, Only a few parents mentioned negative side effects as a disadvantage of 
participation and most claimed not to be concerned about the side effects of antipyretic 
treatment in general. A varying percentage (between 4% and 78%) has been shown in studies 
in which adult participants were involved, with the higher percentages in oncology trials as 
compared with antihypertensive treatment studies,18,20,22 The low recall in our study is 
unlikely to have resulted from the way in which we presented the information, because the 
informed consent form describes all negative side effects reported, in a similar way to the 
standard instl1lction leaflet for ibuprofen syrup, Low recall might be explained by the relative 
safety of ibuprofen and the fact that assessment of dmg safety was not the aim of the trial. 
Similarly, parents were also highly aware (88%) of their child's chance of receiving placebo, 
Only 3% of parents mentioned this as a major disadvantage of participation; for one parent 
this was the reason for refusing to participate in a future trial. In a paediatric study of 
paracetamol, over half of the parents refused to participate, mainly because of a reluctance to 
risk being assigned a placebo,12 In adult studies the awareness of this risk is much lower 
(56%) compared to our study, which might, at least in part, be explained by parental fear of a 
recurrent febrile seizure,20,23,24 
The random assignment procedure was recalled by half of parents, All parents who knew 
about the random allocation procedure were also aware of the 50% chance of being assigned a 
placebo, In adult clinical trial pa!1icipants, this issue plays a role as well; awareness of the 
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random assignment procedure varies between 47% and 75%.18,19,20 The fact that the parents 
trust the investigator implicitly in knowing what is best for their child might explain this 
lower awareness leve1.2 In addition,' random assignment' is a theoretical concept, which is 
difficult to explain. A concrete example of drawing lots might be given. 
The possibility of withdrawing from pal1icipation at any time was remembered by most 
parents (91%). One paediatric study 21 showed a much lower level (45%) compared to 44% to 
87% in adult studies,18,19,22 
Parents can be encouraged to participate in clinical research. This is best illustrated by the 
relatively high participation rate (84%) among the patients who were eligible for our febrile 
seizures trial 4 compared with other febrile seizure studies (50% to 99%).25.29 Secondly, the 
response rate (79%) to our questionnaire study was high compared to other paediatric 
informed consent questionnaire studies (59% to 70%),1,2 The high participation rate in our 
trial might be explained by the setting of the initial invitation to participate: a special 
outpatients' clinic for febrile seizures in a quiet environment with sufficient time and 
attention. 
In our study, 32% of parents stated they participated for the benefit of their own child. This 
was a consistent motive, although not as frequently expressed as the willingness to contribute 
to clinical science (51 %), which was the main and most consistent reason of parents to 
participate. We found that a high percentage of parents in our study (60%) were willing to 
participate again in the future. This was associated with a West European origin of the father. 
Other studies have shown that a substantial number of patients are willing to participate, even 
without being adequately informed about the benefits and risks 2.3.21.22 and despite the fact that 
it will cost them time and effort. 1,22,30 A more reserved attitude towards participation of their 
child in clinical research was found in one of these studies: 21 % of the parents were prepared 
to participate for the benefit of other children, contribution to clinical science and confidence 
in physicians, while 74% would refuse because of the risk of side effects and unproved 
efficacy of the trial medication.2 The attitude on the part of parents might have been 
influenced negatively by the study design; the investigators asked only hypothetical questions 
instead of questions addressed to parents who were actual participants, Obviously, one's own 
benefit is a main reason for participation, but the benefit for future patients and the 
contribution to medical science prevail. l ,2,19,30 We feel this generally positive attitude towards 
clinical research is positive and promising for future studies. Extra attention should be given 
to non-West European trial participants to increase their willingness to participate. 
We found a substantial number of parents mentioning the time consuming aspect and the 
work involved as a major disadvantage of participation; a small group of parents (4%) thought 
that they would refuse to participate in a similar study for this reason. Furthermore, 
participating parents who did not mention an advantage were more hesitant to agree to 
participate in a similar future study. If they mentioned an advantage of participation they were 
prepared to put up with disadvantages; disadvantages playa minor role in future participation. 
We were not sure how parents would experience being asked to participate during their 
appointment at the special febrile seizure outpatients' clinic. We found that 25% of the 
parents felt obliged to participate. This might be related to the feeling of being dependent on 
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the investigator or the hospital. A relatively large number of those hesitant to participate in a 
future study were among the parents who felt obliged to participate, However, of the parents 
who feIt obliged to participate only two (4%) approved because the doctor asked. Other 
explanations might be that they feIt forced to participate because of their responsibility, either 
owning to the rather frightening disease of their own child, other children, or scientific 
development in general. We showed that parents who felt obliged to participate have similar 
major reasons for granting approval and a similar evaluation of the informed consent 
procedure compared with parents who do not feel obliged, indicating that they do not differ as 
much as one might assume. However, we consider the fact that parents felt obliged to 
participate as a failure of our informed consent procedure, because feeling obliged to 
participate might exclude giving truly informed consent. The involvement of a third party 
(such as a research nurse), to provide parents with information and to invite them to 
participate, might be advisable. IS We offered parents some time for reflection, if they so 
requested; a compulsory time period for parents to consider the matter might also be 
implemented to improve the procedure. 
One of the limitations of this study is the number of parents (14%) who did not respond to the 
questionnaire, We do not know their reasons, but it might be that they would evaluate our trial 
less positively than those who were willing to fill in the questionnaire. Thus, we might have 
overestimated the generally positive evaluation of the trial. Furthermore, the questionnaire we 
used has not been completely validated. The questions concerning sociodemographic status, 
awareness of major study characteristics, and advantages and disadvantages of participation 
were formulated using the Lynn method 6, which has been used in other studies, 1,20,30 We tried 
to minimise implied value judgements in our questions, but the difficulty encountered in all 
questionnaire studies regarding participants' tendency to give socially desirable answers 
inevitably played a role in our study too. However, we think that the results of our study are 
relevant to comparable study populations with respect to the subjects (children), the design 
(randomised, placebo-controlled), the disease (good prognosis but distressing), and the 
treatment (safe and not invasive), 
Conclusion 
Parents' understanding of trial characteristics might be improved by a less difficult informed 
consent form and by the investigator giving extra attention and information to non-West 
European parents regarding linguistic problems and paying more attention to cultural 
differences, even in the absence of language difficulties. 
The contribution to clinical science and the benefit of the child are major factors in the 
recmitment of participants, With respect to willingness to participate, advantages of 
participation are more important than disadvantages. Sociodemographic status does not 
influence initial participation, but the origin of the father might determine his willingness to 
participate in future trials, Some parents feel obliged to participate; therefore adequate 
measures should be taken to ensure that informed consent is genuine, 
We gratefully acknowledge Mrs Lillda-Jean Cockcroft for ret'iewillg the manllscript. 
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8 
General discussion and future prospects 

8.1 Diagnostic aspects 
Biochemical parameters 
The evidence regarding the redundancy of routinely performed laboratory tests in children 
with febrile seizures has been growing. In the United Kingdom and the USA consensus has 
been reached and established in guidelines for diagnostic procedures in children presenting 
with a febrile seizure,l,2 The British guidelines give recommendations on diagnostic tests in 
children with febrile seizures in generaL' The American guidelines discuss laboratory 
investigations in the first simple febrile seizure? Both state that measurement of blood 
electrolytes, calcium, phospho11ls, magnesium and glucose should not be performed routinely. 
They recommend to pClform a glucose tcst only, if the patient is still convulsive at hospital 
admission or has a prolonged postictal period of unconsciousness. 
Previous febrile seizure studies described association between abnormal biochemical blood 
test results and complex seizure characteristics, and association between abnormal test results 
and gastrointestinal disease.3-14 Table 8.1 summarises the indications for measurement of 
serum glucose, calcium and sodium, following these previous studies and the international 
guidelines. The previous studies have shown that the prevalence of abnormal findings in 
children with febrile seizures is very low. This has resulted in the recommendation not to 
perfom1 biochemical blood laboratory tests on a routine basis. Although complex 
characteristics were associated with higher prevalences, laboratory tests have not been 
recommended as a routine proedure in all children with complex seizures. The guidelines' 
recommendations when to perform a glucose test have not been based on the prevalence of 
hypoglycaemia, which is very low, but may be based on potential severe consequences of 
hypoglycaemia including cerebral damage. If hypoglycaemia is the cause of the seizure this 
child needs immediate intervention. 
The results of our study (chapter 2,1) are represented in the rightmost column of Table 8,\. 
\Ve have confirmed the low prevalence of hypoglycaemia in children with febrile seizures: 
none was found. In our study the prevalence of hypocalciaemia (J 1%) and hyponatriaemia 
(32%) can not be considered low. Most of the previous studies, however, used lower reference 
levels to define these abnormalities. We aimed to study the probability of normal test results. 
Most of the abnormalities we found were mild and did not need further evaluation or 
treatment. The associations in our study given in Table 8.1 have been based on the results of 
the prediction models of normal findings and the score chart (Table 2,1.3), The most 
important associations with abnormal test results of calcium and sodium were seizure duration 
longer than 15 minutes (calcium), vomiting and diarrhoea (calcium) and multiple type 
seizures (sodium). 
Based on the summary in Table 8.1 we suggest that glucose tests should be performed in 
children who are still convulsive at hospital admission or who have a prolonged postictal 
period of unconsciousness. The test is mainly used to exclude a severe underlying cause. A 
sodium and a calcium test may be indicated in children with a seizure duration of more than 
15 minutes, in children with a multiple type seizure or in children who have a history of 
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Table 8.1 Indications for laboratory blood tests of biochemical parameters in febrile seizures 
previous studies, international guidelines and study results (chapter 2.1) 
Parameter Previous studies 
Glucose F; very low prevalence of 
abnormalities, higher pre-
valence in complex seizures 
I: not indicated 
Calcium F: very low prevalence of 
abnormalities, higher pre-
valence in complex seizures 
I: not indicated 
Sodium F: low prevalence of ab-
normalities, higher preva-
lence in multiple type 
seizures 
I: substantial fluid loss or 
dehydration 
aBritish Guidelines, BMJ 1991 
b American Guidelines, Pediatrics 1996 
International guidelines",b 
still convulsing child 
prolonged postictal period 
not indicated 
not indicated 
C Based on score chart for calcium and sodium separately (chapter 2.1 Table 5). 
FFindings 
1 Indications 
Chapter 2.1" 
F: no abnonlJalilies 
I: not indicated 
F: 11%abnormal(1.90-2.18 
mmolfl), associations with 
seizure duration> 15 minutes 
and 
vomiting/diarrhoea 
I: not indicated 
F: 32% abnormal (126-134 
mmoJII), association with 
multiple type seizure 
I: not indicated 
vomiting or diarrhoea. In mild abnormalities fe-examination of the child is indicated and 
eventually retesting until levels are normalised. In the severe cases further diagnostic 
procedures and treatment will be necessary. 
In the decision whether or not to perform a diagnostic test 'common sense clinical practice' 
plays a major role, The guidelines and the score chart may just give some extra help in the 
decision process. The prediction model of finding normal biochemical blood test results in 
children with febrile seizures which we described in chapter 2.1 has been based on various 
combinations of patient characteristics. The score chart may be used in the individual patient 
in addition to the recommendations just discussed. A low predicted probability of a normal 
test result in the individual patient has to be considered an argument to perfOlrn the test, and 
vice versa. Because the discriminative ability of the constructed models is limited, as was the 
sample size of the study, further validation of the prediction models is necessary in larger 
populations. 
Infectious parameters 
In the diagnostic evaluation of children with febrile seizures, increased leukocyte counts in the 
peripheral blood are often considered a re:-;uIt of the seizure itself, due to stress reactions, 
especially if prolonged seizures (febrile status epiJepticus) are involved. There is some 
evidence for this assumption based on animal and clinical studies. ls-ls These studies, however, 
have not addressed children and especially not children with febrile seizures. Young children 
have an immature nervous system and compared to adults a different physiology. Thus, 
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extrapolation of evidence from animals and htlman adults may not always be possible. One 
study has addressed stress induced reactions on cerebrospinal fluid and blood glucose levels in 
children with febrile seizures. 19 No difference was found in glucose concentrations in simple 
versus complex seizures, which may suggest that both seizure types, including long lasting 
seizures in the complex seizure group, are associated with a similar level of stress. 
To assess the association between increased leukocyte counts and seizure duration, children 
with febrile seizures were studied (chapter 2.2). \Ve reported none of the characteristics of the 
seizure, including seizure duration, to be associated with an increased leukocyte count. Based 
on these results, earlier findings may not be applicable to children with febrile seizures. In 
accordance with the guidelines 1,2 we state that peripheral blood leukocyte counts (and WBC-
differentiation parameters) should be used to assess the origin of the fever causing illness, if 
any clinical suspicion exists of an infection which may dictate further treatment. Routine 
testing of the leukocyte count in children with febrile seizures is not indicated. 
8.2 Parental fear and primary prevention 
Studies performed in 1978, 1981 (United Kingdom) and 1991 (Denmark) have described 
parental anxiety due to the febrile seizures of their child. 61 .63 Most parents think their child is 
dying when it suffers from its initial seizure. After a febrile seizure has occurred they become 
afraid of fever affecting their child. Parental psychological problems mainly consist of 
sleeping problems which have been frequently reported. Anxiety is likely to persist even after 
consultation of their general practitioner or pediatrician. Large follow-up studies show that 
psychomotor development and intellectual performance are normal in children with febrile 
seizures?O-22 The extreme anxiety of parents caused by febrile seizures is thus not in 
accordance with the excellent prognosis. The results of our questionnaire study among the 
parents of the participants of the randomised trial presented in chapter 4 have confirmed the 
earlier findings described in the literature. By means of a mailed questionnaire we have 
addressed parents' perceptions and knowledge about fever and febrile seizures. We concluded 
that about half of the parents were afraid or very afraid of fever (Table 3.2). Their fear of fever 
affecting their child was strongly associated with being afraid of recurrent febrile seizures. 
Consequences of this parental fear included frequent temperature measurements and 
remaining awake at night during fever. These activities possibly affect a normal night's rest of 
the parents (Table 3.3), Further. we described that 47% of the parents thought that their child 
had been dying when it suffered from the initial seizure (Table 3.4). In a study among parents 
of children with febrile seizures recently carried out in Israel (n=46), it was found that 60% 
still reported being very anxious despite the reassuring information provided by the hospital 
after the seizure had occurred.23 The other 40% of the responding parents claimed full relief 
compared to what they had felt at the time of the acute event. Of the parents in our study, 21 % 
said reassuring information had helped them to consider febrile seizures not to be harmful. 
According to our findings, a family history of febrile seizures, possibly a factor increasing 
parental experience with febrile seizures, did not influence parental fear. Special diagnostic 
tests, i.e. electroencephalography and lumbar puncture, increased parental 1lI1xiety.23 Hospital 
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admission of the child yielded some relief in 34% and no relief in 27%, although one other 
study suggested that routine hospitalisation may increase parental anxiety,4 We have not 
studied the influence of special diagnostic tests and hospitalisation on parental anxiety. 
Generally, the information provided to the parents by the hospital staff may lack reassurance, 
may have insufficient clarity or may be provided at a non-optimal moment. Intensive effort is 
required to relieve parental anxiety after febrile seizures. Parental health education has shown 
to be effective. Information about fever has been reported to result in improvement of parental 
confidence and a subsequent decrease in emergency hospital visits for febrile iIInesses?4 
As we discussed in chapter 4, special attention to the provision of information should be paid 
to parents of a different language and culture. Because they are more frightened compared to 
parents from Dutch origin they may need information which is tailored to their language and 
culture. We have confirmed the results of a previous study of parental fear among parents of 
children with epilepsy which showed that a different language and culture may be associated 
with an increased fear of seizures.25 
Information provided immediately after the acute event may be less effective than after for 
instance two to four weeks. During a follO\v-up visit the seizure may be discussed again, 
parents may be told about the excellent prognosis and measures may be taken to prepare them 
for recurrent seizures.23 This was the procedure in our study, but unfortunately parents 
remained anxious. 
\Ve propose to provide information to the parents in an earlier stage. Since febrile seizures are 
a frequent event, occurring in 4 to 5% of children and tend to find the parents unprepared, the 
question rises if not aH parents should be provided information about febrile seizures. If so, 
then of each 100 parents who will be given information only 4 will actual1y have to deal with 
febrile seizures: 96% of the children will never be affected,26 Negative effects of providing 
information may entail increasing fear of fever and may increase medical consumption. 
Balancing the possible positive and negative effects we advocate providing routine 
information about febrile seizures on a regular basis in the child health centre or well-baby 
clinic. This suggestion has been made before,23 The relatively high prevalence of febrile 
seizures, the extreme parental fear at the moment they witness a febrile seizure in their child 
and the excellent prognosis of febrile seizures may be the strongest motives for discussing 
febrile seizures with every parent.6I~63 Minimal infOlmation ubout febrile seizures should 
entail a description of the typical attack, the benign character and how to act in the event of a 
seizure, mainly consisting of contacting the general practitioner for an assessment of the risk 
of meningitis. 27 Antipyretics are not necessary, they should be used moderately and only to 
make the child feel more comfortable. If antipyretics are used they should preferably be 
administered at regular intervals, i.e. every six hours (chapter 4), because it is unknown 
whether one single dose or irregularly administered doses may provoke seizure recurrences. 
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8.3 Preventive treatment of recnrrences 
Previous studies 
Although febrile seizure recurrences do not affect the risk of non-febrile seizures, 
psychomotor developmental problems or brain injury prevention in a safe and simple way 
remains desirable?8-30 But as all options have either proved to be of debatable efficacy or to 
be associated with serious negative side effects preventive treatment of febrile seizure 
recurrences has become questionable.31 Continuous treatment with phenobarbital has become 
obsolete. l •ll -l ] In a review study, published in 1984, the results of 7 studies of valpmate and 
phenobarbital in febrile seizures regarding preventive efficacy and side effects were 
compared.32 Two studies showed a significant reduction in recunences in children treated 
with valproate. None showed risk reduction in the phenobarbital group compared to placebo. 
Side effects were more serious and more frequently reported in the phenobarbital group. A 
metaanalysis of 7 British trials was published in 1988.33 Based on the overall preventive 
efficacy of phenobarbital (OR:0.8 (CI95%:0.5-1.2)), valproate (OR: 1.4 (CI95%:0.9-2.4)), and 
adverse effects it was concluded that neither treatment can be recommended. In a recent 
metaanalysis published in 1997 the data of 9 randomised controlled trials were studied?! 
Continuous phenobarbital significantly reduced the recurrence risk (OR:O.5 (CI95%:0.3-0.9), 
four studies); intermittent phenobarbital showed a similar risk reduction but this was not 
statistically significant (OR:0.5 (CI95%:0.1-2.6), one study); valproate administered 
continuously was significantly effective (OR:O.I (C195%:0.0 1-0.8), one study). Intermittent 
treatment with diazepam has beenrecomrnended, especially after publication of a randomised 
controlled trial in which 406 children participated.34 Children with an increased risk, whose 
parents recognise a febrile illness at an early stage, would benefit from it. The metaanalysis, 
however, showed that intermittent diazepam was not significantly reducing the recurrence risk 
(OR:0.8 (CI95%:0.5-1.2), three studies including the large clinical trial mentioned and two 
smaller studies.31 It was concluded that intermittent diazepam is a debatable option. Other 
studies investigated antipyretic preventive treatment.35,36.84 They concluded that antipyretic 
treatment is not effective in preventing reCllnent febrile seizure. None of these previous 
stndies had a randomised antipyretic-placebo controlled trial design (Table 4.4). 
Intermittent antipyretic treatment: study in this thesis 
As a contribution to finding an effective preventive intermittent therapy with only minimal 
side effects we canied out a randornised placebo-controlled trial in 230 children with an 
increased recurrence risk, using ibuprofen as the preventive alternative (chapter 4). Ibuprofen 
showed to be a strong antipyretic drug in an adequate 6-hourly dose of 5 mglkg body weight. 
Both the intention~to-treat analysis and the per-protocol analysis. however, showed ibuprofen 
to be ineffective in preventing recurrences (HR:0.9 (CI95%:0.6-1.5)). 
Generally, data collected in a randornised controlled trial are analysed according to the 
'intention-to-treat' principle. This means that, regardless of compliance with the protocol, all 
eligible patients are compared in their randomly assigned treatment groups. This is the 
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pragmatic approach providing a more valid assessment of treatment effectiveness as it relates 
to actual clinical practice.33 .]7,38 Alternatively, we may analyse only those subjects, who have 
been treated with the treatment to which they have been allocated: 'per-protocol' analysis. 
This is done especially when a substantial number of study participants failed to take the 
prescribed medication, as was the case in our randomised trial in 178 (32%) of all 555 fever 
episodes (Table 4.2). This alternative approach is explanatory, as it aims to study the 
pharmacological efficacy. It is questionable, however, if an unbiased estimate of efficacy will 
be obtained in this way. Non-compliance may be related to (known and unknown) factors 
affecting the risk of the outcome under study." Thus in a per-protocol analysis the prognostic 
balance, which is hopefully the result of randomisation, is likely to be disturbed. Reduction of 
the sample size and a decrease of the validity of statistical test procedures arc relative minor 
problems of the per-protocol approach. Because of the disadvantages of per-protocol analysis 
every clinical trial report should contain a primary analysis based on intention-ta-treat. 
Secondary analyses may be performed considering only the data of compliant patients. Thus 
any difference between the results of these two different methods of analysis is clearly 
demonstrated and may enlighten interesting explaining mechanisms.40,4! Following this 
strategy we found no differences between the intention-ta-treat analysis and the per-protocol 
analysis. 
In pediatric practice it is suggested that intermittent antipyretic treatment may provoke seizure 
recurrences by making the temperature vary between high (before administering a dose) and 
low (after a dose) temperature. Based on the study results we may conclude that ibuprofen 
administered sixMhourly does not significantly induce seizure recurrences. Antipyretics may be 
safely used to make the feverish child feel more comfortable. It should be clear, however, that 
prevention of seizure recurrence will be beyond reach. 
In view of the risk factors, which have been shown to increase the seizure recurrence risk (the 
frequency of fever episodes (chapter 5.1) and the temperature at fever onset (chapter 5.2)), it is 
not easy to understand the inefficacy of antipyretic preventive treatment to prevent febrile 
seizure recurrences. Perhaps a higher dose of ibuprofen would have shown to be effective, 
although we confirmed in a previous study that ibuprofen 5 mg per kg has a slrong fever 
reducing efficacy in children with febrile seizures, which has been the basis for using this 
dosis in the present mndomised controlled tria1.42 The risk of negative side effects of a higher 
dose may increase, although short term studies have not reported a difference in adverse 
effects associated with 5 mg and to mg ibuprofen per dose.43-45 Antipyretic treatment with 
ibuprofen is associated with a delay in maximum fever reducing efficacy of about 4 hours.43-46 
This reflects the fact that a complex interaction of numerous factors in addition to drug 
concentration (which is maximal at I hour after onset of treatment) determine the antipyretic 
response.46 This includes the sequence of inhibition of prostaglandin synthesis leading to 
lowering of the hypothalamic set point which puts a series of physiologic responses going. As 
most recurrent febrile seizures occur early during fever this delay in fever reducing efficacy 
will remain an additional problem in the prevention of recurrences, which may not be easily 
solved. Another problem associated with the early occurrence of recurrent febrile seizure is 
that they frequently are the presenting sign of fever. In our study (chapler 4) we found that in 
22 of the 67 recurrences the study medication could not be administered in time, because the 
seizure was the presenting sign of fever. Early detection of fever is a substantial problem in 
the prevention of recurrences if intermittent treatment is considered.34,47-49 
136 
General (Uscussioll and future prospects 
One of the findings to be further investigated is that no difference was found in temperature 
reducing efficacy in ibuprofen compared to placebo in the fever episodes with a seizure 
recurrence, based on the defined six-hourly temperature measurements. The 'per-protocol' 
analysis showed similar results in the course of the temperature compared to the 'intention to 
treat' analysis (Table 4.3). Thus the high percentage of children who have not used the study 
medication before the recurrence occurred (55% of the fever episodes with a seizure 
recurrence) is not likely to be the only explanation of the inefficacy of ibuprofen to reduce 
fever in those fever episodes. As the temperature reducing effIcacy of ibuprofen is at its 
maximum at four hours after administration the six-hourly measurements may have given an 
underestimation of the fever reducing effcct.43.46 Since we found a substantial temperature 
reducing effect in the ibuprofen group when we analysed all 555 fever episodes, 
underestimation of the fever reducing effect may only be a part of the explanation. Possibly, a 
higher dose of ibuprofen or another strong fever reducing method could effectively reduce the 
temperature in those fever episodes in which a recurrence occurs. Another part of the 
explanation may be the fever causing agent playing a role in the ineffectiveness of antipyretic 
treatment to lower the temperature in children with a seizure recurrence in the cOlTesponding 
fever episode. There is evidence, however, that the reduction in body temperature of children 
receiving antipyretic treatment does not differ between infectious outcomes.43 ,50 
To get a better insight into the pathophysiological mechanism of seizure recurrence infectious 
agents in children with febrile seizure recurrences may be investigated in future studies. 
Polymerase Chain Reaction (PCR) is a relatively new diagnostic method to assess the cause of 
fever in a quantitative way.51-55 Based on previolls findings in this context we could start with 
studying primary infection with human herpesvints (HHV) 6 and 7 in children with febrile 
seizures.56-58 These infections can be diagnosed using PCR techniques on saliva and 
leukocytes and have been shown to be associated with the occurrence of febrile seizures; in 
the leukocytes the viral load can be measured quantitatively.59.6o Then, the efficacy of 
antipyretics in fever reduction and prevention of recurrence might be assessed in a comparison 
between children with febrile seizures with and without positive PCR-HHV results. 
Pro's and con's of prevention 
Prevention of febrile seizure recurrences serves two purposes: meeting parental fear of 
recurrences in generaI61-64 and reducing the risk of a long lasting and eventually injurious 
seizure.28-3o Febrile seizures, however, even the long lasting and the frequent recurrences, are 
associated with a very small, probably not even existing risk of injury.28-3o Furthermore, there 
is no evidence that in children with febrile seizures developing epilepsy prophylaxis of 
recurrent febrile seizures would have prevented it. 65-68 Therefore, prevention of recurrences 
does not improve the prognosis. Negative consequences of trying to prevent febrile seizure 
recurrences must also be considered.69-71 In clinical trials for intermittent treatment of children 
with febrile seizures, the parents unavoidably focus on any sign or symptom of a febrile illness 
in order to start treatment immediately at fever onset. They may become obsessed by their 
child's behaviour, its feverish symptoms and the thermometer.72,73 The consequence of this 
focusing on prevention of seizure recurrence may entail an iatrogeneous fear of the parents 
and indirectly of the child_ Editorials have been addressing this subject of pro's and con's of 
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prevention of febrile seizure recurrences. They conclude that the efforts should foclls on 
reduction of parental anxiety by providing information about the excellent prognosis of febrile 
seizures. 69-71 
8.4 Prediction of febrile seizure recurrence 
Risk factors for seizure recurrence: previous studies 
Previous studies have investigated risk factors for seizure recurrence. Although not all studies 
found similar associations, some factors have been shown to be quite consistent throughout 
these studies, Table 8,2 shows all the studies published since 1977 which have iuvestigated 
risk factors for febrile seizure recurrence.5,74-86 In these studies children with an initial febrile 
seizure were included. They have studied the association between patient characteristics, 
characteristics of the initial seizure, the family history and other factors versus the occurrence 
of a first recurrent seizure or at least olle recurrent seizure. Three studies have additionally 
investigated factors associated with further recurrences.80,83,86 Table 8.3 illustrates the risk 
factors which have been associated with the first seizure recurrence, in previous studies and in 
our studies (chapter 4 and 5), All risk factors which were significantly associated with seizure 
recurrence had risk estimates in the same direction (> I ,0), Table 3 also illustrates which 
factors have not been associated with seizure recurrence and which factors have not been 
studied, The study numbers in Table 8,3 correspond with those in Table 8,2, 
If the sample sizes of the studies are weighed in Table 8,3 five risk factors show up in 
decreasing order of importance: young age at the initial seizure, family history of febrile 
seizures, low temperature at the initial seizure, multiple type initial febrile seizure and short 
period of fever before the initial seizure. We define these factors as 'known' risk factors and 
consider them as important factors. 
Risk factors for seizu .. e .. ecu .... ence: studies in this thesis 
The study described in chapter 4 of this thesis (study 15 in Table 8,2) has been designed to 
assess the efficacy of administering ibuprofen during fever to prevent a recurrence. Children 
with an increased recurrence risk were included, disregarding the number of previous febrile 
seizures; 36% of all patients had suffered at least one seizure recurrence before study entry 
(Table 8.4). The outcome was the first recurrence after study entry. Using Cox regression 
analysis we have re-analysed these data to predict febrile seizure recurrence. We ,used the 
complete sample (n=230) because ibuprofen showed not to be effective. The results are given 
in Table 8.4. In accordance with previous studies we found young age at the initial seizure and 
multiple type initial febrile seizures to be significantly associated with febrile seiz'ure 
recurrence. Female gender was also significantly associated with recurrence in our data, which 
has never been described in previous studies. Caucasian origin, day nursery care, long 
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duration of the initial seizure and family history of febrile or any other seizures were 
associated with a reduced recurrence risk. Previous studies have shown that a positive family 
history increases the recurrence risk, which is the opposite of what we described. The 
associations we found, however, were not significant. Low temperature at the initial seizure 
(HR= 1) was not associated with febrile seizure recurrence. Thus, this characteristic being a 
strong risk factor as shown in several previous studies could not be confirmed. The results of 
the present study confirmed previous findings that focal initial seizure and previous recurrent 
seizures are associated with an increased recurrence risk. In our study, however, these 
associations did not reach the level of statistical significance. Risk factors of seizure 
recurrence clearly confirmed by our data were young age at the initial seizure and multiple 
type initial febrile seizures. These characteristics were significantly associated with an 
increased risk, as has been described in earlier studies. 
In the study of the number of fever episodes in association with febrile seizure recurrence 
(chapter 5.1, study 16 in Table 8.2) the placebo group of the randomised controlled trial 
(1l~89) and children participating in the cohort study (1l~66) were enrolled (a total of 155 
children), In the univariable logistic regression model no association between 'known' risk 
factors and febrile seizure recurrence was found. Age at sttldy entry (OR~0.6 (0.3-l.l) per 
year increase) and the number of fever episodes (OR~1.8 (1.4-2.4)) were associated with 
febrile seizure recurrence. In the multivariable model only the number of fever episodes was 
retained. Three other studies have defined the importance of the number of fever episodes in 
. h . k f . 78 84 85 0 fit d' d . d assessmg t e flS 0 seIZure recurrence. ., ne 0 t lese s u les was a ran omlse 
controlled preventive trial which induded children with an initial seizure and an average 
recurrence risk. a5 In addition to the number of fever episodes, two of these studies found 
positive family history associated with a febrile seizure recurrence. 78,84 We did not find an 
association between family history and seizure recurrence. 
In the study which showed that age and temperature at onset of fever were predictors of 
seizure recurrence (chapter 5.2., study 17 in Table 8.2) the data of all patients who participated 
in the randomised controlled trial were considered (n~230). 
We constructed a scatter diagram to depict the temperature related to the first febrile seizure 
recurrence for each child, for which we used all temperature measurements in the 509 fever 
episodes (Figure 8.1). The figure illustrates that in the time period two hours or more after 
fever onset the temperature was higher if a seizure recurrence occurred compared to the 
temperature jf seizure recurrence did not occur. 
A second diagram was constructed using all temperatures measured in the fever episodes in 
which a seizure recurrence occurred at two hours or more after fever onset. 
Figure 8.2 illustrates the course of the temperature in the individual patients during the fever 
episodes from fever onset until seizure recurrence, This figure illustrates that the temperature 
at seizure recurrence was higher compared to the temperature at fever onset. We performed a 
Poisson regression analysis to study the association of baseline factors, factors unique for each 
fever episode (age and temperature at onset) and factors unique for each six hours time 
interval of fever (temperature) with febrile seizure recurrence. Multiple type initial febrile 
seizures were associated with seizure recurrence. Young age at onset of fever, which might be 
considered related to young age at initial seizure and short time lapse since previous seizure, 
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Table 8.2 Studies of risk factors for febrile seizure recurrence 
Study number and Journal, Year of publication 
first author 
Sampling Sample size 
I Wolf Pediatrics, 1977 Hospital-based 355 (RCf) 
2 Nelson Pediatrics, 1978 Cohort 1706 
3 Knudsen Arch Dis Child, 1985 Hospital-based 137 
4 Verity BMJ,1985 Cohort 290 
5 Shirts Neurology, 1987 Cohort 687 
6 Knudsen Acta Neurol Scand, 1988 Hospital-based 137 
7 EI-Radhi Nch Dis Child, 1989 Hospital-based 154 
8 Berg J Pediatr, 1990 Meta-analysis3 4414 
9 Berg N Engl J Med, 1992 Hospital-based 347 
100ffringa Dev Med Child Neural, 1992 Hospital-based 155 
110ffringa J Pediatr, 1994 Pooled analysisb 2496 
12 Rantala Acta Neural Scand, 1994 Hospital-based 169 
13 Uhari J Pediutr, 1995 Hospital-based 180(RCf) 
14 Berg Arch Pediatr Adolcsc Med, 1997 Hospital-based 428 
15 Chapter 4 Pediatrics, 1998 Hospital-based 230 (RCf) 
16 Chapter 5.1 Acta Paediatr (submitted), 1998 Hospital-based 155 
17 Chapter 5.2 Arch Pediatr Adolesc Med, 1998 Hospital-based 230 
RCTRandomised controlled trial; FS Febrile seizure 
Study number 3 and 6 had used the same sample. Study 15 and 17 used the same sample. Study 16 used the 
reference group of 15 plus a new cohort. 
a Study 8 included 14 previous studies: 3 population-based studies, 3 cohort studies, 4 ReT's and 4 hospital-ba<;ed 
studies. In study 8 had been included study 1-7. 
b Study II included 5 previous studies, of which the individual patient data were Malysed: 2 cohort studies and 3 
hospital-based studies. Study II included study 2,3,6,7 and 10. 
was also associated with a recurrence. In accordance with one other study high temperature at 
fever onset and throughout the fever episode (measured each six hours) also predicted a 
recurrence in our data.85 
140 
General discllssion and jitfure prospects 
Inclusion Infomled Outcome Statistics 
consent 
Initial FS, unselected unknown First recurrence Life table method 
Initial FS: unselected unknown At least one recurrence Logistic regression 
Initial FS, unselected yes First recurrence Cox regression 
Initial FS, unselected unknown At least one recurrence Chi-square 
Initial FS, unselccted unknown At least one recurrcnce Cox regression 
Initial FS, unselected yes First recurrence Cox regre,ssion 
Initial FS, unselected unknown First recurrence Chi-square tests 
Initial FS, unselccled unknown l.First recurrence Melaanalysis-
2.Subsequent recurrences techniques 
Initial FS, unselccted yes First recurrence Cox regression 
Initial FS, unselected unknown At least one recurrence Cox regression 
Initial FS, unselected inone 1.First recurrence Cox regression 
study:yes 2.Any recurrence 
Initial FS, unselected yes At least one recurrence Logistic regression 
Initial FS, unselected yes First recurrence Cox regression 
Initial FS, unselected yes i.First recurrence Cox regression 
2.Subsequent recurrences 
Any FS, high recurrence risk yes First recurrence after study Cox regression 
entry 
Any FS, high recurrence risk yes First recurrence after study Logistic regression 
entry 
Any FS, high recurrence risk yes First recurrence after study Poisson regression 
entry 
Important risk factors for seizure recurrence 
Some important predictors of febrile seizure recurrence found in several large studies did not 
predict seizure recurrence in our study population. We give several possible explanations. 
According to Table 8.2 the 'known' risk factors for febrile seizure recurrence have been 
verified in several studies, including one large sample of 2496 children who had participated 
in five different follow-up studies.83 In this pooled analysis individual patient data were 
analysed. Four of the five studies had separately previously assessed that similar risk factors 
were associated with febrile seizure recurrence.74.76.79,82 Earlier a metaanalysis was performed 
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including 14 previolls studies and a total of 4414 cases.so Because of the relative small sample 
size (n~230) of our study (number 15) it is most likely that the power has been too limited to 
define all 'known' risk factors. Young age at initial seizure was the most important risk factor 
based on previous studies. This may be the reason that we found this factor associated with 
recurrence. Absence of associations in our data may not be interpreted as a lack of importance 
of the other 'known' risk factors, As shown in Table 8.2 we have included children with 
febrile seizures regardless of the number of febrile seizures they had suffered. They only had 
to have an increased risk based on high-risk inclusion criteria. If also children with a lower 
recurrence risk had been included, the other 'known' risk factors might have been found 
associated with seizure recurrence. Table 8.4 shows the frequency of the risk factors present in 
the sample. Selection based on high risk criteria reduces the power of the study to identify 
these criteria as high risk factors. Further, we studied the first seizure after study entry and 
have not studied risk factors of more than one seizure recurrence during follow-up. This also 
means that follow-up has been shorter in our study. All other previous studies included only 
children who had an initial febrile seizure. These studies investigated the predictors of a first 
seizure recurrence. In addition some studies analysed subsequent recurrences resulting in the 
following risk factors: young age, low temperature at the initial seizure and short time lapse 
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explanation for finding different results may be that in two of our studies (chapter 5) we have 
analysed the data using a different definition of follow-up time 'at risk' compared to the 
literature, This was six months after a previous febrile seizure (5.1) and subsequent fever 
episodes (5.2), respectively. 
Of all parents whose children were eligible to participate in our mndornised controlled trial, 
16% did not give their informed consent and thus declined study participation (Figure 4.1). 
Unfortunately data about the percentage of parents who refused consent to participate in the 
cohort study are not available. It may have been that in previous studies (Table S.2) informed 
consent was asked less frequently; 7 studies did not report whether informed consent had been 
asked. Of the five studies that were included in the pooled analysis83 , only one study76 
reported that informed consent was asked, the others did not report whether they had asked 
consent.74.79,82,87 The evidence whether or not study participation and an informed con:-;ent 
procedure implicate a selection with respect to prognostic factors is still conflicting.88'94 If so, 
this may have contributed to a relative absence of the 'known' risk factors' association with 
febrile seizure recurrence. In the report of the questionnaire studies performed among the 
randomised controlled trial participants (chapter 3 and 7), however, we found no difference in 
education and profession levels compared to the national Dutch population. Besides, the risk 
of getting initially affected by 'febrile seizures' has never been proved to be associated with 
social status or parental income.95.97 
A selection-bias with respect to inclusion in the study of a specific hospital-population is not 
very likely. The majority of the previous studies have been hospital-based studies as well. 
Moreover the Sophia Children's Hospital and the Juliana Children's Hospital both have an 
emergency ward which is open 24 hours per day and the level of care regarding febrile 
seizures is mainly basic specialist care. One of the previous studies included patients from the 
same source (Sophia Children's Hospital) as we t1sed.s2 This study was also used in the pooled 
analysis.S) 
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Table 8.3 Risk factors for first or at least one recurrence after the initial febrile seizure 
Numbers are referring to the study numbers in Table 8.2 
Risk factors Significant Not significant 
Patient characteristics 
Female gender 15 3-6,10-14,16,17 
Ethnic origin 14,15 
Day nursery care 3 6,15 
Abnormal psychomotor develop- 3,6,8,9,14 
ment 
Characteristics of (he initial 
febrile seizure 
Young age: 7\l1b,141 
Continuous 1,2,4,10,15 12,13,16,17 
< 12 months 8 
:::;: 15 months 3 6 
< 18 months 5,9 
Temperature < 40.0 °C 7l ,9C,lO,11 ,14a 15-17 
Short period of fever before the 9,14 
seizure « I hour) 
Complex characteristics: 
Multiple Iype 3,8,10,11,15,17 1,4-6,9,12-16 
Duration ~ 15 minutes 1,3,8 2,4-6,9-14,15" 
Focal type 1,3,8 2,4-6,9-15 
Firstfsecond family history 
Febrile seizures 3,5,6,8-12,14 13,15-17 
Non-febrile seizures 2,3,6,10,11 5,8,9,12-14 
Any lype of seizures 4 1,8,15 
Others 
Time lapse since previous seizure « lOe,15 
6 months) 
Number of fever episodes: 
Continuous 12,13,16 
~ 4 per year 6 
Characteristics of subsequent fever 
episodes: 
Young age at a onset of fever 17 12 
High temperature at onset of feyer 13,17 
High temperature during fever 13,17 12 
Viral etiology of fever 12 
a more than two specific age and temperature categories 
b recurrence risk highest between 12 and 24 months of age 
C analysed as a continuous variable 
d characteristic studied: seizure duration ~ 30 minutes 
Not studied 
1,2,7-9 
1-5,7-13,16,17 
1,2,4,5,7-14,16,17 
2,4,5,7,10-13,15-17 
3,5-9 
1-7,9-17 
1,2,4,5,7-17 
1-4,6-8,10-17 
1-6,8,12,13 
1-8,10-13,15-17 
7 
7,16,17 
7,16,17 
1,2,4,7 
1,4,15-17 
2,3,5-7,9-14,16,17 
1-9,11-14,16,17 
1-11,14,15,17 
1-5,7-17 
1-11,13-16 
1-12,14-16 
1-11,14-16 
1-11,13-17 
143 
Chapter 8 
Table 8.4 Factors associated with febrile seizure recurrence, analysed in RCT data (chapter 4, study 15) 
Risk factors Univariable analysis Multivariable analysis 
HR(C!95%) p~value HR (C!95%) p-value 
Patient characteristics 
Female gender 90 (39%) 1.5 (0.9-2.5) 0.08 1.7 (1.0-2.7) O.04A 
Origin (Caucasian) 145 (63%) 0.8 (0.5-l.3) 0.42 
Day nursery care 88 (38%) 0.7 (0.4-1.1) 0.13 
Characteristics of the 
initial febrile seizure 
Age 1.4 (1.1-1.9)' 0.5 (0.3-0.8) 0.01 0.5 (0.3-0.8) <0,01 3 
Temperature < 40.0 <>e 121 (53%) 1.0 (0.6-1.6) 0.67 
Complex characteristics: 
Multiple type 87 (38%) 1.8 (1.1-2.8) 0.02 1.7 (1.1-2.8) Q,QY 
Duration;:: 30 minutes 20 (9%) 0.6 (0.2-1.6) 0.3! 
Focal type 26 (ll%) 1.6 (0.8-3.1) 0.19 
First/second family history 
Febrile seizures 59 (26%) 0.7 (0.4-1.3) 0.25 
Any type of seizures 93 (40%) 0.9 (0.1-1.4) 0.53 
Others 
Age at study entry 1.9 (lA.2.St 0.5 (0.4-0.8) <0.01 0.8 (0.5-1.2) 0.20 
Time lapse since previous seizure 0.4 (0.1-2.1) 0.29 
0.1 (0.04-0.2)' 
Previous recurrent febrile seizures 1.1 (0.7-1.8) 0.67 
84 (37%) 
The frequency distribution in the study sample has been given in italics 
a significantly associated with febrile seizure recurrence in the multivariablc model 
b median (25-75 percentiles) in years 
HR hazard ratio 
We conclude that based on the studies of risk factors of febrile seizure recurrence which have 
been performed until now, the following factors may be described as important (in order): 
young age at the initial seizure, family history of febrile seizures, low temperature at the initial 
seizure, multiple type initial febrile seizure and short period of fever before the initial seizure. 
Risk factors which clearly suggest an increased risk, but which need further study in larger 
samples, for instance a pooled analysis or a metaanalysis, are: number of fever episodes and 
temperature at onset and during subsequent fever episodes. The main explanations for only 
finding young age at the initial seizure and multiple type initial seizure associated with a 
recurrence in our data and for not confirming the importance of the other 'known' risk factors 
arc most likely the small sample size of our study, the selection based on high risk criteria, 
and young age being a very strong risk factor based on previous studies. 
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!2 !S 24 :n 
Th1a Since /liVer onset (hOurs) 
Temperature versus time since fevcr onset and febrile seizure rccurrence (509 fever episodcs), 
The small white boxes represent the temperature without seizure recurrence and thc black dots 
indicate thc temperature at seizure recurrence. 
!2 !8 14 I) 
Time s,ncalevel onset (Mou,s) 
Temperature versus time since fevcr onset in the fever episodes accompanied by a febrile 
seizure recurrence betwecn 2 hours and ]0 hours after fevcr onset (20 fever cpisodes). Three 
rccurrences occurred after]O hours of fever. The small white boxes represent thc temperature 
without seizure recurrence and the black dols indicate thc temperature at seizure recurrence. 
The lines cOllncctthe tempcmtures in thc individual paticnt. 
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8.5 Pathophysiological aspects 
The 'seizure threshold theory' which implies that the higher the temperature at fever onset, the 
higher the risk of a seizure recurrence is supported by the results of our study. The existence 
of a febrile seizure temperature threshold has been suggested, based on animal studies,98-100 
Later clinical studies have demonstrated that a relatively low temperature at the initial febrile 
seizure is associated with an increased risk of seizure recurrence (Table 8.3). A short duration 
of fever before the initial seizure occurs is also a risk factor for seizure recurrence (Table 
8.3).80 Further, in a matched case-control study the height of the temperature as a 
characteristic of the acute illness was an independent predictor of an initial febrile seizure. 101 
These findings may suggest the existence of such a threshold and may suggest that children 
with a high risk for seizure recurrence may have a lower temperature threshold above which a 
seizure will develop.79,80,83,IOI.103 In children with a high recurrence risk the threshold may be 
reached more easily and thus recurrent seizures will occur more frequently. It is, however, 
very difficult to distinguish if either the absolute temperature itself or the rapidity of its 
increase is the main seizure eliciting factor. In the past hyperthermia studies have been done in 
animal models to investigate the association between temperature and seizures, using very 
frequent or continuous temperature registration and EEG~monitoring.98.100 It was described 
that either the rapidity of temperature increase or the height that was reached or both were 
associated with the occurrence of seizures, clinically as well as in the BEG. Similar results 
were shown in a study of children with hyperthermia, induced by intravenous administering of 
typhoid vaccine.IO-t As the term hyperthermia already indicates these studies were done in 
highly unphysiological circumstances which make extrapolation to normal human conditions 
impossible. The suggestion provided by the results described in chapter 5.1 that the factor 
'chance' plays a role in the occurrence of a febrile seizure may also be considered suggestive 
for the existence of a temperature threshold in the pathophysiological mechanism of febrile 
seizures. This is illustrated by the frequency of fever episodes being independently associated 
with febrile seizure recurrence: the more frequent the child suffers from a febrile illness, the 
longer the time 'at risk', the higher the risk of seizure recurrence. It is unknown whether this 
also holds for initial febrile seizures. 
We assume that whether a seizure will occur (the 'temperature threshold') may be influenced 
by genetic factors. Genetic aspects of febrile seizures are discussed in the next paragraph. One 
of the main factors playing a role in the risk of recurrent febrile seizures as defined by the 
present studies is the child's' age. Increasing age decreases the recurrence risk (chapter 5.2).83 
Young age at the initial febrile seizure and a short time lapse after the last previous febrile 
seizure have shown to be major risk factors for seizure recurrence (Table 8.3).77,80.83 The 
phenomenon of febrile seizures disappears when the child grows older. 105 It might be that age 
modulates the temperature threshold for febrile seizures. We have also demonstrated that the 
influence of age on febrile seizure recurrence is highly associated with the number of febrile 
illnesses (chapter 5.1). This may suggest that environmental factors such as infectious diseases 
also playa role in the pathophysiology of febrile seizures. Despite this result, however, we 
consider age as one of the main factors influencing the susceptibility for febrile seizures. 
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To determine whether an individual seizure temperature threshold exists we should frequently 
measure the temperature in children with recurrent febrile seizures. An individual fever 
pattern in relation to seizure recurrence may be present. The individual pattern may contain, 
for example, that whenever a seizure recurrence occurs, it occurs in the first hours after the 
onset of .fever. Age might change this pattern. For frequent temperature measurements an 
easily applicable infrared tympanic thermometer can be used. This allows a safe, reliable and 
relatively comfortable body temperature measurement. 106-108 If such an individual pattern does 
not exist the results may be considered suggestive for an infectious cause or other exogenous 
factor playing a role in the development of a seizure. 
It would be interesting to monitor the child electroencephalographically (EEG) during fever. 
We started a pilot study in children for EEG measurements during fever in September 1995 in 
collaboration with the Depmiment of Clinical Neurophysiology. We aimed to assess the 
frequency of abnormal EEG-phenomena during the first hours of fever. The hospital ethical 
review board approved the protocol. The children participated in the randomised trial of 
ibuprofen to prevent recurrent febrile seizures. At fever onset we performed an standard-EEG 
as soon as possible (at least within two hours after fever onset). The rectal temperature was 
assessed at the onset of the EEG-registration. The registration took one hour on average and 
was only carded out during daytime. Only five parents gave informed consent for the EEG 
during fever of their child. The refusing parents did not want to subject their feverish child to 
the investigation. All five children had a fever (2038.5 0c) at EEG-registration onset. We found 
no EEG-abnormalities. This study was terminated after one year because the inclusion rate 
was very low. This pilot illustrates that EEG-registration during fever in children with febrile 
seizures does not appear to be feasible. 
8.6 Genetics of febrile seizures 
Evidence about genetic factors predisposing for febrile seizures has been provided by several 
previous studies.81 ,83,84,109-I12 The most important argument of a genetic predisposition has 
been provided by two studies showing that febrile seizures are most likely to occur with a 
frequency of 10% in families where there is already a documented history of febrile seizures 
compared to 4% in the general population. II3,I14 This may suggest a mode of inheritance 
according to a polygenic multifactorial threshold model. The mode of inheritance, however, is 
still unclear: polygenic, autosomal dominant and autosomal recessive all have received some 
support.IIS-117 
We have studied the two candidate genes on chromosome 20q and 8q linked to Benign 
Familial Neonatal Convulsions (BFNC) (chapter 6.2).'18.[23 One previous febrile seizures 
study has suggested a linkage with febrile seizures of the same locus on chromosome 8q.124 A 
previous genetic study of febrile seizures pcrfonned in the Sophia Children's Hospital showed 
no linkage of chromosome 20q and 8q with febrile seizures. 12S These two studies investigating 
gene localisations for febrile seizures have used linkage analysis to study a large multi-
generation family with multiple affected subjects. 124,125 We have three motives to use the 
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affected sib pair method instead. Large families with multiple affected subjects are not 
frequently available in febrile seizures. 124 In the Sophia Children's Hospital only one large 
famBy was suitable for a linkage study of febrile seizures these last five years, 125 Further, the 
affected sib pair method allows us to limit the study to affected pairs that have been diagnosed 
recently, which is important becnuse 'febrile seizure' is a clinical diagnosis. In most cases the 
diagnosis is based on the history told by the parents. Linkage studies of multi~generation 
families will have difficulties in assessing the diagnosis because detailed information is only 
available for the younger generations. 124,125 The third reason is that the affected sib pair 
method has proved to be robust in that it is effective under circumstances of 10calising genes 
for genetically heterogeneous disorders in ethnically diverse populations as are febrile 
seizures. 126 
The results of chapter 6.2 showed no linkage of febrile seizures with loci on chromosome 8q 
and 20q. A slight non-significant suggestion of linkage on chromosome 20q was present in the 
non-Caucasian sample. This sample consisted of 12 families from a varied ethnic origin. Thus 
this suggestive observation was based on a limited number of informative families and 
remains to be confirmed. Each non-Caucasian family contributed approximately equally to the 
resuits; no single family had paid a relatively large contribution to the slight suggestion of 
linkage on chromosome 20q. This reduces the probability that the suggestion for linkage of 
febrile seizures with the locus flanked by marker D20S 1085 is based on the presence of a gene 
locus for febrile seizures. The results of the exclusion analysis of chromosome 20q in the 
Caucasian sample confirmed that linkage to this area on chromosome 20q of febrile seizures 
is very unlikely. Accordingly, linkage to chromosome 8q showed to be unlikely. One other 
study of an extended family with febrile seizures which has been published recently excluded 
linkage to the chromosome 8q locus. 127 This study did not investigate the involvement of loci 
on chromosome 20q in febrile seizures. 
There is little evidence in our study that the loci on chromosome 8q and 20q involved earlier 
in febrile seizures and BFNC play an important role in the occurrence of febrile seizures in the 
general population. Further searching of the genome will be necessary to identify genes 
involved in febrile seizures. To increase the power of the present study to detect linkage the 
sample size of the study population needs to be enlarged. Recently provided evidence for an 
autosomal dominant gene for familial febrile seizures on chromosome 19p requires 
confirmation in other fanli1ies with febrile seizures, including ours. 127 In addition, given the 
findings on the role of potassium channels in BFNC further research may be targeted towards 
these channels. 122,123,128,129 
Specific phenotype subgroups may help in localising genes predisposing for febrile seizures. 
According to the results described in chapter 6.1 the phenotype consisting of complex 
characteristics of initial febrile seizures may not be helpful. Previous studies have found 
association between the phenotype of frequent febrile seizure recurrences and familial febrile 
seizures.76,82.83.lo9 ,We will perform additional analyses using the frequency of seizure 
recurrences as a weighing factor to increase the likelihood of iocalising a gene in familial 
febrile seizures. 
LocaHsing genes for febrile seizures may not directly result in implications for preventive 
treatment of febrile seizures. Insight in the pathophysiologic basis of febrile seizures and, 
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possibly, of seizure disorders in general may become available when studying the genetic 
basis of febrile seizures. 
8.7 Ethical aspects of pediatric research 
Pediatric research 
These last decades increasing attention has been paid to the protection of participants in 
clinical research. Legal and ethical aspects of clinical research in children have been 
frequently addressed in the international literatureYO-136 Currently national Dutch legislation 
is about to permit non-therapeutic clinical research in children.137-14o An overview of the 
debate previous to this proposal has been published. 141 The main issue has been whether or 
not an individual child has to gain benefit from study participation or study results. The main 
motive, however, for clinical research to be permitted and performed in children is that as a 
group they have an equal right to benefit from scientific knowledge as adults have. 141 ,142 If 
non-therapeutic clinical research in children is prohibited children are exposed to unknown 
risks and normal physiology and pathophysiology in children may remain largely unknown. 143-
146 Main conditions for allowing studies in children are: minimal risks, minimal disadvantages 
(no unequal invasive, painful or uncomfortable procedures), results not obtainable by studying 
adults, and informed consent from the parents. 140,145,147,148 Furthermore it has been stated that 
a child should be withdrawn from the study when, due to study procedures, it is unduly 
stressed. 137,148 
In studies aiming to assess a hereditary basis of a disease, for instance the DNA study 
discussed in this thesis (chapter 6.2), there is no benefit for the individual participants. 
Disadvantages of participation in such a study include the inconveniences of a venapuncture 
and a (very small) risk of being told to carry a genetically determined disease. This disease 
may be either the disease that is studied (febrile seizures), an associated but more severe 
disease (in febrile seizure studies for instance a severe type of epilepsy), or a 'chance hit' (a 
disease unrelated to febrile seizures, for instance a hereditary type of malignancy), 
Consequences of serious, unexpected findings may include psychological problems and 
difficulties concerning insurance or selection procedures for a job. In our informed consent 
procedure we have discussed these risks with every parent whose family was eligible. In the 
informed consent form of the genetic study of febrile seizures the issue was addressed as 
follows: 'When the study results are known, we will acquaint you with the general final 
results. Your individual results will be provided to you only, if you explicitly wish so. This 
way we prevent you or others involved to receive information unexpectedly or unintendcdly. 
If you wish to receive your individual results you will be referred to the Clinical Genetics 
Centre involved in the study.' 
Despite the possible negative consequences of study participation and the few or even non-
existing benefits for the participant there is evidence that people are willing to participate in 
research even without being adequately provided with information 149-151 and despite the costs 
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of time and effort.91 ,93,152 The main motive of participation is the willingness to contribute to 
clinical science,152,153 The general willingness to participate in clinical research has been one 
of the reasons mentioned in the advice to the government with respect to allowing nOll-
therapeutic studies in children. 137 We found that the wish to contribute to clinical science was 
the main reason for parents to initially consent to participate in clinical research (51 %) and to 
be willing to participate in the future (24%) (Table 7.3 and 7.6).153 
The willingness of parents to let their child participate in clinical research may be illustrated 
by our data, Of all children who met the inclusion criteria of the raodornised controlled trial 
(chapter 4) 84% (n=230) of the parents consented to participation (Figure 4.1). In the Sophia 
Children's Hospital and Juliana Children's Hospital 80 children with febrile seizures had a 
sibling who suffered fro.m febrile seizures as well and who met the criteria for the genetic 
study (chapter 6). Of their parents, 68 (85%) approved to participate. The parents of 15 
children with febrile seizures and an affected sibling responded to our announcement in the 
magazine 'Ouders van Nu'. After explaining the study 10 (67%) said to be willing to 
participate. The remaining 5 parents refused participation, mainly because of the necessary 
venapuncture. Thus high percentages of the parents gave informed consent for the randomised 
controlled trial (84%) and the genetic study of febrile seizure studies (85% and 67%). 
Informed consent 
In pediatric studies not the participant but the parents or legal representatives are asked to give 
informed consenl. If the child is 12 to 16 years old the child has to consent as well. 140,147,154 In 
the USA it has been recommended that children older than 7 years of age should have the 
right to refrain from participation. 14S,155,156 The parents should be informed about any risks 
and extra procedures their child has to undergo, they should know who will benefit from the 
study or the results and to what extenI.140.147,I48 They should be offered time to consider the 
proposal. 140 As the main parental responsibility is taking care of their child, they will balance 
the pros and cons of the information provided and then decide whether or not to consent. 131 In 
chapter 7 we described that 75% of the parents knew why they had signed the informed 
consent form, while 9% thought it was for the protectional rights of the investigator and 9% 
did not know. Although 75% is quite a high percentage we think the other 25% should also 
have known that asking informed consent and signing the form is meant to protect their 
individual rights. 147 Attention should be paid to explaining the reason of the signature. This 
should also prevent that parents think they cannot withdraw their consent due to the 
signature. 140,147,148 
In the process of providing information to possible study participants, we make a choice 
between providing extensive and detailed information versus an easy-reference version with 
comprehensible information. The extensive informed consent information may entail every 
detail of the study, which could confuse the reader. It also may include specific rather negative 
and depressing prognostic details which occur only rarely. We prefer a clear and sufficiently 
short informed consent form which may not include each and every detail of the study and the 
disease. A main criterium may be that the information provided is sufficient to make a 
responsible decision whether or not to participate. ls7 It should contain honest and clear 
information about the risks, disadvantages and inconveniences of study participation. 
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complex, 159,161 In chapter 7 we asked the parents how they evaluated the difficulty of the 
verbal and written information. Betwecn 2 and 5%, mainly non~West European parents, 
thought the information was difficult to understand,. Further, we found that parents of West-
European origin were more aware of the major study details. This iBustrates that thc 
information should be adjusted to the sociocultural differences among the possible 
participants of the study.15J,162 In the Sophia Children's Hospital general guidelines for 
compiling an informed consent form have been developed recently. They have been based on 
a survey of the available literature and the results of a questionnaire study among ethical 
review boards of hospitals in the Netherlands to which 75% responded. 163 
Future studies of informed consent issues in pediatric clinical research are necessary to assess 
the willingness of parents and children to participate. These studies may reveal further flaws 
in recall, comprehension and evaluation of the information provided at informed consent 
procedures (chapter 7). It would be interesting to interview the participating families of the 
affected sib pair analysis of febrile seizures (chapter 6.2) using a similar questionnaire as the 
one used in the informed consent study (chapter 7). 
The dilemma of being physician and investigator 
In our randomised placebo controlled trial of ibuprofen to prevent febrile seizure recurrence 
the doctor and the investigator were the same person. This means two different relationships 
with the patient and his or her parents. 147,16-t The physician aims to serve the benefit of the 
patient while the investigator is responsible for the quality of the study. There are situations in 
which these two different roles arc conflicting. This may elicit some 'ethical uncertainties' for 
the research-physician. 
The illformed COllsent procedure 
Parents were given information about the study and were asked informed consent during their 
visit at the special febrile seizures outpatient clinic two weeks after a febrile seizure of their 
child, Although 91 % of the interviewed parents felt positive about this setting, 25% also felt 
obliged to participate (chapter 7). Asking for informed consent while also having to treat the 
patient may cause an area of tension. 147 A high patient inclusion rate is beneficiary to the 
study, but study participation may not always mean the best treatment for each individual 
patient. In our study the parents may have fcIt pressured to participate, which is not in 
accordance with freely given informed consent. They may have assumed that the physician 
would not have asked their consent if study participation would not have been the best 
treatment option for their child. A suggestion for this assumption may be that only 50% of the 
parents in our Ntudy had been aware of the random allocation procedure. A total of 88% was 
aware of the use of a placebo group, including all parents who knew about random allocation 
Crable 7,2), 
Bellefilojparlicipalioll 
In our study parents said to appreciate the investigator being on call 24 hours a day (38%) and 
the extra medical care provided (37%) as an advantage of participation (Table 7.5). This 
appreciation may have influenced the informed consent procedure. Parents may have 
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consented because of these advantages and may have evaluated the other study characteristics 
as less important, probably because of the relatively low risk of side effects of ibuprofen and 
the non-invasive approach of the study procedures. For the investigator it may be tempting to 
stress the advantages aiming to increase the recmitment rate, while the treating physician 
should pay attention to possibly uneasy study procedures and the risk of negative side effects 
of the study medication. 
Treatment evaluation 
Doctors evaluate the medication they have prescribed or advised: they assess its efficacy in the 
individual patient. If this is not satisfactory other treatment options will be considered, which 
is in the interest of the patient. The investigator and the participants, however, must remain 
'blind'. For the benefit of the study compliance has to be assessed. In our study we did so by 
asking the parents whether the medication had been taken according to the protocol and in 
addition the patient diary was checked. Evaluation of the treatment efficacy (reduction of 
fever, feeling more comfortable) might have revealed the allocated treatment. This would also 
have 'triggered' the parents to which of the two groups their child had been allocated. Most 
parents in our study, however, did not need such a triggering question. Of all parents 51 % had 
an opinion about the medication allocated, which was based on observing the child and the 
temperature measurements. After finishing the study we asked the parents to what treatment 
group they thought their child had been allocated (Table 8.5). Parents who were certain about 
the prescribed treatment were more often right than the others. The child of parents who 
guessed placebo and of parents who did not respond had been more frequently allocated to 
ibuprofen. Based on these results we may hypothesise that at least 88 (49%) had been blind 
('do not know' and 'no response') and at least 32 (18%) had been unblind (parents who were 
certain and right). We may also consider all 50 (28%) parents who were certain about the 
prescribed treatment as 'psychologically unblinded', because they thought they knew to which 
treatment group their child had been allocated and thus had behaved accordingly (Table 8.5). 
In general the more obvious the signs and symptoms of the medication used, the more difficult 
it is to keep the doctor and the patient (parent) blind. We think that in general antipyretic 
treatment such as ibuprofen is more than sufficiently variable in its telltale capacities to be 
adequately used in randomised controlled trials. 
Table 8.5 Parents' opinion about treatment allocation (n=181) 
Parent,,' opinion Ibuprofen Placebo 
(n=96) (n=8S) 
Certain ibuprofen (n=31) 19(61%) 12 (39%) 
Certain placebo (n=19) 6 (32%) 13 (68%) 
Guess ibuprofen (n=27) 13 (48%) 14 (S2%) 
Guess placebo (n=16) I 1(69%) S (31%) 
Do not know (n=58) 29 (SO%) 29 (50%) 
No response (n=30) 18 (60%) 12 (40%) 
Placebo-group 
In our randomised controlled trial participating children were not allowed to use additional 
antipyretic treatment. The placebo group was needed to obtain comparability of effects. 165 Use 
of antipyretics in the placebo group would have diluted the study results. A possible negative 
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effect on placebo-using children may be 'under-treatment'. They may have felt more 
uncomfortable because of high fever, compared to children in the ibuprofen group and, 
eventually also compared to children who were not participating in the study. The justification 
of performing our randornised controlled trial was the unknown efficacy of antipyretics to 
prevent febrile seizure recurrences and the generally accepted assumption that antipyretic 
treatment of children with febrile seizures might provoke recurrent febrile seizures as soon as 
the fever reducing effect had ceased. There is no evidence for this assumption. Thus until the 
study was ended it remained unknown whether or not ibuprofen is beneficiary to the patient 
and whether or not the placebo group had been under_treated. 147,166.167 Of the participating 
parents a rather high percentage (88%) had been aware of the 50% chance of being assigned a 
placebo (Table 7.2). Participating parents were not allowed to administer antipyretics to their 
child which excludes also commonly used pain reducing medications. For only 2% of the 
parents this was the main disadvantage of study participation (Table 7.5). The physician-
investigator, however, experienced being unable to advice antipyretic-analgesic drugs a 
problem. 
We conclude that the conflicting role of the physician-investigator remains a difficult issue. 
Physicians may feel guilty or even experience moral conflicts in situations in which the 
benefit of the individual patient differs from the benefit of the study. Real problems arise if 
physicians (or their departments) are financially dependent of inclusion of patients in the 
study.145,168,169 The problems of having a double role are not easily solved by extra financial 
support in order to appoint another person for one of the two functions. Some tasks are 
preferably done by someone who is both the doctor and the researcher. This is especially the 
case in clinical research in which not the individual patient per se but the patients as a group 
will benefit. In such studies both knowledge about the individual patients and specific 
knowledge about the research project is necessary.157 Provided that the problems to be 
balanced are clear and the study fulfils the criteria of research in children we think that 
separation of the two roles is usually unnecessary.138,141,I47.148 
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9 Summary 
This thesis presents clinical and genetic studies in children with febrile seizures. Febrile 
seizures· have been registered prospectively in the Pediatric Department of the Sophia 
Children's Hospital Rotterdam since 1988. In 1994 collaboration started with the Pediatric 
Department of the Juliana Children's Hospital the Hague and since then registration has taken 
place in both hospitals. The follo\V~up of children with febrile seizures has been centred round 
an outpatients' clinic set up for children with febrile seizures. 
Chaptet'l presents a survey of the literature of clinical and genetic aspects of febrile seizures. 
Febrile seizures afC a common seizure disorder of childhood. They occur in children between 
3 months and 5 years of age in association with a febrile illness, without an underlying cause 
of the seizure. Febrile seizures have an excellent prognosis, which is in contrast with the 
impact of febrile seizures on daily family life. This impact is substantial and is usually caused 
by extreme parental fear. 
Risk factors for febrile seizure recurrence have been widely studied and include: young age at 
onset of febrile seizures, family history of febrile seizures, a low body temperature at the 
initial febrile seizure and a multiple-type initial febrile seizure. Preventive treatment of febrile 
seizure recurrences with antiepileptic dl1lgs has shown to be debatable because of their 
ineffectiveness or the high risk of severe side effects. Intermittent treatment with diazepam 
has reduced the risk of side effects. Results about its efficacy, however, have turned out to be 
conflicting due, at least partly, to the inherent problem of the recurrent seizure being the first 
presenting symptom of fever. Previous studies have also addressed the possibility of 
antipyretics to prevent febrile seizure recurrences. None of these studies were randomi:-;ed 
placebo controlled trials with a standardised antipyretic treatment schedule. Thus, the results 
were inconclusive. 
The pathophysiologic basis of febrile seizures is yet unknown. There is evidence for a genetic 
basis, which has been provided by clinical studies. Differentiation of subgroups of phenotypes 
may be helpful in localising predisposing genes, such as the phenotype of frequently recurring 
febrile seizures. which has been shown to have a familial predisposition. Localisation of genes 
involved in febrile seizures remained unsuccessful until now. 
Ethics of clinical research in children have widely been debated. Knowledge about the reasons 
for parents to permit participation of their child and their evaluation of specific study details 
may be considered a contribution to this debate. Further, this knowledge may lead to 
improved quality of the study itself. 
In chapter 2.1 a predictive model to assess the probability of normal biochemical blood test 
results in children presenting with a seizure associated with fever is described. The models 
were based on various combinations of characteristics of the history and physical examination 
of 203 children who visited the Sophia Children's Hospital between 1990 and 1992 with a 
seizure associated with fever. Normal test results of serum levels of sodium (n=115, 68%), 
calcium (n~149, 89%) and glucose (n~173, 100%) were reported. The prevalence of abnormal 
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test results was rather low and the abnormalities were outside the morbidity range. Logistic 
regression was used to relate the outcome (normal test results) to the clinical characteristics. 
The discriminative ability of the models was 'moderate' (ROC between 0.63 and 0.66). 
Chaptel' 2.2 presents the results of the study of the diagnostic value of leukocyte counts in 
children with febrile seizures. \Ve used the same data set described in chapter 2.1. No clear 
association was found between seizure duration and blood leukocytosis (;:::.: 15.0* 109 cells/I). 
In chapter 3 parents' perceptions of fever and febrile seizures and their knowledge of them 
arc reported. 'Ve carried out a mailed questionnaire study among the parents whose children 
participated in the randomised controlled trial presented in chapter 4. Of the 181 responding 
parents, 45% were afraid or very afraid of fever. Fear of fever was strongly associated with 
fear of recurrent febrile seizures. Parents of children with a nOll-West European background 
were more afraid. \Vitnessing a febrile seizure is a very frightening experience for parents. A 
majority thought febrile seizures to be harmful, because they appear dangerous. In 47% the 
parents thought that their child was dying during the initial febrile seizure. Consequences of 
parental fear included frequent temperature measurements (25% measured five times per day 
or more), sleeping in the same room as the child (24%) and remain awake at night during 
fever (13%). Reassuring information about fever and febrile seizures may be helpful: 21% 
mentioned the information provided as their reason to consider febrile seizures not harmful 
anymore. 
In chapter 4 the results of the randomised double blind placebo controlled trial of ibuprofen 
to prevent febrile seizure recurrences are presented. In this study 230 children were enrolled. 
They had visited one of the two participating hospitals with a febrile seizure between 1994 
and 1996. They were 1 to 4 years old and had one or more risk factors for febrile seizure 
recurrence. They were randomly assigned to either ibuprofen symp 5 mg per kg body weight 
per 6-hourly dose (Ill children) or matching placebo (119 children), to be administered 
during fever. Median follow up time in both groups was about I year. The probabilities of first 
recurrence after study entry (2 years' Kaplan-Meier %) were 32% in the ibuprofen group and 
39% in the placebo group (p::::0.70). Cox regression analysis showed that the recurrence risk in 
the ibuprofen group was 0.9 (CI95% 0.6-1.5) times the recurrence risk in the placebo group 
(,intention-to-treat'). Adjustment for baseline characteristics did not affect the risk reduction 
estimate. A 'per-protocol' analysis, which was limited to those recurrences which occurred in 
the context of study medication compliance, showed similar results. 
The objective of chapter 5.1 was to assess the association between the number of fever 
episodes and febrile seizure recurrence. For this purpose we performed a 6 months' follow-up 
study of 155 children aged 3 months to 5 years with a history of a first or a recurrent febrile 
seizure. We used the data of 89 children who had participated in the randomised controlled 
trial (chapter 4). The other 66 children were included afterwards; they had visited one of the 
two participating hospitals with a febrile seizure in 1996 or 1997. The occurrence of fever 
episodes and febrile seizure recurrences was prospectively documented. With logistic 
regression analysis we studied the association between the baseline characteristics and the 
number of fever episodes and the outcome: a febrile seizure recurrence. \Ve registered 260 
fever episodes in which 29 children experienced one or more febrile seizure recurrences 
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during follow-up. \Ve identified two factors associated with febrile seizure recurrence: number 
of fever episodes (OR=1.8 per fever episode) and age at study entry (OR=0.6 per year 
increase). In a multivariable model only the number of fever episodes remained significant. 
In chaptm' 5.2 the prediction of a recurrent febrile seizure during subsequent fever episodes is 
described. \Ve studied the data of the temperatures, ~ejzure recurrences and baseline patient 
characteristics coBecled at the randomised controlled trial reported in chapter 4. Of all 
children 182 had at least one fever episode during follow-up. We registered 509 fever 
episodes with 67 recurrences. Half of the recurrent ~eizures occurred in the first two hours 
after fever onset. These recurrences occurred at a lower median temperature (39.3 DC) than 
those occurring after more than two hours of fever (40.0 DC, p<O.OOI). Multivariable Poisson 
regression resulted in two predictors of a seizure recurrence during a subsequent fever 
episode: age at fever Ollfiet (RR=O.7 per year increase) and temperature at fever onset (RR=1.7 
per degree increase). If we included the temperature at onfiet of each six hours time interval, 
the prediction showed to be more accurate. A chart is presented which can be used to assess 
the recurrence risk if age and temperature at the onset of fever are known. 
The aim of the study described in chapter 6.1 was to assess whether familial febrile seizures 
are aSfiociated with complex characteristics of the initial seizure. Such a familial phenotype 
subgroup may be helpful to study the localisation of genes predisposing for febrile seizures. In 
this study 51 Caucasian children with febrile seizures with one or more affected first degree 
relatives and 177 without an affected first degree relative were compared with respect to 
complex characteristics of the initial febrile seizure. They had visited the Sophia Children's 
Hospital Rotterdam or the Juliana Children's Hospital Den Haag between 1994 and 1996. We 
used logistic regression for the statistical analysis. No difference was found in the frequency 
of febrile status epilepticlls, multiple type initial seizure and focal characteristics. 
In chapter 6.2 an affected sib~pair analysis of febrile seizures is presented. Recently, linkage 
of febrile seizures to markers on chromosome 8q has been ~uggested. In previous studies 
chromosome 20q and 8q have been shown to be important in Benign Familial Neonatal 
Convulsions (BFNC). Because of the clinical association between BFNC and febrile seizures 
both loci are interesting candidate regions of febrile seizures in the general population. \Ve 
studied several polymorphic markers flanking the loci on chromosome Sq and 20q in 72 sib-
pairs with febrile seizures. The majority of these sib-pairs had visited the Sophia Children's 
Hospital Rotterdam between 1988 and 1997 or the Juliana Children's Hospital Den Haag 
between 1992 and 1997. The remaining children were recruited by collaboration with 
pediatric departments of regional hospitals, general practitioners and by an announcement in a 
popular family magazine in 1997. In this analysis 55 of the families were of Caucasian origin 
and 17 were from other backgrounds including Turkey, Morocco, the Philippines and 
Surinam. Mierosatellite markers were used to genotype the regions (D8S 1132, DSS592, 
D8S 1179, D20S 1085 and D20S 171). A multipoint sib-pair analysis was performed using the 
'dominance variance' option. \Ve found no significant linkage between febrile seizures and 
the loci studied. The maximum average number of alleles shared between affected siblings 
was 68% on chromosome 20q in the non-Caucasian population. This result may be considered 
only a slight, non-significant suggestion for linkage to this chromosome. In the Caucasian 
families the percentage alleles :;;hared remained close to 50%. An exception was shown by the 
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analysis of chromosome 8q (58%), which was also shown by the overall analysis. An 
additional exclusion analysis performed in the Caucasian families showed that linkage of 
febrile seizures to chromosome 20q and 8q is very unlikely in this sample. 
In chapter 7 we aimed to assess the quality of the informed consent process, \Ve sent a 
questionnaire to the parents of the children who participated in the randomised controlled trial 
presented in chapter 4. Some results of this mailed questionnaire were presented in chapter 
3. The sociodcmographic status of the responding parents was similar to the Dutch national 
distribution. On average 73% of them were aware of the major study characteristics. Their 
reasons for granting approval were contribution to clinical science (51 %) and the benefit of 
their child (32%). Their perception of the informed consent procedure in the outpatients' 
clinic for children with febrile seizures was also assessed: 89% felt positive but 25% felt also 
obliged to participate. The parents experienced the investigator being on call 24 hours a day 
(38%) and the extra medical care and information (37%) as advantages of participation. 
Disadvantages were mainly the time consuming aspects and the hassle factor (23%). 
Interestingly, 60% of the parents were willing to participate in future studies, mainly to 
contribute to clinical science (24%) and for the benefit of their child and other children (18%). 
In chapter 8 we discuss the results of the previous chapters in the light of the literature. \Ve 
present the conclusions for the laboratory diagnostics, treatment, prognosis and parental 
experience of febrile seizures and conclusions about the informed consent procedure in the 
randomised clinical trial. 
\Ve confirmed that routine testing of sodium, calcium and glucose is not indicated. Two 
specific conditions in which a glucose test is indicated have been given by the international 
guidelines: a still convulsing child and a prolonged postictal period. The score chart that we 
constructed is an additional tool to a carefully performed patient history and physical 
examination. It may help to decide if a biochemical test is indicated for the individual patient. 
In children with a low probability of a normal result as calculated by the score chart the test 
may be indicated. Increased peripheral leukocyte counts should not be misinterpreted as 
related to the seizure duration. In children with febrile seizures leukocyte counts should be 
lIsed to evaluate the underlying cause of the fever. 
Parental fear of fever and febrile seizures is a major problem. We suggest that information 
about fever and febrlle seizures should be provided to all parents preferably during their 
contact with preventive health care providers. Parents of children with a non-West European 
background need information which is tailored to their language and culture. 
\Ve found no evidence that ibuprofen 5 mg per kg per six-hourly dose administered during 
fever in children with febrile seizures prevents recurrent seizures. We found similar results if 
we limited the analysis to those events which occurred in the context of study medication 
compliance (,per-protocol analysis'). Further studies may reveal whether this is due to the 
inefficacy of ibuprofen to reduce fever in those fever episodes in which a recurrence occurs, 
Antipyretics may be given during a febrile illness to make the child feel more comfortable. 
Consultation should emphasise the generally benign character of febrile seizures. 
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Based on the studies of risk factors for febrile seizure recurrence which have been performed 
until now the following factors may be described as important: young age at the initial seizure, 
family history of febrile seizures, low temperature at the initial seizure, muHiple type initial 
febrile seizure and short period of fever before the initial seizure. In addition to these 
previously established risk factors prediction of recurrence may be more concise using the 
number of fever episodes and the age and temperature at onset of subsequent fever episodes. 
These factors may provide further suggestions for the hypothesis of a 'temperature threshold' 
in the pathophysiology of febrile seizures. 
The familial type of febrile seizures is not likely to be associated with complex characteristics 
of the initial febrile seizure. Complex seizure characteristics may not be helpful in the 
distinction of phenotype subgroups for genetic studies of febrile seizures. We did not find 
evidence for linkage of febrile seizures to chromosome 8q and 20q. Further searching of the 
genome is necessary to localise the genes predisposing for febrile seizures. Localising genes 
for febrile seizures may not result in direct implicalions for preventive treatment. Insight into 
the pathophysiologic basis, however, Illay become available. This can help us to improve our 
understanding of febrile seizures and seizure disorders in generaL 
The informed consent procedure which we have studied functions adequately. Suggestions for 
improving the procedure are presented. Extra attention and information to non-west-European 
parents are necessary to improve parental understanding of the study involved. The main 
motive for parents to be willing to participate is the wish to contribute to clinical science . 
. Measures should be taken to avoid parents feeling obliged to participate. The issue in the 
discussion about whether or not to permit clinical research in young children is the possible 
benefit for the individual child. It might be suggested that studies in children without an 
individual benet1t should be permitted provided that some criteria are met, including parental 
informed consent. Ethical uncertainties of being treating physician and investigator are 
discussed. We think that separation of these two functions is usually not necessary. 
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Samenvatting 
Dit proefschrift bcschrijft kHnisch en genetisch onderzoek bij kinderen met koortsconVlllsies. 
Sinds 1988 worden koortsconvulsies prospectief geregistreerd op de afdeling 
Kindcrgeneeskunde van het Sophia Kinderziekenhuis Rotterdam, Vanaf 1994 vindt eveneens 
registratie plaats op de afdeling Kindergeneeskunde van het Juliana Kinderziekenhuis Den 
Haag. In beide ziekenhllizen wordt voar het vervolgen vall de kindercn met koortsconvulsies 
cen speciaal spreekuuf gehoudcn. 
In hoofdstuk 1 wordt cen overzicht gegeven van de Iiteratuur met betrekking tot klinische en 
genetische aspecten van koortsconvulsies. Koortsconvulsies is cell frequent voorkomendc 
aandoening op de kinderleeftijd. De aanvallen treden op bij kinderen in de leeftijd van 3 
rnaanden tot 5 jaar, in associatie met een koortsende ziekte, zonder dat er een onderliggend 
lijden voor de aanval is. De prognose van koortsconvulsies is zeer gunstig. Voor de auders is 
het meemaken van een koortsconvulsie eehter een buitengewoon angstwekkende ervaring, 
welke een aanzienlijke invloed kan hebben op het dagelijkse gezinsleven. 
Er is uitgebreid onderzoek gedaan naar risicofactoren voor het optreden van recidief 
koortseonvulsies. De belangrijkste factoren zijn: het doannaken van de iniW:He 
koartsconvulsie op jonge leeftijd, een positieve familie-anamncse, het optredcn van een 
iniW~lc koortsconvulsie bij eell rclatief lage temperatuuf, en een multipele initiele 
koortsconvulsie. Het behandelen van koortseollvulsies met anti-epileptiea om recidief 
koortsconvulsies te voorkomen staat ter discussie, omdat een gunstig effect niet duidclijk is 
aangetoond en het fisico op negatieve effecten tamelijk groot is. Intermitterendc behandeling 
met diazepam heeft de kuns op negatieve effecten verminderd, maar de resultaten over de 
effectiviteif ervan zijn eehter niet eenduidig. Dit is waarsehijnlijk mede het gevolg van het 
frequent optreden van recidief koortsconvulsies als eerste verschijllsel van eell koortsende 
ziekte. De mogelijkheid am met antipyretica recidief koortsconvulsies te voorkomen is oak 
onderzoeht. Geen van deze studies was gerandomiseerd, placebo-gecontroleerd en met een 
gestandaardiseerde antipyretische dosering, zodat de betekenis van de resultaten moeilijk vast 
te stellen is. 
De palhofysiologie van kOOltsconvulsies is nag steeds onbekend. Klinisehe studies hebben 
aanwijzingen gegeven voor een genetische basis. De differentiatie van koortsconvulsies in 
versehillende fenotype-subgroepen zou kunnen bijdragen aan het lokaliseren van 
predisponerende genen. Een voorbeeld hiervan is het fenotype van frequent optredende 
recidief koortsconvulsies, waarvoor een duideJijke familiaire predispositie bestaat. Tot Ill! toe 
is de lokalisatie van genen die betrokken zijn bij het ontstaan van koortsconvulsies nag niel 
sueeesvol gebleken. 
De discussie over de ethiek van klinisch wetensehappelijk onderzoek bij kinderen heeft veel 
stof doen opwaaien. Kennis over de beweegredenen van ouders om hun kind mee te laten 
doen aan klinisch onderzoek, en over de manier waarop zij het meedoen aan onderzoek 
ervaren, kan worden besehouwd als een bijdrage aan deze diseussie. Bovendien kan deze 
kennis ook van be lang zijn voor het verbeteren van de kwaliteit van het onderzoek zeIf. 
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In hoofdstuk 2.1 wordt een predictiemodel beschreven, dat kan worden gebruikt am te 
schatten hoe groot de kans is op een normale biochemie-testuitslag bij kinderen die zich 
presenteren met een convulsie bij koorts. De modellen zijn gcbaseerd op verschi1lende 
combinaties van klinische karakteristieken van de anamncse en het lichameIijk onderzoek van 
203 kinderen. Deze kinderen hebben vanwege een convulsie bij koorts het Sophia 
Kinderziekenhuis Rotterdam bezocht in de periode 1990-1992. Bij 115 (68%) van de kinderell 
wcrd een Bonnaal natriumgehaite in het bloed gevonden, bij 149 (89%) werd cell normaal 
calcium gevonden, en bij 173 (100%) werd cen normaal glucose gevonden. De prevalentie 
van afwijkende testuitslagen was tamelijk laag en de gevonden afwijkingen waren mild. Met 
logistische regressie werden normale testuitslagen gerelateerd aan de klinische 
karakteristieken. Hel discriminerend vennogen van de modellen was 'matig' (ROC tussell 
0.63 en 0.66). 
Hoofdstuk 2.2 geeft de resultaten weer van het onderzoek l1aar de diagl10stische waarde van 
het leukocytengetal bij kinderen met koortscol1vulsies. Dezelfde data set werd gebmikt als 
beschreven in hoofdstuk 2.1. Er werd geen duideJijk verband gevonden tussen duur van de 
convulsie en Ieukocytose van het perifere bloed (;0, 15.0* 10' cellenll). 
Hoofdstuk 3 richt zich op de vraag hoe ouders koorts en koortsconvulsies beleven en hoe 
groot hun kennis hierover is. \Vij hebben cell enquete-onderzoek gedaan bij de ouders van de 
kinderen die hebben meegedaan aan de gerandomiseerde gecontroleerde studie beschreven in 
hoofdstuk 4. Van aile 181 responderende ouders was 45% bang of erg bang voor koorts. 
Angst voor koorts was duidelijk geassocieerd met de angst voor recidief koortsconvulsies. 
Ouders van kinderen met een niet-\Vcsteuropese afkomst hadden relaticf meer angst. Het 
mcemaken van cen koortsconvulsie bij een kind is een zeer angstwekkende crvaring voor 
ouders. Een meerdcrheid dacht dat koortsconvulsies schadelijk waren, omdat het er zo 
gevaarlijk uitziet. Van aile ouders dacht 47% dat het kind stervend was op het moment dat het 
de eerste koortsconvuIsie kreeg. Frequent meten van de tcmperatuur (25% van de ouders meet 
vijf keer of vaker per dag), in dezelfde kamer slapen als het kind (24%) en's nachts wakker 
blijven (13%) als het kind koorts heeft zijn mogclijke gevolgen van de angst van ouders. 
Gemststellcnde informatie over koorts en koortsconvulsies kan helpen: 21% van de ouders 
gaf aan als gevolg vail de informatie die zij hadden gekregen, koortsconvulsies niet meer als 
schadelijk te beschollwen. 
In hoofdstuk 4 worden de resultaten gepresenteerd van de gerandomiscerde, placebo-
gecontroleerde stlldie naar de cffectiviteit van ibuprofen om recidief koortsconvulsies te 
voorkomen. Aan deze studie namen 230 kinderen dee I. Zij bezochten tussen 1994 en 1996 cell 
van de twee ziekenhuizen in verband met cen koortsconvulsie. Deze kindcrcn waren 1 tot 4 
jaar oud en hadden een of meer risicofactoren voor recidief koortsconvulsies. Zij werden 
gerandomiseerd voor ibuprofen siroop 5 mg per kg liehaamsgewicht per dosis a 6 um (111 
kinderen) of placebo (119 kinderen), toe te dienen bij koorts. De mediane follow-up tijd in 
beide groepen was ongeveer 1 jaar. De kans op een eerste recidief koortsconvulsie na 
randomisatie was 32% in de ibuprofen-groep en 39% in de placebo-groep (2 jaars Kaplan-
Meier %, p:::O.70). Cox regressie analyse Iiet zien dat de recidiefkans in de ibuprofen-greep 
0.9 (CI95% 0.6-1.5) maal de recidiefkans in de placebo-groep was (,intention-to-treat'). 
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Correctie yoor baseline kenl1lcrken veranderde deze uitkornst niet. Een 'per-protocol' analyse, 
waarin aileen die recidieven werden beschouwd welke optraden bij toediening van de 
studiemedicatie volgens het protocol, liet eveneens hetzelfde resultaat zien. 
Het doe I van hoofdstuk 5.1 was am de s3mcnhang te bepalen tussell het aantal 
koortsperiodcn dat cen kind doormaakt en het optreden van recidief koortsconvulsics. Daarom 
werd een follow-up studie gedaan van 6 maanden bij 155 kinderen in de lceftijd tussell 3 
maanden en 5 jaar. Deze kinderen hadden aile een of meerdere koortsconvulsies doorgemaakt. 
Voar deze studie werden de data gebruikt van 89 kinderen die hadden meegedaan aan de 
gerandomiseerde gecontroleerde studie (hoofdstuk 4), De andere 66 kinderen werden later 
geYncludeerd; zij hadden in verband met een koortsconvulsie een van beide ziekenhuizen 
bezocht in 1996 of 1997, Het optreden van koortsperioden en koortsconvulsies werd 
prospectief gedocumenteerd. Met logistische regressie analyse onderzochten wij de associatie 
tUssell de baseline kenmerken en het aantal koortsperioden, en de uitkomst: een recidief 
koortsconvulsie. Er werden in de 6 maanden follow-up 260 koortsperioden geregistreerd, 
waarbij 29 kinderen een of meer recidief koortsconvulsies doormaakten, Twee factoren waren 
geassocieerd met het optreden Van recidief koortsconvulsies: aantal koortsperioden (OR=1.8 
per koorlsperiode) en leeflijd aan hel begin van de sindie (OR=O.6 per jaar onder). Hel aanlal 
koortsperiocien bleef significant in een multivariabel model. 
In hoofdstuk 5.2 wordt de predictie van recidief koortsconvulsies in opeenvolgende 
koortsperioden beschreven. \Vij bestudeerden de data van de temperaturen, de recidief 
koortsconvulsies en baseline patientkarakteristicken welke werden verzamcld voor de 
gerandomiseerde, gecontroleerde studie beschreven in hoofdstuk 4. Van aIle kinderen hadden 
182 minimaal een koortsperiode tijdens follow-up, Er werden 509 koortsperiodcn 
geregistreerd met 67 recidief koortsconvulsies, Dc helft van de recidieven trad op in de eerste 
twee uur na het begin van de koorts. Deze recidieven gingen gepaard met een lagere mediane 
temperatuur (39,3 °C) vergeleken met de recidieven die optraden na twee um koorts (40,0 °C, 
p<O,OOI). Multivariabele Poisson regressie analyse toonde twee voorspellers voor recidief 
koortsconvulsies in opeenvolgende koortsperioden aan: leeftijd aan het begin van de 
koortsperiode (RR=0,7 per jaar ouder), en temperatum aan het begin van de koortsperiode 
(RR=1.7 per graad hoger), \Vanneer tevens de temperatuur aan het begin van iedere 6-uurs 
peri ode werd beschouwd resulteerde dit in een bet ere voorspelling. Met behulp van het 
gepresenteerde diagram kan, als de leeftijd van het kind en de temperatuur aan het begin van 
de koortsperiode bekend is, gemakkelijk het recidief fisko worden bepaald, 
Hel doel van hel onderzoek dal wordl beschreven in hoofds!uk 6.1 was om Ie bepalen of 
familiaire koortsconvulsies geassocieerd zjjn met complexe kenmerken van de initiele 
koortsconvulsie. Een subgroep van cen bepaald familiair fenotype kan van belang zijn om de 
lokalisatie te bestudercn van genen die predisponeren voor koortsconvulsies, In dit onderzoek 
werd de ti·equentie van complexe kenmerken van de initiele koortsconvulsie van 51 
Kaukasische kinderen met cen positieve eerstegraads familie-anamnese voor koortsconvulsies 
en 177 kinderen zonder cell aangedaan eerstegraads familielid met elkaar vergeleken, Aile 
kinderen hadden een van beide deelnemende ziekenhuizen bezocht in verband met een 
koortsconvulsie in de peri ode 1994-1996. Met behulp van logistische regressie analyse kon 
geen verschil in frequentie van complexe kenmerken worden aangetoond, 
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Hoofdstuk 6.2 presenteert eell 'affected sib-pair' analy:;;e van koortsconvulsies. Een rccentc 
studie Iaat zien dat er mogeJijk linkage van koortsconvulsies is met markers op chromosoom 
8q. Chromosoom 20q en 8q zijn belangrijk gebleken bij Benigne Familiaire Neonatale 
COllvuisies (BFNC). Beide loci zijn interessante kandidaat regio's voor koortsconvulsies in de 
algemene bevolking, vanwege de klinische associatie tussen BFNC en koortsconvulsies. Met 
behulp van polymorfe markers, welke diehtbij de loci op chromosoom 20q en 8q Iiggen, we I'd 
het erfelijk materiaal van 72 sib-pairs met koortsconvulsies bestudeerd. De meerderheid van 
de sib-pairs had het Sophia Kinderziekenhuis Rotterdam bezocht tussen 1988 en 1997 of het 
Juliana Kinderziekenhuis Den Haag tussen 1992 en 1997. De overige kinderen dcden aan het 
onderzoek mee via kinderartsen en huisartsen uit de regio en met behulp van een oproep in 
een populair tijd:;;chrift voorjonge gezinnen in 1997. Van de deelnemende families waren 55 
van Kaukasische origine en 17 families hadden een andere afkomst: Turkije, Marokko, de 
Filippijnen en Suriname. Voor de genotypering werden de volgende markers gebruikt: 
D8S 1132, D8S592, D8S 1179, D20S 1 085 en D20S 171. Bij de multipoint sib-pair analyse met 
aanname van 'dominance variance' werd geen linkage gevonden van koortsconvulsies met de 
bestudeerde loci. Het gemiddelde aantal allelen dat beide siblings overcenkomstig had was 
maximaal 68% op chromosoom 20q in de niet-Kaukasische populatie. Dit resultaat mag ten 
hoogste worden beschouwd als een zwakke, niet-significante aanwijzing voor linkage met dit 
chromosoom. In de Kaukasische families bleef het percentage overeenkomstige allelen dicht 
bij de 50%, met als enige uitzondering 58% bij chromosoom 8q. Dit percentage werd oak in 
de volledige analyse gezien. Ais aanvulling werd in de Kaukasische families een exclusie-
analyse verricht, welke liet zien dat in deze onderzoekspopulatie linkage van koortsconvulsies 
met chromosoom 20q en 8q erg onwaarschijnlijk is. 
In hoofdslllk 7 wordt het onderzoek besproken naar de kwaliteit van de 
toestemmingsprocedure. Wij stuurden een vragenlijst naar de ouders van de kinderen die 
hadden meegedaan aan de gerandomiseerde gecontroleerde studie beschreven in hoofdstul{ 4. 
Een deel van de resultaten van deze enquete wordt beschreven in hoofdstuk 3. De 
sociodemografische status van de responderende ouders was vergelijkbaar met die van de 
verdeling in de Nederlandse bevolking. Gemiddeld was 73% van de auders op de hoogte van 
de belangrijkste kenmerken van de studie. Hun beweegredenen om toestemming te gcven 
waren: een bijdrage willenleveren aan de medische wetenschap (51%), en het voordeel voor 
hun kind (32%). \Vij vroegen ook naar hun beleving van de toestenullingsprocedure op het 
speciale sprcekuur voor kinderen met koortsconvulsies: 89% heef dit als positief ervarcn, 
maar 25% van de ouders had zich ook verplicht gevocld om mee tc doell. Als voordeel van 
het meedoen aan de studie werd genoemd dat de onderzoeker 24 UUl' per dag bereikbaar was 
(38%), en de extra medische zarg en infonnatie (37%). Nadclen waren voornamelijk die 
onderdelen van de shldie die tijd en aandacht kostten (23%). lnteressant was dat 60% van de 
ouders opnieuw zou willen meewerken aan cell vcrgelijkbaar ondcrzoek in de toekomst, met 
als belangrijkste reden een bijdrage te willen leveren aan de medische wetenschap (24%) en 
het voordecl voor hun eigen kind en andere kinderen (18%). 
In hoofdstuk 8 worden de resultaten besproken in het licht van de literatuur. De conclusies 
voor laboratoriumdiagnostiek, behandeling en prognose worden gepresenteerd. Ook worden 
de conclusies van het onderzoek naar de beleving van ouders van koortsconvulsies en van het 
onderzoek naar de toestcmmingsprocedure in de gerandomiseerde gecontroleerde studie 
besproken. 
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\Vij hebben bevestigd dal routinematige bepaling van natrium, calcium en glucose nict nodig 
is. Twee specifieke indicaties waarvoor cen glucose bepaling ge"lndiceerd zijn worden gegeven 
in de internationale richtlijnen: cen kind dat bij binnenkomst nog convulsief is, en cen lange 
postictale peri ode. He! scorings-diagram is cen extra hulpmiddel bij cen nauwkeurige 
anamnese en Iichamelijk onderzoek. Bij de individuele patient kan het behulpzaam zijn bij de 
afweging of een biochemisch bloedonderzoek gei'ndiceerd is. Bij killdercil met cell lage kuns 
op cell normale testuitslag, berekend met het searings-diagram, kan de bepaling gClndiccerd 
zijn. Een verhoogd Icukocytengetal moel niet verkeerd geYnterpreteerd worden als een gevolg 
van de duur van de convulsie. Bij kinderen met koortsconvulsies kan de bepaling van het 
aantal leukocyten aileen gebruikt worden om de onderliggende oorzaak van de koorts vast te 
slelien. 
Angst van ouders voor koorts en koortsconvulsies is een belangrijk probleem. Informatie over 
koorts en koortsconvulsies zou 1110eten worden gegeven aan aIle ouders, bij voorkeur tijdens 
hun contact met de preventieve gezondheidszorg. Ouders van kinderen met eell niet-
\Vesteuropese afkamst hebben informatie nodig, welke speciaal is toegesneden op hun eigen 
taal en cultuur. 
Wij vanden geen aanwlJzlIlgen voor een preventief effect op recidief koortsconvulsies van 
ibuprofen 5 rug per kg per dosis, bij koarts toegediend om de zes um, bij kinderen met 
koortsconvulsies. Vergelijkbare resultaten werden gevonden wanneel' de analyse werd bepel'kt 
tot die recidieven, welke optraden bij gebmik van de studieruedicatie volgens het protocol 
('per-protocol analyse'). VerdeI' onderzoek zou kunnen aantonen of dit veroorzaakt wordt 
door de ineffectiviteit van ibuprofen 0111 de koorts te verlagen in die koortsperioden, waarin 
een recidief koorlsconvulsie optreedt. Voor het comfort van het kind kunnen bij een 
koortsende ziekte antipyretica worden gegeven. In het contact met de ouders zou de gunstige 
prognose van koorlsconvulsies benadrukt moeten worden. 
Gebaseerd op de studies naar de risicofactoren voor recidief koortsconvulsies die tot nu toe 
zijn gedaan, kunnen de volgcnde factoren als belangrijk worden beschouwd: het optl'eden van 
de initiele koortsconvulsie op jonge leeftijd, een positieve familie-anamnese voor 
koortscanvulsies, een relatief luge tempcratuur bij de initiele koortscollvulsie, een multipele 
initiele koortscol1vulsie, en een korte dum van de koorts voordat de initiele koortsconvulsie 
optreedt. In aanvulling op deze risicofactoren kan de voorspelling van een recidief 
koortsconvulsie verdeI' worden verbeterd, wanneer het aantal koortsperioden en de leeftijd en 
temperatuur aan het begin van de opeenvolgende koortsperioden ook in beschouwing wordt 
genomen. Deze faeloren kunnen bovendien als ondersteuning worden gczien voor de 
hypothese dat cr een 'temperatuUfsdrempel' bestaat in het ontstaansmechanisme van 
koortsconvulsies. 
Waarschijnlijk is het familiaire type van koortsconvulsies niet geassocieerd met complexe 
kenmerken van de initielc koortsconvulsie. Complexe kenmerken van de convulsic zijn 
waarschijnlijk niet zo beJangrijk bij het onderscheiden van fenotype subgroepen Vaal' 
genetisch onderzoek van koortsconvulsies. \Vij hebben geen aanwijzingen gevonden voor 
linkage van koortsconvulsies met ehromosoom 8q en 20q. Om de gcncn te lokaliseren die 
prcdisponeren voor koortsconvulsics is nader onderzoek van het genoom nodig. De lokalisatie 
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van deze genen heeft waarschijnlijk geen directe gevolgen voor preventieve behandeling, WeI 
kan inzicht in de pathofysiologie worden verkregen, wat een bijdrage kan leveren aan het 
vermeerderen van OIlze kennis over koortsconvulsies en convulsievc aandoeningen in het 
algemeen. 
De toestemmingsprocedurc die wij hebben bestudeerd functioneert voldoende, Om de 
procedure te verbeteren zijn enkele voorstellen gedaan. Extra aandacht en infonnatie aan niet-
\Vesteuropese ouders zijn nodig om te zorgen dat ouders de studie waarvoor hun toestemming 
wordt gevraagd betel' begrijpen, De belangrijkste beweegreden voor ouders om mee te doen is 
de wens om een bijdrage te willen leveren aan de medische wetenschap, Er zouden 
maatregelen genomen moeten worden om te vermijden dat ouders zich verpJicht voclen am 
deel te nemen, In de discussie over de toelaatbaarheid van klinisch onderzoek bij kinderen 
speelt het mogelijke belang dat het individuele kind bij deelname heef! een zeer belangrijke 
roL Gesteld kan worden dat onderzoek bij kinderen zonder een individueel be lang voor het 
kind toelaatbaar is, op voorwaarde dat voldaan wordt aan bepaalde criteria, zouls de 
toestemming van de ouders. Ethische dilemma's die zich kunnen voordoen wanneer een 
behandelend arts tegelijkertijd de functie van onderzoeker heeft worden besproken, Wij 
vinden dat scheiding van deze twee roIlen meestal niet noodzakelijk is, 
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